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  ;<=<=<;-.!$/$'-0',-&DE"#($?"%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-Jb 
  ;<=<=<=-84 +"4"'(0($&'-0',-&!/0'$10($&'-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-Jh 
  JGHGS "<<3!20+!-5& -7 ,!0;5-&+!2 +%&+ 2/!+%/!0 GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG HI 
  ;<=<B<;-F!",$#($?"-?0+)"%-&2-0-("%(-!"%)+(-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HJ 
  ;<=<B<=-G$H"+$6&&,-!0($&-&2-0-("%(-!"%)+(-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HS 
  ;<=<B<B-922$#$"'#>I-J&),"'-$',"KI-,$0/'&%($#-&,,%-!0($&-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-Hh 
  ;<=<B<C-A04 +"-%$1"-#0+#)+0($&' GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG Hf 
  ;<=<B<L-M!)"- !"?0+"'#"-"%($40($&' GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG SI 
  ;<=<B<N-O"("!4$'0($&'-&2-2$('"%%-2&!- )! &%"-&2-0-("%($'/-%(!0("/>-<<<<<<<<<<<<<<<<<<-SI 
  ;<=<B<P-8'("! !"(0($&'-&2-,$0/'&%($#- 0!04"("!%-0(-(6"-6"!,-+"?"+-<<<<<<<<<<<<<<<<<<<-SJ 
  ;<=<B<Q-8'("! !"(0($&'-&2-,$0/'&%($#- 0!04"("!%-@$(6- &&+",-%04 +"%-<<<<<<<<<<<<-Sh 
  ;<=<B<R-9?0+)0($&'-&2-4)+($ +"-("%($'/- "!2&!40'#"%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-RJ 
  ;<=<B<;S-T)!(6"!-0%%"%%4"'(%-&2-("%(-"22$#0#> GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG RR 
 
 JGS D57%2+!-(& '03*-5 "50%*!0 GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG Rh 
  ;<B<;-5$%(&!$#-0',-4&,"!'-#60++"'/"%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-Rh 
- - ;<B<=-.!/0'-&2-#6&$#"-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-gI 
- - ;<B<B-O"?"+& ",-8A3U-,$0/'&%($#-4"(6&,% GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG gg 
 A!!!
  ;<B<C-F0%(-"?0+)0($&'%-&2-8A3U-,$0/'&%($#-("%(% GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG gb 
 
 JGR >%+$-,-3-;4 +- %A03(0+% </%2!&!-5 -7 ,!2$-+-*-(& +%&+ GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG ge 
  ;<C<;-A(),>-,"%$/'-0',-0%%&#$0(",-D$0%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-gf 
- - ;<C<;<;-O"%$/'-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-gf 
- - ;<C<;<=-A04 +$'/-#&'%$,"!0($&'%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-bJ 
- - ;<C<;<=<;-V)4D"!-&2-%04 +"%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-bH 
- - ;<C<;<=<=-V0()!"-0',-&!$/$'-&2-%04 +"%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-bR 
- - ;<C<;<B-W$0%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-bb 
- - ;<C<=-3'0+>%$%-4"(6&,&+&/>-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-bb 
- - ;<C<=<;-3/!""4"'(- 0!04"("!%-7F!& &!($&'-&2-0/!""4"'(-X-Y0  0:-<<<<<<<<<-bh 
- - ;<C<=<=-A(0($%($#%-Z#V"40![%-X-A>44"(!>-X-Z0!/$'0+-,$%(!$D)($&'-<<<<<<<<<<<<-hJ 
 
 JGg >%+$-,-3-;4 +- %A03(0+% +/(%5%&& -7 ,!2$-+-*-(& +%&+ GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG hR 
  ;<L<;-A(),>-,"%$/'-0',-0%%&#$0(",-D$0%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-hg 
- - ;<L<;<;-O"%$/'-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-hb 
- - ;<L<;<=-A04 +$'/-#&'%$,"!0($&'%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-eb 
- - ;<L<;<=<;-V)4D"!-&2-%04 +"%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-eb 
- - ;<L<;<=<=-.!$/$'-&2-%04 +"%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-ef 
- - ;<L<;<B-.(6"!-0%%&#$0(",-D$0%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-fR 
- - ;<L<=-3'0+>%$%-4"(6&,&+&/>-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-fg 
- - ;<L<=<;-M!)"'"%%- 0!04"("!%-7OA"I-OA I-92I-¥I-O.]:-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-fg 
- - ;<L<=<=-9%($40($&'- !&#",)!"-@$(6&)(-0-/&+,-%(0',0!,-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-fh 
- - ;<L<=<=<;-^%$'/-0'-$4 "!2"#(-%(0',0!,-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-fh 
- - ;<L<=<=<=-*$(6&)(-!"2"!"'#"-%(0',0!, GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG ff-
 
 JGb #$%&!& 80+!-503%Q 102+-/& 077%2+!5; ,!0;5-&+!2 022(/024 GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG JIH 
 
 JGh #$%&!& -)_%2+!A%& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG JIg 
 
 JGe 8%7%/%52%& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG JIb 
 
DDG #8":D#D^T"M :B'E8D6#D?B "T"MU'D' "T: T^?BM ?D'@"M 
8B68B'BT#"#D^T ^1 :D".T^'#DE 8B6B"#"LDMD#U "T: 
8B68^:@EDLDMD#UQ "66MDE"#D^T #^ "T DT1BE#D^@' '"M>^T 
"T"B>D" ?D8@' 8#V6E8 "''"U 
 
 ")&+/02+ GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG GJHI 
  
 HGJ D5+/-,(2+!-5 GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG JHJ 
- - =<;<;-M!0,$($&'0+-"?0+)0($&'-&2-,$0/'&%($#- !"#$%$&'-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JHJ 
- - =<;<=-V&?"+-0  !&0#6-(&-,$0/'&%($#- !"#$%$&'I-$'% $!",-D>- 6>+&/"'"($#%-<<<<<<<<<<-JHH 
- - =<;<B-8'2"#($&)%-%0+4&'-0'0"4$0-?$!)%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JHS 
- - =<;<C-]" "0(0D$+$(>-0',-!" !&,)#$D$+$(>-&2-(6"-8A3U-]M_F`]-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JHR 
- - =<;<L-.DE"#($?"%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JHR 
 
 !O
 HGH >0+%/!03& 05, >%+$-,& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG JHg 
  =<=<;-A(),>-40("!$0+-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JHg-
- - =<=<;<;-A04 +"-%"+"#($&'-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JHg-
- - =<=<;<=-A04 +"-0++&#0($&'-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JHb-
- - =<=<=-M"%($'/- !&(&#&+-7]M_F`]:-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JHe-
- - =<=<B-A(0($%($#0+-3'0+>%$%--<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JHf-
- - =<=<B<;-O"%#!$ ($?"-A(0($%($#%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JHf-
- - =<=<B<=-O$%(0'#"-40(!$K-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JSJ-
- - =<=<C-M"%(-!)'- 6>+&/!04-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JSJ-
- - =<=<C<;-F%"),&/&+,-%(0',0!,-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JSJ-
- - =<=<C<=-3+$/'4"'(-2&!40(($'/-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JSS-
- - =<=<C<B-O$%(0'#"_40(!$K-D0%",-(!""-!"#&'%(!)#($&'-4&,"+-<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JSS-
 
 HGS 8%&(3+& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG JSR 
  =<B<;-O"%#!$ ($?"-A(0($%($#%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JSR-
- - =<B<=-M"%(-!)'%- 6>+&/!04-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JSb 
  
 HGR :!&2(&&!-5 GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG JRH 
  =<C<;-T&!40+-,"%#!$ ($?"-0'0+>%$%-&2-0/!""4"'(-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JRH-
- - =<C<;<;-]" "0(0D$+$(>-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JRH-
- - =<C<;<=-]" !&,)#$D$+$(>-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JRR-
- - =<C<=-5&4&/"'$10($&'-"22"#(-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JRb-
- - =<C<B-V&?"+-,"%#!$ ($?"-0'0+>%$%-&2-0/!""4"'(-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JRe-
- - =<C<B<;-M"%(-!"%)+(-0+$/'4"'(-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JRe-
- - =<C<B<=-M"%(-!)'%- 6>+&/!04-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JRf-
 
 HGg E-523(&!-5& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG JgH 
 
 HGb 8%7%/%52%& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG JgS 
 
DDDG " >^:BMMDT. "668^"E= #^ 68B:DE# #=B ?"8D"#D^T ^1 
8B6B"#"LDMD#U "T: 8B68^:@EDLDMD#U ^1 "T DT1BE#D^@' 
'"M>^T "T"B>D" ?D8@' 8#V6E8 "''"U "E8^'' DT1BE#D^T 
68B?"MBTEB' "T: DT1BE#D^T '#".B' 
 
 ")&+/02+ GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG GJgg 
  
 SGJ D5+/-,(2+!-5 GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG Jgb 
- - B<;<;-O$0/'&%($#- !"#$%$&'-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-Jgb-
- - B<;<=-O$0/'&%($#-0/!""4"'(-!"+0($?$(>-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-Jgh-
- - B<;<B-8A3U-]M_F`]-!" "0(0D$+$(>-0',-!" !&,)#$D$+$(>-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-Jgf-
- - B<;<C-A(),>-&DE"#($?"%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JbJ-
 
 SGH >0+%/!03& 05, >%+$-,& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG JbH 
  B<=<;-O0(0I-#&4 +"4"'(0!>-("%($'/I-0',-0- %"),&/&+,-%(0',0!,-<<<<<<<<<<<<<<<<<<<<<<<<-JbH-
- - B<=<;<;-O0(0-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JbH-
 O
- - B<=<;<=-`&4 +"4"'(0!>-("%($'/-7a]M_F`]:-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JbH-
- - B<=<;<B-F%"),&/&+,-%(0',0!,-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JbS-
- - B<=<=-Z)+($+"?"+-+&/$%($#-4&,"+%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-Jbb-
- - B<=<=<;-O0(0-6$"!0!#6>-0',-4&,"+-#&'%(!)#($&'--<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-Jbb-
- - B<=<=<=-W0>"%$0'-0'0+>%$%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-Jbe-
- - B<=<B-3/!""4"'(-#&4 )(0($&'-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-Jbf-
- - B<=<B<;-9%($40(",-0/!""4"'(-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JhI-
- - B<=<B<=-`60'#"-0/!""4"'(-0',-`&6"'b%-H0  0-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JhH-
- - B<=<C-3+("!'0($?"-0  !&0#6-(&-4&,"++$'/-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JhS-
- - B<=<L-3/!""4"'(-/!0 6$#0+-!" !"%"'(0($&'-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JhR-
 
 SGS 8%&(3+& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG JhR 
  B<B<;-F%"),&/&+,-%(0',0!,-0',-&D%"!?",-?0+)"%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JhR -
- - B<B<=-Z)+($+"?"+-+&/$%($#-4&,"+%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JhR-
- - B<B<=<;-V&'_$'2"#(",-%0+4&'-4&,"+-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-Jhe-
- - B<B<=<=-G&@_$'2"#(",-%0+4&'-4&,"+-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-Jhe-
- - B<B<=<B-5$/6_$'2"#(",-%0+4&'-4&,"+-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-Jhf-
- - B<B<B-3/!""4"'(- !",$#($&'-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-Jhf-
- - B<B<B<;-9%($40(",-0/!""4"'(-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-Jhf-
- - B<B<B<=-`60'#"-0/!""4"'(-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JeJ-
- - B<B<B<B-Y0  0-?0+)"%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JeS-
- - B<B<C-3+("!'0($?"-"%($40($&'-(&-4&,"+$'/ GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG Jeg 
 
 SGR :!&2(&&!-5 GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG Jeg 
  B<C<;-O" "',"'#"-&2-!" "0(0D$+$(>-0',-!" !&,)#$D$+$(>-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-Jeg--
- - B<C<;<;-O" "',"'#"-&'-6&4&/"'$10($&'-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-Jeh-
- - B<C<;<=-O" "',"'#"-&'- !&#"%%$'/-+0D&!0(&!>-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-Jee-
- - B<C<;<B-O" "',"'#"-&'-$'2"#($&'- !"?0+"'#"-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JfI-
- - B<C<;<C-O" "',"'#"-&'- !& &!($&'-&2-$'2"#($&'-%(0/"%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JfH-
- - B<C<=-U0+$,$(>-&2-(6"-4&,"++$'/-0  !&0#6-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-JfS-
- - B<C<=<;-`&4 0!$%&'-@$(6-&D%"!?",-0',-,"%#!$ ($?"-"%($40("%-<<<<<<<<<<<<<<<<<<<<<<-JfR-
- - B<C<=<=-A"'%$($?$(>-&2- !",$#($&'-(&-(6"- %"),&/&+,-%(0',0!,-,"2$'$($&'-<<<<<<<<-Jfg-
- - B<C<=<B-O" "',"'#"-&2-,$0/'&%($#-%"'%$($?$(>-0',-% "#$2$#$(>-&'-
$'2"#($&'- !"?0+"'#"-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-Jfb-
 
 SGg E-523(&!-5& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG Jfh 
 
 SGb 8%7%/%52%& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG Jfe 
 
D?G @'B ^1 " #=D8: EM"'' DT M"#BT# EM"'' >^:BMMDT. 1^8 
:D".T^'#DE #B'# B?"M@"#D^TQ "66MDE"#D^T #^ #=B 
B?"M@"#D^T ^1 1D?B DT1BE#D^@' '"M>^T "T"B>D" ?D8@' 
:B#BE#D^T "''"U' 
 
 ")&+/02+ GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG GHII 
  
 O!
 RGJ D5+/-,(2+!-5 GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG HIJ 
- - C<;<;-G0("'(-`+0%%-Z&,"++$'/-2&!-,$0/'&%($#-"?0+)0($&'-0',-)',"!+>$'/-
0%%)4 ($&'%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HIJ-
- - C<;<=-U0+$,$(>-&2-(6"-("%(-$'," "',"'#"-#&',$($&'0+-&'-(6"-
$'2"#($&'X,$%"0%"-%(0()%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HIH-
- - C<;<B-U0+$,$(>-&2-(6"-0%%)4 ($&'-&2-#&'%(0'(-#+0%%$2$#0($&'-0#!&%%-
 & )+0($&'%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HIS-
- - C<;<C-3  +$#0($&'-&2-G`Z-(&-$'2"#($&)%-%0+4&'-0'0"4$0-?$!)%-,"("#($&'-<<<<<<<<<<<-HIg-
- - C<;<L-.DE"#($?"%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HIb-
 
 RGH >0+%/!03& 05, >%+$-,& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG HIe 
  C<=<;-M0!/"(-0',-%(),>- & )+0($&'%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HIe -
- - C<=<=-A)DE"#(-!"#!)$(4"'(-0',-%04 +"-#&++"#($&'-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HIf-
- - C<=<B-O0(0-#&++"#($&'-0',-40'0/"4"'(-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HJI-
- - C<=<B<;-M"%($'/- !&(&#&+%-0',-$'("! !"(0($&'-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HJI-
- - C<=<B<;<;-]M_F`]-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HJI-
- - C<=<B<;<=-a]M_F`]-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HJH-
- - C<=<B<;<B-U$!)%-$%&+0($&'-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HJH -
- - C<=<B<;<C-8',$!"#(-2+)&!"%#"'(-0'($D&,>-("%(-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HJS--
- - C<=<B<;<L-G0("!0+-2+&@-$44)'&0%%0>-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HJR-
- - C<=<B<=-O0(0-0+$/'4"'(-0',-("%(-0/!""4"'(-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HJR-
- - C<=<B<B-A)% "#(",-#&',$($&'0+-," "',"'#"-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HJg-
- - C<=<C-G0("'(-`+0%%-Z&,"++$'/-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HJg-
- - C<=<C<;-F0!04"("!%-0',-$,"'($2$0D$+$(>-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HJg-
- - C<=<C<=-F!$&!-$'2&!40($&'-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HJh-
- - C<=<C<B-Z&,"+-!"2$'"4"'(-2&!-#&',$($&'0+-," "',"'#"-04&'/-("%(%-<<<<<<<<<<<<<<-HJe-
- - C<=<C<C-3%%"%%4"'(-&2-Z`Z`-#60$'%-#&'?"!/"'#"-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HJf-
- - C<=<C<L-Z&,"+-?0+$,$(>-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HHI-
 
 RGS 8%&(3+& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG HHJ 
  C<B<;-M"%(-!"%)+(-0+$/'4"'(-0',-0/!""4"'(-(!""-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HHJ-
- - C<B<=-Z&,"+-D)$+,$'/-0',-!"2$'"4"'(-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HHg-
- - C<B<B-T$'0+-(6!""_#+0%%-G`Z-7BG`Z:-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HHg-
- - C<B<C-A"'%$($?$(>-0'0+>%"% GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG HSI 
 
 RGR :!&2(&&!-5 GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG HSh 
  C<C<;-U0+$,$(>-&2-(6"-4&,"+-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HSh-
- - C<C<=-8'("! !"(0($&'-&2-(6"-(6$!,-#+0%%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HSf-
- - C<C<B-F0%(-"?0+)0($&'%-0',-$'("! !"(0($&'-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HRg-
 
 RGg E-523(&!-5& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG HRh 
 
 RGb 8%7%/%52%& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG HRf 
 
 O!! 
?G 'BMBE#D^T ^1 " E@#6^DT# ?"M@B 1^8 8B"MV#D>B 6E8 8B'@M#' 
#^ 1D# " :D".T^'#DE 6@86^'BQ "T"MU#DE"M "T: 
B6D:B>D^M^.DE"M "668^"E=B' 
 
 ")&+/02+ GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG GHgS 
  
 gGJ D5+/-,(2+!-5 GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG HgR 
- - -
 gGH B*<!/!203 _(&+!7!20+!-5& -7 2(+<-!5+& 7-/ /%03V+!*% 6E8 0&&04 GGGGGGGGGGGGGGGGGGGGGGGGGGGG Hge 
  L<=<;-¥)%($2$#0($&'%-0',-%"+"#($&'-&2-#)( &$'(-0(-(6"-cD"'#6d-+"?"+--<<<<<<<<<<<<<<<<<<<<-Hge-
- - L<=<;<;-T+)&!"%#"'#"-%$/'0+-(6!"%6&+,-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-Hge-
- - L<=<;<=-G$4$(",-')4D"!-&2-#>#+"-704 +$2$#0($&'-"22$#0#>:-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-Hgf-
- - L<=<;<B-`)( &$'(-0%-(6"-+$4$(-&2-,"("#($&'-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-Hgf-
- - L<=<;<C-8'?"%($/0($&'-&2-0!($20#()0+-!"%)+(%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HbS-
- - L<=<=-¥)%($2$#0($&'%-0',-%"+"#($&'-0(-(6"-c & )+0($&'d-+"?"+-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HbR-
- - L<=<=<;-M"%(-& "!0($'/-#60!0#("!$%($#%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HbR-
- - L<=<=<;<;-O$0/'&%($#-0##)!0#>-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HbR-
- - L<=<=<;<=-M@&_/!0 6-!"#"$?"!-& "!0($'/-#60!0#("!$%($#- +&(-<<<<<<<<<<<<<<<<<<<-Hbh-
- - L<=<=<=-Z$'$4$10($&'-&2-(6"- !&D0D$+$(>-&2-4$%#+0%%$2$#0($&'-<<<<<<<<<<<<<<<<<<<<<<<<<-Hbf-
- - L<=<=<=<;-F!&D0D$+$(>-&2-4$%#+0%%$2$#0($&'-/$?"'-(6"-6"0+(6-%(0()%-<<<<<<<<<<<-HhI-
- - L<=<=<=<=-A"+"#($&'-#&4 0!$'/-!0($&-&2-#&!!"#(-0',-$'#&!!"#(-
4$%#+0%%$2$#0($&'-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HhJ-
- - L<=<=<B-F!&D0D$+$(>-&2-4$%#+0%%$2$#0($&'-/$?"'-0-("%(-!"%)+(-<<<<<<<<<<<<<<<<<<<<<<<<<<<-HhS-
- - L<=<=<C-`&%(-&2-4$%#+0%%$2$#0($&'-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-Hhg-
- - L<=<=<C<;-O$22"!$'/-4$%#+0%%$2$#0($&'-#&%(%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-Hhg-
- - L<=<=<C<=-F0!($#)+0!-#0%"-&2-"a)0+-#&%(e-922$#$"'#><<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-Hhb-
 
 gGS D33(&+/0+!-5& C!+$ 05 0<<3!20+!-5 GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG Hhe 
  L<B<;-W0#H/!&)',-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-Hhe-
- - L<B<=-F!&D0D$+$%($#-0  !&0#6-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HeI-
- - L<B<B-`&%( 0  !&0#6 GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG Heb 
 
 gGR :!&2(&&!-5 GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG Hee 
 
 gGg E-523(&!-5& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG HfI 
 
 gGb 8%7%/%52%& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG HfJ 
  
?DG  .BTB8"M E^TEM@'D^T  
 
 bGJ D5+/-,(2+!-5 GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG HfS 
 
 bGH ?!&(03!&0+!-5 05, /%<-/+!5; -7 ,%&2/!<+!A% ,!0;5-&+!2 +%&+ &+(,!%&  GGGGGGGGGGGGGGGGGGGGGGGGGGG HfR 
  N<=<;-A#!""'$'/-&2- 0$!",-("%(-!"%)+(%-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-HfR-
- - N<=<=-T)++-,"%#!$ ($&'-&2-0/!""4"'( GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG Hfb 
 
 O!!!
 bGS E-A0/!0+%V&<%2!7!2 %&+!*0+!-5 GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG Hfe 
  N<B<;-]" "0(0D$+$(>-0',-!" !&,)#$D$+$(>-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-Hfe-
- - N<B<=-O$0/'&%($#-%"'%$($?$(>-7OA":-0',-% "#$2$#$(>-7OA : GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG Hff 
 
 bGR "<<3!20+!-5 05, (&% -7 2-A0/!0+%V&<%2!7!2 %&+!*0+%& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG SIJ 
  N<C<;-F!",$#($&'-&2-("%(-0##)!0#>-$'-"K("!'0+- & )+0($&'-<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<-SIJ-
- - N<C<=-A"+"#($&'-&2-%(!0("/>-(&-2$(- )! &%"  GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG SIg 
 
 bGg E-523(&!-5& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG SJI 
 
 bGb 8%7%/%52%& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG SJJ 
 O!A 
#&-%)'*)*&.$, - 
 
1!;(/% JGJG "&&04 ,%A%3-<*%5+ 05, A03!,0+!-5 <0+$C04 022-/,!5; +- 
^DB ;(!,%3!5%& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG g 
 
1!;(/% JGHG #$% 10;05P& 5-*-;/0*G GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG Hb 
 
1!;(/% JGSG E-(5+ <%/ 4%0/ -7 <()3!&$%, /%7%/%52%& 7-/ !57%2+!-(& 
&03*-5 050%*!0G GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG Re 
 
1!;(/% JGRG D57%2+!-(& &03*-5 050%*!0 ,!&+/!)(+!-5 *0< )0&%, -5 
HIIgVHIIf /%<-/+&G GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG Re 
 
1!;(/% JGgG :%2!&!-5 +/%% +- &%3%2+ %&+!*0+!-5 </-2%,(/%& 7-/ +%&+ 
+/(%5%&&G GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG hh 
 
1!;(/% HGJG '0*<3% 033-20+!-5 05, !5A%&+!;0+!-5 -)_%2+!A%& +- &+(,4 
8#V6E8 /%<%0+0)!3!+4 05, /%</-,(2!)!3!+4 GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG JHh 
 
1!;(/% HGHG #%&+ /%&(3+ 03!;5*%5+G GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG JSf 
 
1!;(/% HGS"G '+0/ &$0<%, (5/--+%, <$43-;/0* /%</%&%5+!5; 0;/%%*%5+ 
0*-5; +%&+ /(5&G GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG JRI 
 
1!;(/% HGSLG #/%% &$0<%, (5/--+%, <$43-;/0* /%</%&%5+!5; 0;/%%*%5+ 
0*-5; +%&+ /(5&G GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG JRJ 
 
1!;(/% SGJG #%&+ /%&(3+ 03!;5*%5+Q &0*<3%, &03*-5 [!5 2-3(*5&¥ C%/% 
23(&+%/%, )4 !57%2+!-5 &+0;% 022-/,!5; +- +$% <&%(,-;-3, 
&+05,0/, GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG Jbg 
 
1!;(/% SGHG =!%/0/2$!203 &+/(2+(/% -7 +$% ,0+0&%+Q SV3%A%3 &+/(2+(/% ["¥i 
HV3%A%3 &+/(2+(/% [L¥ GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG Jbh 
)
1!;(/% SGSG E-*<(+%, %&+!*0+%, 0;/%%*%5+ -7 D'"? 8#V6E8 GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG JeI 
 
1!;(/% SGRG E-*<(+%, 2$052% 0;/%%*%5+ -7 D'"? 8#V6E8 GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG JeH 
 
1!;(/% SGgG E-*<(+%, E-$%5P& a0<<0 A03(%& -7 D'"? 8#V6E8 GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG JeR 
 
1!;(/% RGJG '0*<3% 2-33%2+!-5 W +%&+ 033-20+!-5 +- %A03(0+% 7!A% D'"? 
,%+%2+!-5 0&&04& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG HJJ)
 
1!;(/% RGHG 6/!-/ ,!&+/!)(+!-5& 7-/ </-<-/+!-5 -7 230&& " &03*-5 [5-5V
!57%2+%,¥ !5 +$% 3-C </%A03%52% <-<(30+!-5 [6-< D¥ GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG HHH)
)
 OA
1!;(/% RGSG #%&+ /%&(3+ 03!;5*%5+Q &0*<3%, 7!&$ [!5 2-3(*5&¥ C%/% 
23(&+%/%, )4 20;% -/!;!5 05, </%A03%52% 3%A%3 <-<(30+!-5& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG HHS)
)
1!;(/% RGRG @5/--+%, <$43-;/0* /%</%&%5+!5; 0;/%%*%5+ 0*-5; +%&+ 
/(5& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG HHR)
)
1!;(/% RGgG 6-&+%/!-/ ,!&+/!)(+!-5& -7 +$% </-)0)!3!+!%& -7 %02$ D'"? 
0&&04 +- +%&+ <-&!+!A% !7 +$% 7!&$ !& !57%2+%, !5 230&& "Q 
:'%" ["G¥i !57%2+%, LQ :'%L [LG¥i 05, 5-5V!57%2+%,Q JV
:'< [EG¥ GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG HHe)
)
1!;(/% RGbG 6-&+%/!-/ ,!&+/!)(+!-5& -7 +$% </%A03%52%& -7 230&& L 05, E 
-7 %02$ -7 +$% R &0*<3%, <-<(30+!-5& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG HSJ)
)
1!;(/% RGhG SV230&& ME> <-&+%/!-/ *%05& -7 </%A03%52%& 05, +%&+ 
-<%/0+!5; 2$0/02+%/!&+!2& 02/-&& D1"# 2(+<-!5+& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG HSg)
)
1!;(/% RGeG SV230&& ME> <-&+%/!-/ *%05& -7 </%A03%52%& 05, +%&+ 
-<%/0+!5; 2$0/02+%/!&+!2& 02/-&& 98#V6E8 2423% +$/%&$-3, 
2(+<-!5+& GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG HSb)
)
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In 2005 world,wide, the contribution of fish to total animal protein intake was 
15.3% which represents 16.4 kg per capita. In low,income, food,deficit countries, fish 
protein contribution was significantly higher with 18.5% (13.8 kg per capita). From the 
143 million tonnes of fish produced in 2005, approximately a third was supplied by 
aquaculture. While the global capture fisheries production has been stable over the last 
decade at around 90 million tonnes per year, aquaculture continues to increase the fish 
supply and represents the fastest growing food animal production, outpacing population 
growth (FAO, 2009). In terms of consumption, a recent study reported that aquaculture 
provides half of the fish protein consumed (Naylor et al., 2009).  
Development and implementation of stock health programs represents the 
cornerstone of sustainable aquaculture. Fish health management is further hampered by 
limited pathognomonic clinical manifestations of disease. The intensive international 
exchange of fish products represents increased risk of disease introduction and 
dissemination, resulting in direct economic, food safety and environmental impacts. 
Therefore, use of standard diagnostic tests remains an important method of evaluation of 
the health of aquatic animals, and their products, at the local, regional, national and 
international level.  
Etymologically, the adjective “diagnostic” is derived from the ancient Greek root 
of diagnōsis (διάγνωσις), meaning dia, “split”, and gnosi “to learn,knowledge”. It refers 
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to the capacity to discern or distinguish a disease by its signs, symptoms, and from the 
results of testing procedures.  In this thesis, the terms “test”, “assay” or “test method” will 
be employed as synonyms and refer to the principles, systematic procedures, and 
processes used to detect or quantify an analyte of interest. International institutions and 
local authorities are mainly concerned with infectious diseases that can be introduced and 
transmitted to populations free of the pathogen. Thus, in the usual context, “diagnostic 
test” is assumed to refer to the technique that identifies an infectious disease of interest, 
and more specifically that detects infection and/or carrier stages that are frequently 
asymptomatic (i.e. presence or absence of the infectious agent). It is possible to classify 
assay outcomes as continuous, ordinal or dichotomous. This introductory chapter will 
focus on the evaluation of 8;:!7$7<79='$%=$'&%=9>$= (i.e. binary outcome: positive or 
negative) since, often, the two other test categories (i.e. continuous and ordinal) are 
dichotomized for decision making using a threshold or cut,point value. Also, the terms 
“positive” and “negative” are used here to characterize a test result, while “non,
infected/non,diseased” (D,) and “infected/diseased” (D+) will be used to describe the 
status of an individual or a sample. 
The interpretation of diagnostic tests results is particularly pertinent for disease 
surveillance and control in the case of infections where therapeutic options are lacking. A 
well,suited disease for investigating the use of diagnostic tests for surveillance and 
control in aquaculture is infectious salmon anaemia virus (ISAV) which represents a 
serious economic threat to the Atlantic salmon farming industry worldwide. This thesis 
addresses, develops and applies diagnostic test evaluation methods within an ISAV 
framework. The introduction chapter reviews the international and national requirements 
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to evaluate diagnostic test accuracy, the estimation methods and their limitations, and the 
application of these estimations. 
'
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 Aquaculture has in recent  years has become globalized and is now primarily 
ruled by international trade and production policies. Historically, the Office International 
des Epizooties (OIE) set diagnostic requirements exclusively for international trade or 
movement of animals and their products (Wright et al., 2006). This organization, which 
has been recently renamed as the World Organization of Animal Health, progressively 
expanded its scope to include guidelines for the integration of diagnostic applications in 
the development of health programs in local settings (Wright et al., 2006). As a 
consequence of these internationally agreed upon protocols, standards for diagnostic tests 
used in aquatic species primarily follow international guidelines before being adapted 
into national or regional programs. 
 
1.2.1 World Organization for Animal Health (Office International des Epizooties) 
 
 The Office International des Epizooties was originally created in 1924 in Paris 
from an international agreement to address animal disease (OIE website). In 2003, it was 
renamed the World Organization for Animal Health but still uses the same well,
recognized acronym (OIE) known world,wide. The OIE membership is comprised of 174 
countries and territories and provides leadership in improving animal health worldwide 
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(OIE website). Every year, the OIE publishes the “Health Code for Aquatic Animals” 
(OIE, 2009a) that establishes the international standards for trade of aquatic animals and 
their products. The code lists infectious diseases of concern for international trade and 
refers to methods for testing and self,certifying animals as specifically disease,free 
before product movement is allowed across national boundaries. Detailed protocols for 
#&%=:&;C%8'$%=$= are published in parallel in the “Manual of Diagnostic Tests and 
Vaccines for Aquatic Animals” (OIE, 2009b). The manual also outlines protocols for 
">$%&6"$;B%'$%=$= that can be used within local settings or for import/export after bilateral 
agreements are established (Wright et al., 2006). To be included in the manual as a 
prescribed or alternative test, a new diagnostic method must be validated and approved 
by the OIE’s Biological Standards Commission. Outlined in detail in the introductory 
chapters of the manual, the OIE also provides condensed guidelines on the validation of 
tests in the “OIE Standard for Management and Technical Requirement for Laboratories 
Conducting Tests for Infectious Animal Diseases” (OIE, 2008). This standard is an 
interpretation of the international quality standard for testing laboratories (ISO/IEC 
17025: 2005) with a clear conceptual distinction that the validation of a test is appropriate 
only if it is relevant for its intended application (Wright et al., 2006). In other words, the 
test must be “fit for purpose” and validated as such (Wright et al., 2006).  
 The overall evaluation process begins with the actual development of the assay, 
followed by validation and finally continuous monitoring of the assay performance once 
the assay has been put into routine diagnostic service (Fig. 1.1). These three phases in the 
process are independent but equally important for the OIE quality standards. According 
to the OIE guidelines, test validation is an incremental process composed of 4 stages. 
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Methods comparability 
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1.2.1.1 Assay development pathway 
 
 While provisional status may be recognized after the first stage (Fig. 1.1) of 
validation, data to support the next validation stages, collected over a period of actual 
use, is essential for full recognition. In the following sections, the three major pathways 
consisting of development, validation and maintenance as reported in the OIE manual 
(OIE, 2009b) and the assay validation criteria required for certification will be reviewed. 
 Prior to the development of a new assay, the method designers must clearly define 
the intended purpose of the test and the laboratory has to fulfill “essential prerequisites”. 
OIE classifies 8;"A67=$;:'$%=$'#9&#7=%='"68'"##>;:"$;76= into six general categories: 
 
1. Demonstration of freedom from infection (prevalence apparently nil) in a defined 
population including 3 situations: ‘free’ with vaccination, historical ‘freedom’, 
reGestablishment of ‘freedom’ postGoutbreak 
2. Certification of freedom from infection or agent in individual animals or products 
for trade purposes 
3.  Eradication of disease or elimination of infection from defined populations 
4.  Confirmatory diagnosis of suspect or clinical cases 
5. Estimation of infection or exposure prevalence to facilitate risk analysis (surveys, 
classification of herd health status, implementation of disease control measures) 
6.  Determination of immune status in individual animals or populations (postG
vaccination) 
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 According to the purpose, the validation requirements for operating characteristics 
of the test may be different. For instance, if a test is intended for screening for an 
infectious disease (e.g. category #1 above), its diagnostic sensitivity will be prioritized, 
but when intended for disease confirmation (e.g. category #4 above), its diagnostic 
specificity will be prioritized (see section 1.2.3.7). In addition, the facilities where the test 
will be developed require that a system of quality assurance (QA) and quality control 
(QC) be established to ensure high value and confidence in the results. 
  The technical development of a test method includes the design of a detailed 
protocol describing the selection of reagents and reference materials for controls. 
Biological, physical and chemical parameters must be optimized to suit the intended test 
purpose. First, the influence of biological factors, such as the analyte concentration, is 
assessed by estimating the >;6%"&'7#%&"$;6A'&"6A%'7@'$!%'"=="E.  Defined as the interval 
of analyte concentration over which the test provides suitable accuracy and precision 
(OIE, 2009b), the linear operating range describes the “dose,response curve” and implies 
preliminary estimation of the lower and upper limits of detection of the assay. Then, the 
&7C9=$6%== is evaluated to investigate the critical physical parameters that may impact 
test performance. Also defined as the resistance of the test to expected variations of 
testing conditions (OIE, 2009b), robustness identifies critical factors during 
transportation, storage and repeated use that may impact the stability of reagents 
(Crowther et al., 2006). A test method may be “transport robust” and/or “laboratory 
robust” (storage and handling). The objective of this assessment is ultimately to define 
the optimal transport and laboratory conditions in which the test would routinely be used 
to ensure consistent operating characteristics. 
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 The last step of the development pathway is the calibration of the test method. 
This aspect of standardization requires use of reference samples (or standards), well 
defined in terms of analyte and concentration.  To facilitate calibration and comparison of 
results among testing laboratories, international and/or national reference standards 
should be used, where available. These highly characterized standards are usually 
available for international reference laboratories in limited quantity as primary reference 
standards or may be prepared by national reference laboratories as secondary and/or 
working standards. As a working (or tertiary) standard, they are used to monitor and 
control the quality of test results on a continual run,by,run basis.  They may also be used 
to normalise test results of a continuous nature, resulting in units that are standardized 
across laboratories (e.g. optical density ratios for ELISA’s). 
 At this stage, the test method should be robust and functional and available for 
further evaluations of its analytical and diagnostic performance through the validation 
pathway.  
 
1.2.1.2 Assay validation pathway 
 
 By OIE definition, the validation of a test refers to the “process that determines 
the fitness of an assay that has been properly developed, optimized and standardized for 
an intended purpose”. Illustrated in Fig. 1.1, the validation pathway is a succession of 4 
evaluation stages: analytical characteristics, diagnostic characteristics, reproducibility and 
implementation. Although the assay can receive a provisional recognition after the 
analytical evaluation (Stage 1), the method will only be considered fully validated for the 
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original intended purpose if the first three stages of the validation pathway are completed. 
According to Van den Bruel et al. (2006), the procedure prescribed by OIE would only fit 
the studied population (internal validation). The authors further suggested that an 
additional confirmatory study be conducted on an independent but similar population to 
externally validate the results of the first evaluation (external validation). This is the 
intent of the last stage 4 described below (see section 1.2.1.2.4 ). 
 
1.2.1.2.1 Stage 1G Analytical performance characteristics 
The first analytical validation criterion of interest is the &%#%"$"C;>;$E. According 
to the international standards, repeatability is defined as a measure of variation in test 
results that are obtained using the same method on identical test items in the same 
laboratory by the same operator with the same equipment over a short interval of time 
(within,laboratory consistency) (IS0 5725,1, 1994). Repeatability and robustness should 
not be confused. Robustness is the characterization of physical, chemical and biological 
variations (e.g. pH, temperature or time fluctuations, sample integrity, etc.) that can be 
tolerated without appreciably altering assay performance. Repeatability measurements 
essentially quantify and monitor robustness.  Robust assays generally display a high 
degree of repeatability. Often referred to as a measure of precision, variation of binary 
results is in fact a combined measure of imprecision (random error) and inaccuracy 
(systematic error or bias) (Van den Bruel et al., 2007). This analytical estimation of 
repeatability is considered the baseline of the internal quality control program (IQC). To 
avoid any confusion later on, we further characterized this parameter as "6">E$;:">'
&%#%"$"C;>;$EG'as opposed to field repeatability, described below. Repeatability of test 
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results is further refined during the field validation and continuously monitored during 
IQC. 
The next analytical criteria to be considered are "6">E$;:'=%6=;$;B;$E (ASe) and 
"6">E$;:">'=#%:;@;:;$E (ASp). ASe is defined as the ability of the test to detect and 
distinguish a minimum concentration of analyte from the sample matrix with a specified 
probability (OIE, 2009b). Also referred to as the limit of detection (LOD), ASe is 
estimated by serially diluting a solution of analyte in an analyte,free matrix of the same 
constitution as samples from the targeted population. Depending on the method, the OIE 
requires that the LOD be expressed as a number of organisms, genomic copies, colony,
forming units, complement,forming units, or plaque,forming units for a defined sample 
volume or weight (i.e. concentration). Often the LOD is reported as a numerical quantity 
and not as a concentration (e.g. number of genome copies), but this practice is not 
recommended because an absolute number has no practicality since it ignores the critical 
information of dilution and/or sampling fraction. 
ASp is defined as the ability of the test to test negative for components that may 
be present in the sample matrix and that are closely related to the targeted analyte (OIE, 
2009b). In practice, ASp is estimated by testing a range of exposed animals or a group of 
animals infected by closely related organisms. Satisfactory levels of cross,reaction 
depend on the intended purpose of the test and on the relative frequency of the competing 
organism in the targeted population.  
 If the analytical evaluation of the assay is considered satisfactory, it is possible to 
obtain a provisional recognition of validity (i.e. OIE recognized but not OIE certified). To 
obtain this partial certification, OIE requires additional preliminary estimations of 
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diagnostic sensitivity, diagnostic specificity and reproducibility (see sections 1.2.1.2.2 
and 1.2.1.2.3) on a small scale, and a direct comparison between the candidate (or index) 
test and a recognized standard test method. If satisfactory, the assay obtains the 
provisional recognition of validity for use in emergency situations and as part of bilateral 
agreements. However, it is important to recognize that bench (or analytical) validation 
does not replace the field (diagnostic) validation which will be the focus of later 
discussion. 
 
1.2.1.2.2 Stage 2G Diagnostic performance characteristics 
 To report the efficiency or discriminatory accuracy of a diagnostic test, OIE 
requires the use of 8;"A67=$;:'=%6=;$;B;$E (DSe) and 8;"A67=$;:'=#%:;@;:;$E (DSp), two 
parameters introduced by Yerushalmy (1947) that rely on the principle of conditional 
probability. DSe (or true positive rate) is defined as the proportion (probability) of  D+ 
individuals that test positive. DSp (or true negative rate) is defined as the proportion 
(probability) of D, individuals that test negative. 
Others parameters of test accuracy maybe used but have with some limitations.'
0!%'%@@;:;%6:E (Ef), or overall accuracy, is the overall proportion of tested individuals 
that are correctly classified. However, this parameter depends on the prevalence (i.e. 
prevalence,weighted average of DSe and DSp) and can strongly vary when (i) DSe and 
DSp differ substantially from each other and (ii) the prevalence of the targeted population 
substantially deviates from 50% (Alberg et al., 2004). 
In 1950, Youden introduced a new summary index of discrimination efficiency 
renamed later as the H798%6';68%I (J). It is the average of “successes” (difference in 
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proportions of correctly and incorrectly classified individuals across disease groups(D+ 
and D,)). When J is above 0, samples have more chance to be correctly classified and the 
test is, therefore, considered useful (positive discrimination). 
2;"A67=$;:'788='&"$;7 (DOR) is another measure of diagnostic accuracy that 
reflects the ratio of the odds of being correctly classified over the odds of being 
misclassified (Lijmer et al., 1999). The greater DOR is above 1, the more useful the test 
is. If DOR is < 1, tested individuals are more likely to be misclassified (negative 
discrimination) than if the test had not been performed. 
The advantages of J and DOR are that they are independent of the prevalence of 
D+ and are expressed as a single measurement of diagnostic performance that can be 
used as an outcome for test comparisons or meta,analysis studies (Glas et al., 2003). 
Conversely, the main drawback of these two parameters is the impossibility to 
differentiate classification performance in true D+ versus D, groups. Since a proper 
evaluation of “fitness for purpose” necessitates separate test performance indicators (e.g. 
DSe & DSp), it follows that these criteria are not part of in the OIE validation 
requirements. Also, it is possible to subsequently calculate Ef, J and DOR from DSe/DSp 
and others parameters (see section 1.5.2.1). 
For tests with continuous outcome results, OIE requires the determination of a 
threshold or cut,off value(s) to dichotomize or categorize (i.e. negative, positive and/or 
intermediate) results. According to the purpose of the test, the cut,off can be selected 
based on overall accuracy, disease status,specific efficacy, clinical impact, or cost 
impact. 
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1.2.1.2.3 Stage 3G Ruggedness, reproducibility and repeatability refinement 
An OIE prescribed test is expected to be used in multiple laboratories. Therefore, 
it is required to estimate the &9AA%86%== and 8;"A67=$;:'&%#&789:;C;>;$E'of the test. 
Ruggedness is defined as the capacity of a test to resist expected variation in test 
conditions across laboratories (OIE, 2009b). It identifies critical user variables that 
impact the transferability of a technique including sampling and storage procedures 
(Crowther et al., 2006). For instance, freezing (,80 ºC) was shown to increase DSe for 
samples submitted for ISAV testing by RT,PCR (Nérette et al., 2005a). A method may 
not be considered as “rugged” if it is highly affected by sampling conditions (Crowther et 
al., 2006). Influencing factors are user,dependent and consequently difficult to control.  
The diagnostic reproducibility is a defined as a measure of the variation in test 
results obtained with the same method on identical test items in different laboratories 
with different operators using different equipment (between,laboratory consistency) (IS0 
5725,1, 1994). Like robustness and repeatability, ruggedness identifies critical factors 
affecting test result variation across or between laboratories whereas reproducibility 
quantifies this variation. Similar to repeatability, reproducibility combines the measure of 
imprecision (random error) and inaccuracy (systematic error) in diagnostic results across 
laboratories. OIE guidelines encourage using replicate samples in each participating 
laboratory to further measure the repeatability and estimate its variation across 
laboratories. 
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1.2.1.2.4 Stage 4G Program implementation 
 Ultimately, the usefulness and success of a diagnostic test is revealed by its 
inclusion within regional, national or international programs. In essence, this is a form of 
external validation. OIE guidelines emphasize the inclusion of information from tested 
populations (i.e. prevalence of infection) to account for the probability to sample a D+ 
individual from the population. For instance, if the actual prevalence of infection is very 
low, the probability of a false positive result may be higher than the probability of getting 
a true positive result. Therefore, it is recommended that additional confirmatory and 
verification procedures  be incorporated to further investigate potentially false test results 
(e.g. traceable analyte in positive control to identify cross,contamination). 
The deployment of a recognized test involves a wide range of applications and 
requires extensive evaluation of assay ruggedness and production of large quantities of 
reliable reference reagents. The test must demonstrate consistent operating 
characteristics, regardless of the conditions of utilization (e.g. field conditions) and 
reagents must be homogeneous and stable (e.g. identical control aliquots).  
Once approved by the OIE’s Biological Standards Commission, the assay is listed with 
other validated and certified methods for a specified purpose. However, to be designated 
as a #&%=:&;C%8 or ">$%&6"$% test for trade, the method must be recognized as useful at 
the regional, national and international level.  
 Thereafter, OIE requires that the validation status must be maintained by 
continuously monitoring the assay operating characteristics (maintenance pathway).  
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1.2.1.3 Assay validation maintenance 
Following the initial evaluation of the operating characteristics of the assay, it is 
necessary to continuously control and monitor the test performance. 
  First, an ;6$%&6">'J9">;$E':76$&7> (IQC) program must be implemented to detect 
potential changes in accuracy over time. Control charts are recommended to graphically 
monitor the repeatability of control samples. Particularly applicable for tests with 
continuous outcomes, control charts include daily detailed data (DDD) and summary data 
charts (SDC) (Crowther et al., 2006). Secondly, laboratories are encouraged to participate 
in %I$%&6">'J9">;$E':76$&7> (EQC) programs. Most EQC programs require annual or bi,
annual proficiency testing or ring tests. This is accomplished using panels of highly 
defined samples representing a range of analyte concentrations that are test ‘blind’ by the 
participating laboratories. The continuous assessment of repeatability and reproducibility 
is designed to ensure the consistency across time of test performance within, and 
between,laboratories. 
 The expression of a disease and associated pathogens may vary with time and 
location. For instance, it is expected that a test would not perform the same with different 
strains and/or virulence of the pathogen. As new strains or genotypes of pathogens arise, 
laboratories are advised to re,evaluate the ASe and ASp of the assay to ensure that any 
changes to the pathogen have not compromised the diagnostic accuracy of the test. In 
some cases, the test may require modification to accommodate these changes. 
 During the lifespan of an assay, improvements to the technique, reagents and/or 
equipment may enhance detection efficiency and/or the cost,effectiveness of the assay. In
  
1This section was adapted directly from the information available on the Canadian Food Inspection Agency 
(CFIA) and Department of Fisheries and Ocean Canada (DFO) websites (http://www.inspection. 
gc.ca/english/anima/aqua/aquaproge.shtml and http://www.dfo,mpo.gc.ca/aquaculture/health,sante,
eng.htm#n1, respectively) 
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such cases, the OIE does not require a total re,validation of the method. However, the 
OIE does require a demonstration of <%$!78':7<#"&"C;>;$E. It is recommended that 
equivalency be evaluated by assessing the agreement between the original and modified 
protocols run side,by,side at least 20 times suing a panel of samples representing a full 
range of analytes and concentrations. Similarly for depleted reagents, an overlap of paired 
runs (one with the reagent nearing depletion and its replacement) should be conducted to 
evaluate and confirm similar test performance. 
 Since confidence levels around estimated validation criteria are expected to 
improve with more evidence and increased frequency of testing, the OIE encourages the 
submission of additional information on test performance as its use becomes more 
common. However, it may not be appropriate to combine information from different over 
time since the population characteristics may have changed. 
 After demonstrating “fitness for purpose”, a recently developed test may not 
necessarily be listed in the OIE Manual. The assay must prove to be useful and successful 
in surveillance programs. Before it can be recognized internationally, the test must prove 
its usefulness at regional or national levels.  
 
1.2.2 National Aquatic Animal Health Program in Canada1 
 
1.2.2.1 Origin and objectives 
Canada is a member of the OIE and the World Trade Organization (WTO), and therefore 
accepts the OIE standards for trade of aquatic and terrestrial animals. Most of Canada's  
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major trading partners have also adopted OIE international standards within their own 
aquatic animal health programs (e.g. National Aquatic Animal Health Plan in the US). 
For exportation, Canada may be required to attest that aquatic animals and their products 
are free of OIE reportable diseases. In reciprocal arrangements, Canada may require that 
imported aquatic products be controlled and certified to prevent the introduction of 
serious infectious diseases. Finally, numerous activities in Canada rely on aquatic 
resources (e.g. aquaculture, recreational fishing, ornamental hobbyists) and it is essential 
to limit disease spread within Canada to safeguard these industries. Therefore, Canada 
implemented its own regulatory framework to meet international standards, to protect 
Canadian aquatic resources (wild and farmed) from serious infectious diseases, and to 
maintain competitive access to international markets. 
 In 2005, the Government of Canada invested CDN$ 59 million over five years, 
with permanent funding thereafter, for CFIA and DFO to implement and deliver a 
National Aquatic Animal Health Program (NAAHP). This science,based program 
consists of regulatory measures needed to prevent, control and/or eradicate aquatic 
animal diseases of concern. 
 
1.2.2.2 Implementation and organization 
 
The implementation of the NAAHP is a joint responsibility of the Canadian 
Department of Agriculture and Agri,Food (responsible for the CFIA) and the Canadian 
Department of Fisheries and Oceans. CFIA was designated the lead federal agency for 
the NAAHP under the legislative authority of the Health of Animals Act and Regulations 
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(http://laws.justice.gc.ca/en/H,3.3?noCookie). The CFIA is responsible for disease 
surveillance protocols and control measures for reportable diseases, whereas DFO 
delivers and oversees the National Aquatic Animal Health Laboratory System 
(NAAHLS) and research to support NAAHP. 
In Canada, the management of the wild fisheries and aquaculture is shared 
between the federal and provincial/territorial jurisdictions. The responsibilities and 
expertise within provinces/territories and industry provide complementary efforts which 
should minimize redundancy and gaps. To facilitate the development of the NAAHP, a 
National Aquatic Animal Health Steering Committee was created and includes 
representatives from all Canadian provinces and territories, Aboriginal and First Nations 
Peoples' associations, wild and farmed industry associations, veterinary associations, and 
academia. 
The structure of the NAAHP is articulated around 8 interdependent actions: 
1) >%A;=>"$;B%'"68'&%A9>"$7&E'@&"<%F7&K: currently under the Fisheries Act (Fish 
Health Protection & Fishery Regulations), the protection of wild and farmed fish 
against serious infectious diseases will in the future, be included under the Health 
of Animal Act, as for terrestrial animals;  
2) %I#7&$'!%">$!':%&$;@;:"$;76: under CFIA responsibilities, the Agency will be 
releasing health certificates that conform to importing country requirements 
and/or OIE international standards;  
3) ;<#7&$':76$&7>: under CFIA responsibilities, the Agency will target control of 
imported products based on the risk of introduction that they represent (e.g. health 
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status of the exporting country, ultimate use in Canada), to prevent the 
introduction of reportable diseases;  
4) 87<%=$;:'8;=%"=%':76$&7>: under CFIA responsibilities, the Agency will develop a 
framework, based on risk assessment and surveillance reports, to control the 
spread of serious infectious diseases within Canada and to implement emergency 
actions after introduction of a listed disease in Canada or part of Canada;  
5) =9&B%;>>"6:%: under CFIA responsibilities, the Agency will coordinate 
surveillance programs to document freedom from notifiable diseases, to meet 
certification requirements, to assist the investigation of disease outbreaks, and to 
monitor the efficacy of control measures;  
6) &;=K'"==%==<%6$: under CFIA responsibilities, the Agency will use available 
scientific information to identify the critical domains where regulatory control and 
policy development are needed;  
7) >"C7&"$7&E'$%=$;6A: under DFO responsibilities, DFO will set and manage four 
national reference laboratories spread across the country (Gulf Fisheries Centre, 
Moncton, NB; Freshwater Institute, Winnipeg, MB; Pacific Biological Station, 
Nanaimo, BC; and Charlottetown Aquatic Animal Pathogen & Biocontainment 
Laboratory, Charlottetown, PEI) to develop and provide quality detection 
methods for listed diseases, confirmatory testing for suspicious findings by other 
laboratories, suspicious die,offs of wild or farmed fish, and surveillance programs 
to report freedom from OIE listed diseases;  
8) &%=%"&:!: under DFO responsibilities, DFO will'try to address the knowledge 
gaps that impact regulatory decision making (e.g. risk assessment, diagnostic 
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validation). The research program is coordinated by the Centre of Expertise for 
Aquatic Animal Health Research and Diagnostics (Moncton, NB). 
 
The use of diagnostic tests is essential in several of these interacting activities, 
including export certification, import control, surveillance, risk assessment, disease 
investigation, and emergency response. Therefore, it is required that any diagnostic 
method used to detect reportable diseases in the NAAHLS be validated according to the 
international guidelines and standards. 
 
1.2.3 Applications of diagnostic test criteria 
 
 The OIE test validation guidelines describe 13 qualitative and quantitative assay 
validation criteria to assess the fitness for purpose of a test. Although post,estimation 
utilisation of these factors is not clearly stated in the OIE guidelines, these criteria have 
numerous applications in the interpretation of test results and to the decision,making 
process. Appropriate interpretation of a test result relies on the discriminatory accuracy of 
the test and on the conditions in which the test was applied (Shapiro, 1999). These 
conditions will include clear definitions related to the testing objectives, sampling design 
and unit of sampling (e.g. number of specimens or individuals sampled), unit of testing 
(e.g. pooled or multiple testing), unit of interpretation (e.g. individual, herd, region), and 
statistical method employed (e.g. statistical parameter, software) (Greiner & Gardner, 
2000a). We will review the most common applications of diagnostic criteria, starting with 
the only one suggested by OIE: predictive value of a test result.  
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1.2.3.1 Predictive values of a test result 
 
 By definition, DSe and DSp are probabilities of a test result conditional on the 
fact that the health status is known. Practically, these parameters have limited use since 
the health status of any given animal prior to testing is rarely, if ever, known. Therefore, 
with the test result as the primary piece of information (i.e. the condition), the relevant 
probability of concern is: what is the probability of the true health status when the test 
result is known? This probability was introduced by Vecchio (1966) as the #&%8;:$;B%'
B">9% (PV) of a test result. The test result can be positive (PV+) or negative (PV,), and 
the status of interest can be either D+ (positive predictive value, PPV) or D, (negative 
predictive value, NPV). According to the test result and the status of interest, four 
conditional probabilities can be estimated: PPV+, NPV+, PPV,, and NPV,. The two 
parameters of most common interest are PPV+ and NPV,, conveniently called PPV and 
NPV. PPV is defined as the proportion or probability of a test positive individual to be 
D+, whereas NPV is the proportion or probability of test negative individual to be D,. In 
addition, predictive values can be estimated for different targeted populations using the 
test DSe, DSp (both assumed constant across populations) and expected prevalence (Pr). 
Deduced from the Bayes’ theorem, it is possible to calculate predictive values as (Dohoo 
et al., 2009): 
 
PPV = Pr DSe / (Pr DSe + (1GPr) (1GDSp))      (1) 
NPV = (1GPr) DSp / (Pr (1GDSe) + (1GPr) DSp)     (2) 
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These conditional probabilities can also be estimated directly from a 2X2 table including 
the true status information (see section 1.5.2.1) as: PPV = a/(a+c) and NPV = d/ (b+d) 
(Akobeng, 2007a). If the prevalence of D+ is < 50%, DSe has more influence on NPV 
while DSp has more influence on PPV. In addition, predictive values are population 
parameters that strongly depend on prevalence. However, prevalence of D+ in 
populations is rarely known exactly before testing. It is advisable to explore different 
realistic levels of prevalence and assess the practical consequences based on the 
estimated predictive values. For instance, one of the most delicate scenarios for decision,
makers is to have one positive test result during the surveillance of a truly D, population. 
With an almost perfect test (DSe = 99.99% and DSp = 99.99%) and a prevalence 
expected close to zero, the PPV will be very low.  With a DSp of 99.99%, we expect one 
false positive result every 10,000 samples tested from a disease,free population. 
According to the sampling strategy, it would be biologically unlikely to have a single true 
positive individual to an infectious disease that has a tendency to spread within the 
population. Most likely to result from a cross,contamination (Wilson, 1997), it is 
recommended to set subsequent confirmation and verification procedures within the 
internal quality control strategy to investigate and track potential contamination and 
improve the level of confidence of the test result. No decision,threshold is set for 
predictive values since any decision process for animal health combines biological 
evidence and social, economic, and political considerations.  
  Although DSe and DSp are often believed to be constant, it is reasonable to 
believe that DSe and DSp vary with prevalence (Greiner & Gardner, 2000b). Modelling 
  23
analysis of predictive values has shown that the dual dependence of predictive values on 
prevalence (direct and indirect through DSe and DSp) tends to buffer their overall 
variation across prevalences (Brenner & Gefeller, 1997). Several software programs exist 
that facilitate the computation of predictive values. One of the most popular in veterinary 
applications is included in the epidemiological analysis package Survey Toolbox 
(Cameron & Baldock, 1998a &b, 
http://www.ausvet.com.au/content.php?page=res_software). A parallel version, Bayes 
FreeCalc1, was developed under the BDFree software to use posterior distribution 
parameters when DSe and DSp were estimated in a Bayesian framework (Johnson et al., 
2004; http://www.epi.ucdavis.edu/diagnostictests/module02.html).  
 
1.2.3.2 Likelihood ratio of a test result 
 
 /;K%>;!778'&"$;7= (LR) are clinically relevant parameters that apply the 
information from DSe/DSp estimates. The likelihood ratio of a test result is defined as the 
proportion or probability of this test result among D+ individuals divided by the 
proportion or probability of this same test result among D, individuals (Akobeng, 2007b). 
Test result can refer to a defined category of measures when the test outcome is 
continuous or ordinal (category specific LR) or to a dichotomized test outcome (cutpoint 
LR). In this section, we restricted the discussion to cuptoint LR adapted to binary 
outcome test. Since a test results may be positive or negative, the LR of a positive test 
result (LR+) and the LR of negative test result (LR,) can be determined. LR+ provides 
information about how much more likely D+ individuals are to test positive compared to 
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a D, individual. Likewise, LR, provides information about how much less likely D+ 
individuals are to test negative compared to a D, individual. In general, when LR is 
greater than 1, D+ individuals are more likely to get the test result than D,. When LR is 
less than 1, D, individuals are more likely to get the test result than D+. If there is 
insufficient evidence of LR being different from 1, the test does not perform differently 
in D+ and in D, individuals. Ultimately, the larger LR+ (above 1) and the closer LR, is to 
0, the greater is the discriminatory power of the test.  
  For each cut,off value there are different DSe and DSp, so for each cut,off, LRs 
can be computed (Dohoo et al., 2009):  
 
LR+ = DSe / (1GDSp)         (3) 
LRG = (1GDSe) / DSp         (4) 
 
LRs can also be computed directly from a 2X2contingency table (see section 1.5.2.1) as 
follows: LR+ = a (c+d) / c (a+b); LR, = b (c+d) / d (a+b). 
The main utilization of LR is for clinical interpretation. During the diagnostic 
process, a test method is employed by the clinician in combination with other information 
to rule in or rule out a suspected cause. Before the test is conducted, based on the animal 
history and clinical examination, and published information, the clinician should be able 
to have a rough estimate of the preGtest probability of the patient being D+. Based on the 
result category or continuous measure and associated test performances (i.e. DSe & 
DSp), the clinician can estimate the postGtest probability of the patient being D+. Using 
the principles of the Bayes theorem, it is possible to calculate the #7=$L$%=$'788= of the 
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probability to be D+ by multiplying LR with the #&%L$%=$'788= of the probability to be 
D+: 
 
OddsPOSTGTEST = LR x OddsPREGTEST       (5) 
 
Based on the test result (i.e. positive or negative), LR+ or LR, are respectively used and 
the odds of the pre,test prevalence (Pr) is computed as Pr / (1GPr). Post,test probability 
can be back calculated from the post,test odds using OddsPOSTGTEST / (1 + OddsPOSTGTEST). 
However these calculations are intensive and not very intuitive, so a simpler method to 
determine the post,test prevalence is to use the nomogram developed by Fagan 
(Akobeng, 2007b). Fagan’s nomogram is a graphical tool (Fig. 1.2) requiring two 
information entries (i.e. assumed pre,test prevalence and computed LR) to obtain directly 
the post,test prevalence based on the test results (Fagan, 1975). In general, for low 
prevalences (i.e. < 5%), the odds can be approximated to the prevalence itself (Dohoo et 
al., 2009).  
 This approach mainly targets continuous outcomes test with category specific LR 
but can be adapted for cutpoint LR of dichotomous test. The obtained estimations of post,
test prevalences match then the estimations of predictive values. For instance, in 
surveillance or control programs settings, with no history or clinical information 
available, pre,test probability can be interpreted as the expected prevalence in the 
population when post,test probability is interpreted as the PPV based on the test result. 
According to the test result (i.e. positive or negative), the PPV of this test result can be 
assessed with the LR of the same test result (LR+ or LR,) with the assumed target  
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'
D;A5'45?5'0!%'D"A"6M='67<7A&"<'(adapted from Deeks & Altman, 2004). By drawing a 
straight line between the assumed pre,test prevalence (or population prevalence), on the 
left axis, and the calculated likelihood ratio (LR) of the observed test result (negative or 
positive: LR, & LR+, respectively), on the middle axis, the post,test prevalence (or 
positive predictive value, PPV) is estimated at the intersection of this line with the right 
axis. For value of LR+ and LR, according to customary values of DSe & DSp refer to 
Appendices 1 & 2, respectively. LR+ is computed as DSe / (1GDSp), and LRG as (1GDSe) / 
DSp. 
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population prevalence (i.e. pre,test prevalence). This estimation, as for individual clinical 
patient post,test prevalence, can be done mathematically or graphically with Fagan’s 
nomogram (Fig. 1.2). To facilitate LR calculation, separate estimation tables were 
constructed to assess LR+ and LR, as functions of DSe and DSp (Appendices 1 & 2, 
respectively).  
 
1.2.3.3 Efficiency, Youden index, diagnostic odds ratio 
 
 The overall accuracy of a test is conventionally expressed using three indices: 
efficiency (Ef), Youden index (J) and diagnostic odds ratio (DOR). When the true status 
of the sampled individual is known, these indices can be computed directly from the 2X2 
table (see section 1.5.2.1). As information about the true status is rarely known before 
hand, estimation of overall accuracy can be accomplished using DSe and DSp estimates. 
In this instance, Ef expresses the proportion of correctly classified individual (among D+ 
and D, combined) and is computed as a function of the DSe/DSp and prevalence (Pr) 
(Shapiro, 1999): 
 
Ef = Pr DSe + (1GPr) Dsp        (6) 
 
Ef is directly dependent on prevalence (i.e. prevalence,weighted average of DSe & DSp) 
and therefore has limited generalization compared to the status,specific accuracy 
measures of DSe and DSp (Alberg et al., 2004).  
Next, J can be directly computed from DSe and DSp independent of the prevalence: 
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J = DSe + DSp G1         (7) 
 
By restraining the added status,specific proportions of correctly classified individuals to 
the  interval [,1,1] this index is a useful single measure of test accuracy to compare test 
methods, conduct meta,analysis on diagnostic performance studies, or select cut,off 
values for continuous tests.  
 Finally, DOR is also independent of prevalence and can be expressed as a 
function of DSe/DSp or PPV+/NPV, or LR+/LR,: 
 
DOR = DSe DSp / (1GDSe) (1GDSp) = PPV+ NPVG / (1GPPV+) (1GNPVG) = LR+ / LRG (8) 
 
This index mirrors the ratio of correctly classified individuals over misclassified 
individuals, thus providing a measure of the overall discrimination performance of the 
test. DOR is a symmetrical parameter and therefore allows for conditional interpretations, 
on either the health status or the test result. As for J, DOR is a convenient single indicator 
of diagnostic accuracy that facilitates test comparisons, meta,analyses, and selection of a 
threshold (cut,off) (Glas et al., 2003). In addition, DOR is particularly meaningful when 
interpreting variation in test performance across studies using logistic regression models 
(Glas et al., 2003). 
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1.2.3.4 Sample size calculation for demonstration of freedom of disease 
  
A major assumption for a sample size calculation to demonstrate freedom from 
infection/disease is that the diagnostic test used to screen individuals is perfect (100% 
DSe & DSp) (Cannon & Roe, 1982). However, test methods are rarely perfect and 
sample size calculations need to be adjusted for misclassification bias. In this instance, a 
sample size calculation for freedom of disease can be corrected by dividing the initially 
computed sample size (n) by the DSe: 
 
n’ = n / DSe = (ln α / ln (1GPr*)) / DSe      (9) 
 
where α refers to the type I error (complement of confidence level) and Pr* refers to the 
minimum expected prevalence if the disease is present in the population. Potential 
misclassification of D+ individuals is adjusted by increasing the sample size to ensure 
that, if present in the sample set, at least one D+ will be correctly classified. 
 Open access software packages are available to compute sample sizes to 
demonstrate freedom of disease in frequentist or Bayesian frameworks respectively: 
FreeCalc, Survey Toolbox (Cameron & Baldock, 1998a&b); Bayes FreeCalc2, BDFree 
(Johnson et al., 2004). 
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1.2.3.5 True prevalence estimation 
 
 Another useful application of DSe and DSp is to calculate the $&9%'#&%B">%6:% 
(TP, proportion of D+ individuals) by adjusting the "##"&%6$'#&%B">%6:% (AP, 
proportion of positives) generated by the test. The AP can be expressed as a function of 
DSe and DSp using the sum of the proportion of true positives and the proportion of false 
positives in the population of prevalence TP: 
 
AP = TP DSe + (1GTP) DSp        (10) 
 
From Eq. (2), it is possible to arithmetically deduce TP as a function of the three other 
factors (DSe, DSp, AP) (Rogan  & Gladen, 1978): 
 
TP = (AP + DSp G 1) / (DSe + DSp G 1)      (11) 
 
where  DSe +DSp is expected to be greater than 1. 
Open access software available in the Survey Toolbox package (Cameron & Baldock, 
1998a&b) can be used for these calculations. 
 
1.2.3.6 Determination of fitness for purpose of a testing strategy 
 
 Ultimately, the user aims to maximize the level of certainty (i.e. predictive value) 
to facilitate the decision,making process according
  31
values are influenced by population factors (i.e. prevalence) over which the test user has 
very limited control. However, according to the testing purpose, the sampling strategy 
can be optimized (e.g. targeted sampling strategy) to increase prevalence for instance. 
The targeted operating characteristics of a testing strategy of a test may vary substantially 
and fit different purposes according to the intrinsic performance of a test, potential test 
combinations and interpretations (e.g. parallel or series), and the unit of interest (e.g. 
individual, herd).  
Commonly, the operating characteristics of interest are selected based on the 
mnemonic “SnNout and SpPin” (Akobeng, 2007a). For initial screening purposes, a well 
suited test is expected to be highly =%6sitive to increase the confidence of a 6egative test 
result (NPV,) and rule 79$ disease (N6,79$). For confirmation purposes, a well suited 
test is expected to be highly =#ecific to increase the confidence of a #ositive test result 
(PPV+) and rule ;6 disease (N#O;6).  
 According to OIE, 6 different categories of intended purposes exist and require 
different discriminative abilities (OIE, 2009b). Table 1.3 summarizes these purposes and 
the required discriminative skills to fit them.  
 
1.2.3.7 Interpretation of diagnostic parameters at the herd level 
 
Herd interpretation , Conventionally in veterinary epidemiology, the term herd 
refers to a group or aggregate of animals (e.g. tank or netpen group of fish). If the unit of 
sampling and testing is at the herd level (unit of concern), the interpretation of a test 
result, follows the same approach (e.g. a count of sealice larvae in a water sample from a 
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Although, this table is presented at the individual level, it can also be interpreted at the herd level. 
 
(6$%68%8'#9&#7=%=' 1CP%:$;B%' 0"&A%$'
0%=$'=$&"$%AE'
:&;$%&;"'&%J9;&%<%6$'
 
1. Demonstration of population ‘freedom’ from infection Min. FP Max. PPV+& LR+ Maximize DSp, r/RD, 
 
2. Demonstration of freedom from agent in trade product Min. FN Max. NPV,& Min. LR, Maximize DSe, r/RD+ 
 
3. Eradication of infection from defined populations 
 
Min. FP (economic concern) 
Min. FN (zoonotic concern) 
Max. PPV+& LR+ 
Max. NPV,& Min. LR, 
Maximize DSp, r/RD, 
Maximize DSe, r/RD+ 
 
4. Confirmatory diagnosis of clinical cases Min. FP Max. PPV+& LR+ Maximize DSp, r/RD, 
 
5. Estimation of prevalence of infection for risk analysis 
  
Min. FP & FN (estimation error) 
 
Max. PPV+,NPV,, LR+ 
Min. LR, 
Maximize DSe/DSp, r/R 
 
6. Determination of immune status (post,vaccination) 
 
Min. FP & FN (estimation error) 
 
Max. PPV+,NPV,, LR+ 
Min. LR, 
Maximize DSe/DSp, r/R 
 
FP: fraction of false positive 
FN: fraction of false negative 
PPV+: positive predictive value of a positive test, probability to be diseased if test positive 
NPV: negative predictive value of a negative test, probability to be non,diseased if test negative 
DSe: diagnostic sensitivity, probability to test positive if diseased 
DSp: Diagnostic specificity, probability to test negative if non,diseased 
r: repeatability, test results agreement within a laboratory for a non,diseased (D,) or diseased individual (D+)  
R: repeatability, test results agreement between laboratories for a non,diseased (D,) or diseased individual (D+) 
LR+: likelihood ratio of a positive test, ratio of the probability to test positive if diseased and the probability to test positive if non,diseased 
LR,: likelihood ratio of a negative test, ratio of the probability to test negative if diseased and the probability to test negative if non,disease
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salmon cage is interpreted at the cage level), as previously described (Dohoo et al., 2009). 
However, if the unit of sampling and testing differ from the unit of concern (e.g. 
individual salmon tested but level of concern is the cage), the herd level interpretation of 
the test performance relies on DSe and DSp, and also on the prevalence of D+ within the 
herd (Pr), the number of animals sampled (n), and the cut,off number of reactors (k) (i.e. 
animals testing positive) needed to declare the herd infected. 
 For individual fish from an infected cage, the probability to test positive is 
expressed by the apparent prevalence of the infected cage (AP+): 
 
AP+ =Pr DSe + (1GPr) (1GDSp)       (12) 
 
Consequently, the probability for a fish to test negative in this infected cage is the 
complement probability: 1G AP+. Assuming that sampled fish are independent (i.e. no 
clustering among samples) and that the lack of replacement of sampled fish does not 
substantially impact test result probabilities (i.e. there is a small sample size compared to 
total population size), the probability that the n sampled fish will test negative is: (1G 
AP+)n. 
 If a single reactor is required to call the cage positive (k = 1), then the probability 
to declare the cage positive given it is infected (!%&8'=%6=;$;B;$E, HSe) is the complement 
probability of all sampled fish testing negative: 
 
HSe = 1 G (1 G AP+)n         (13)  
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When the number of required reactors is ≥ 1, HSe is computed using the binomial 
probability distribution (Martin et al., 1992) assuming that the individual probabilities of 
a test result are not impacted by the lack of replacement during sampling (binomial 
approximation) and the health status of sampled fish are conditionally independent: 
 
HSe = 1G Σ0kG1 CkG1n (AP+)kG1(1G AP+)nG(kG1)       (14) 
Note: Cba is computed as a! / (aGb)! b!; and a!= a * aG1 * … * 1 
 
The binomial probability distribution approximation is only valid if the sample size (n) is 
lower than 20% of the total population size (N) and sampling with replacement can be 
extrapolated (i.e. probability of a fish to be samples is constant) (Christensen & Gardner, 
2000). When the sample size is larger, this approximation is not acceptable and HSe and 
HSp have to be computed using a hypergeometric probability distribution approach 
(Martin et al., 1992). 
For individual fish from a nonGinfected cage, the probability to test negative is 
simply computed as the complement of the apparent prevalence in this population when 
Pr = 0% using Eq. (12): Prob(TG) = 1 – AP+ = DSp. 
 Assuming that D, fish are independent, that the binomial approximation is valid 
and a single reactor is required (k =1) for a cage to be classified as test,positive, the 
probability to declare the cage negative (i.e. n samples tested negative), given it is free 
from infection (!%&8'=#%:;@;:;$E, HSp) is: 
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HSp = DSpn          (15) 
 
When the number of required reactors is ≥ 1, HSp is computed as (binomial 
approximation): 
 
HSp =  Σ0kG1 CnkG1 (1 G DSp)kG1(DSp)nG(kG1)      (16) 
 
If the binomial approximation is not acceptable, the hypergeometric probability approach 
can again be used (Martin et al., 1992). In addition, it is expected that, conditional on the 
health status, sampled fish are dependent (clustered) (Christensen & Gardner, 2000). 
Adjustment for clustering are beyond the scope of this discussion and are covered 
elsewhere (Donald et al., 1994). 
 According to the individual test accuracy (DSe & DSp), the population 
characteristics (Pr), and surveillance design (n & k), HSe and HSp may vary substantially 
(Christensen & Gardner, 2000). The influence of each factor is described in Table 1.2.  
Developed by Jordan in 1996 
(http://www.vetschools.co.uk/EpiVetNet/Sampling_software.htm), an open access 
software called HERDACC version 3 enables the computation of HSe and HSp with 
binomial or hypergeometric probability distribution approaches for different values of 
within herd prevalence (Pr), sample size (n) and number of reactors (k). A major 
advantage of this software is the possibility to compute the number of reactors necessary 
for specified HSe or HSp (Jordan, 1996). A more flexible version of HERDACC was 
developed in a Bayesian framework that takes lack of independence of test results into  
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  !"6A%' TN%' TN#'  7<<%6$='
Diagnostic sensitivity (DSe) 
up up no influence  
down down no influence  
Diagnostic specificity (DSp) 
up down upa afor n fixed 
down up downa afor n fixed 
Number of animal tested (n) 
up upb downc bminimal if Pr>.4; cfor DSp < 1 
down downb upc bminimal if Pr>.4; cfor DSp < 1 
Number of reactor threshold (k) 
up down up  
down up down  
Within herd prevalence (Pr) 
up up no influence For n fixed & DSe>(1,DSp) 
down down no influence For n fixed & DSe>(1,DSp) 
Diseased correlation (cov+) 
up down no influence  
down up no influence  
Non,diseased correlation (cov,) 
up downd  dminimal if k>2 
down upd  dminimal if k>2 
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account (Jordan & MacEwen, 1998). Donald et al. (1994) also developed a software 
(AGG.exe) that explores effects of correlation using a betabinomial probability 
distribution. Finally, Freecalc (from Survey Toolbox) uses the maximum number of 
positive test results to declare a herd free of disease as the required number of reactors 
(Cameron & Baldock, 1998a&b). 
 It is also possible to compute herd predictive values (HPPV & HNPV) (Martin et 
al., 1992), likelihood ratios (HLR), efficiency (HEf), Youden index (HJ), diagnostic odds 
ratio (HDOR) and herd true prevalence (HTP) by replacing the individual level 
parameters (DSe, DSp, and Pr) with HSe, HSp and the prevalence of infected herds (HPr) 
(Christensen & Gardner, 2000). 
 
1.2.3.8 Interpretation of diagnostic parameters with pooled samples 
 
 One strategy to increase the proportion of total animals screened and/or reduce the 
testing costs per individual animal is to pool the samples (e.g. tissues or fluids) from 
several individuals and test them as a single unit. This practice is particularly attractive 
during surveillance programs when the probability of sampling a D+ fish is low (i.e. low 
prevalence). In this instance, the unit of sampling (fish) is now different from the unit of 
testing (i.e. pool of samples) leading to an interpretation at the pool level or at the herd 
level (several pools tested in a herd).  
At the pool level, it is possible to use individual estimates of the test DSe and DSp 
to predict the DSe and the DSp of a pool of m randomly collected samples (PSe and PSp, 
respectively). These calculations account for the probability to sample D+ individuals 
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from the herd. The following calculations do not apply for pools of samples that include 
specimens of different origin or with different probabilities to be D+. Assuming that no 
clustering occurred within pools (conditional independence among sampled fish), the 
probability that a pool of m D, fish test negative (PSp) from a free population (Pr =0) is 
(Christensen & Gardner, 2000): 
 
PSp= DSpm          (17) 
 
This formula assumes that the binomial approximation is acceptable (i.e. fish are sampled 
without replacement and the sample size is < 20% total population size). Computation of 
the pool sensitivity (PSe) can be very complex due to its dependence on numerous factors 
and can end very complex (Muñoz,Zanzi et al., 2006). We suggest here one approach 
that requires to be validated. Using the assumptions of no fish clustering, binomial 
approximation, homogeneous pools of samples, and the power of individual detection is 
not influenced by dilution (i.e. a single true positive in the pool is sufficient to yield a 
positive result for the pool), the probability that a pool of m fish with at least one D+ 
(k≥1) that tests positive (PSe) follows: 
 
PSe =1 G  Σk=1m Ckm (Pr (1GDSe))k ((1G Pr) DSp)mGk     (18) 
 
The assumption of no dilution effect is frequently incorrect. Depending on the pooling 
technique, the final pooled specimen can be either diluted (e.g. mixture of specific 
volumes of biological tissues or fluids) or concentrated (e.g. sequential dipping of 
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sampling swabs in the same set volume of transport media). Since it is associated with the 
analytical sensitivity (ASe) and potential inhibitor concentration, PSe decreases with 
diluted pools (especially when prevalence is low) (Christensen & Gardner, 2000), while 
DSe may increase with concentrated pools. Conversely, concentrated pools should 
increase the concentration of a potential contaminant and therefore decrease PSp 
(Christensen & Gardner, 2000), while diluted pools may increase PSp.  
 The dilution or concentration effect of pooling generates some clustering effect 
among samples according to their biological characteristics (Dohoo et al., 2009). For 
instance, the detection of D+ samples may depend on the concentration of analyte, the 
non,detection of D, samples may depend on the degree of exposure to different 
contaminants, and the interaction between D, and D+ samples may change the detection 
characteristics, depending on the homogeneity of mixing and increased complexity of the 
sampling matrix. Therefore, the assumption that test performance is independent among 
samples (conditional or not on the health status) associated with the 
dilution/concentration effect and the homogeneity of the pool is rarely legitimate. 
 Furthermore, by increasing the number of animals screened for a similar cost of 
analysis, sample pooling can be used to increase the HSe (and decrease of HSp) 
(Christensen & Gardner, 2000). In this instance, the unit of sampling (e.g. fish) is 
different from the unit of testing (pool), and different from the unit of interpretation (herd 
level). By binomial approximation, the probability that a pool of m samples tests negative 
when the herd prevalence is Pr, the complement of the pool apparent prevalence (PAP) is 
calculated as follows: 
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1GPAP = (1G(1GPr)m) (1GPSe) + (1GPr)m PSp      (19) 
 
The herd pool sensitivity (HPSe) is then calculated including the number of pools tested 
(r) and the number of required reactor pools (k): 
 
HPSe = 1G Σ0kG1 CkG1r(1G(1GPAP))kG1(1GPAP)rG(kG1)      (20) 
 
Alternatively, the herd pooled specificity is calculated as: 
 
HPSp = 1G Σ0kG1 CkG1r (1 G PSp)kG1(PSp)rG(kG1)      (21) 
 
For the particular case where k = 1, the HPSe and HPSp are, respectively (Christensen & 
Gardner, 2000): 
 
HPSe = 1G [(1G(1GPr)m) (1GPSe) + (1GPr)m PSp]r     (22) 
HPSp = PSpr          (23) 
   
A program to compute within herd prevalence from pool testing results (at least two 
sample pools tested) was developed for both frequentist and Bayesian approaches and is 
reviewed elsewhere (Cowling et al., 1999). 
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1.2.3.9 Evaluation of multiple testing performances 
Utilization of multiple assays may improve the overall performance of testing and 
may, in some instances, reduce operating cost. More than two test methods can be used, 
however, the interpretation and the estimation of the combined operating characteristics 
may be complicated. The following discussion will be limited to the combination of 2 
tests for the sake of brevity.  
Paired results from 2 tests can be interpreted either ;6'#"&">>%> or ;6'=%&;%=. For 
parallel interpretation of paired results, an individual is deemed positive if it yields at 
least one positive result; and a sample is deemed negative if it yields two negative results. 
For series interpretation of paired results, an individual is deemed positive if it yields two 
positive results; and a sample is deemed negative if it yields at least one negative result. 
 The proportions of the four possible test result combinations (i.e. ++, +,, ,+, ,,) 
can be expressed using individual DSe and DSp of the respective test and a covariance 
factor representing the test dependence, conditional on the health status (cov+ & cov,, 
respectively) (Table 1.3). Therefore, parallel and series DSe/DSp (DSeP/DSpP & 
DSeS/DSpS, respectively) are as follows: 
 
DSeP = 1G [(1GDSe1)*(1GDSe2) + cov+]      (24) 
DSpP = DSp1 * DSp2 + covG        (25) 
DSeS = DSe1 * DSe2 + cov+        (26) 
DSpS = 1G [(1GDSp1)*(1GDSp2) + covG]      (27) 
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Infected/Diseased  Test 2 
  Positive  Negative  
Test 1 Positive DSe1*DSe2+cov+ DSe1*(1GDSe2)Gcov+ Negative (1GDSe1)*DSe2Gcov+ (1GDSse1)*(1GDSe2)+cov+ 
 
NonGinfected/NonGdiseased  Test 2 
  Positive  Negative  
Test 1 Positive DSp1*DSp2+covG DSp1*(1GDSp2)GcovG Negative (1GDSp1)*DSp2GcovG (1GDSp1)*(1GDSp2)+covG 
 
0"C>%'45['
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#&7#7&$;76=' 7@' #";&%8' &%=9>$=' @7&' ;6@%:$%8R8;=%"=%8' SO2YV' "68' 676L;6@%:$%8R676L
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Infected/Diseased (D+)  Test 2  
  Positive Negative  
Test 1 Positive P
D+++ PD++G PD++. 
Negative PD+G+ PD+GG PD+G. 
  PD+.+ PD+.G 1 
 
NonGinfected/NonGdiseased (DG)  Test 2  
  Positive Negative  
Test 1 Positive P
DG++ PDG+G PDG+. 
Negative PDGG+ PDGGG PDGG. 
  PDG.+ PDG.G 1 
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When the two tests are :768;$;76">>E';68%#%68%6$, the covariate factors (cov+ & 
cov,) are nil. In other words, for a defined infection class (i.e. condition), the results of 
one test does not depend on the result of the other test (i.e. the proportion of a test result 
is the same in the two result categories of the other test) (Dohoo et al., 2009). Note that if  
DSe (or DSp) of one test is perfect (100%), the two tests are conditionally independent in 
D+ (D,).  
 If the tests are conditionally independent, parallel interpretation improves 
the DSe for screening purposes; and series interpretation improves the DSp for 
confirmatory purposes. When tests are conditionally dependent (cov+ and/or cov, not 
nil), combined performances may partially increase or decrease according to the degree 
of correlation between tests. For D+ animals, when tests are positively correlated (cov+ > 
0), DSeP decreases and DSeS increases compared to when the tests are conditionally 
independent.  Reciprocally, when tests are negatively correlated (cov+ < 0), DSeP 
increases and DSeS decreases. For D, animals, if tests are positively correlated (cov, > 0), 
DSpP increases and DSpS decreases; and if tests are negatively correlated (cov, < 0), 
DSpP decreases and DSpS increases. When the true status of the specimens is known, 
cov+ and cov, can be estimated by comparing the observed (Table 1.4) and the expected 
proportions of paired result combinations (Table 1.3) as follows: 
 
Cov+ = PD+++ G (DSe1 * DSe2)      (28) 
CovG = PDGGG G (DSp1 * DSp2)       (29) 
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where PD+++ is the observed proportion of the two test results that are positive in the D+ 
group while PD,,, is the observed proportion of the two test result that are negative in the 
D, group. When the true status is unknown, latent class modelling procedures can be used 
to estimate cov+ and cov, under specified conditions (see section 1.5.2.2.2). 
Statistical procedures to test for test dependence (conditional or not) include: 
Cohen’s kappa significance test (compared to 0), odds ratio significance test (compared 
to 1), logistic regression modelling (log odds ratio), loglinear/association/quasi,symmetry 
modelling.  
Multiple tests can be used =;<9>$"6%79=>E, but =%J9%6$;"> testing provides more 
practical cost reductions by processing the less expensive test first. For parallel 
interpretation, only samples initially testing negative are subsequently submitted to the 
second test. For series interpretation, only samples initially testing positive are 
subsequently submitted to the second test. Assessment of the most cost,effective strategy 
to combine and interpret multiple tests in a Bayesian framework is discussed in detail by 
Geisser & Johnson (1992). 
 
1.2.3.10 Further assessments of test efficacy 
 
 Although not specified in OIE guidelines, alternative evaluation methods to assess 
test efficacy or usefulness can be used. For instance, the test can be evaluated on the basis 
of clinical patient outcomes or economic consequences of the test result (Van den Bruel 
et al., 2007). the health management of an animal is, however, often primarily directed by 
economic concerns especially in the international trade of animal food and products. 
Nérette et al. (2008a) conducted detailed analysis for selection of the most economic 
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strategies for ISAV surveillance programs in Atlantic salmon aquaculture. According to 
the intended objectives, the factors to consider when in designing and comparing testing 
strategies in animal production are: 
1. Animal production structure – The organisation of the industry and the different 
sectors (in time and in space) of the production system must be clearly defined. 
For instance, Nérette et al. (2008a) identified four separate production sectors in 
salmon industry: seawater broodstock, freshwater broodstock, pre,smolt 
(freshwater) and grow,out salmon (saltwater). 
2. Estimation of test performance at the fish level – For all test methods of interest, 
estimates of individual DSe and DSp must be known and their validity in the 
different production sectors identified (i.e. external validity). Performances of test 
combination (usually two) should be explored and estimated (see section 1.2.3.9).  
For instance, Nérette et al. (2008a) investigated parallel and series interpretation 
of paired tests. 
3. Definition of a case and level of interpretation – According to the production 
sector, identification of the appropriate unit of concern (fish, tank, cage or 
hatchery level) and the corresponding criteria to classify the unit of concern as 
test,positive (e.g. number of reactors). For instance, Nérette et al. (2008a) 
interpreted broodstock at the individual level, while pre,smolt and grow,out 
salmon were interpreted at the pen level.  
4. Test criteria for comparison. When the individual fish is the unit of concern 
appropriate for the intended purpose, the testing strategies are compared based on 
PPV+ or NPV, and their associated costs. When the herd is the unit of concern 
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appropriate for the intended purpose, the testing strategies are compared based on 
HPPV+ or HNPV, and their associated costs. If the clinical patient outcome is the 
primary interest, the testing strategy would be based on the probability of a 
favourable patient outcome. 
5. Selection of testing strategiesG For individual interpretation, all fish must be 
sampled and tested. Therefore, the best testing strategy is based on the best 
detection performances and lowest costs across different levels of realistic 
infection prevalence. For herd interpretation, the best testing strategy is based on 
the lowest associated cost for targeted detection performance. Only a portion of 
fish are sampled and tested in a herd. Therefore, the optimal detection 
performance (HPPV+ & HNPV,) depends on the number of sampled fish, if the 
samples are pooled or not, the minimum required number of reactors, the within 
herd prevalence (Pr) and the herd level prevalence (HPr). Consequently, different 
sample, pool and reactor sizes should be considered and compared across 
different levels of Pr for minimum targeted values of HSe and HSp and specific 
levels of HPr. For instance, Nérette et al. (2008a) compared different sample (not 
pooled) and reactor sizes suited for a minimum HSe and HSp of 95% and the 
assumed HPr of 0.1%. 
 
 Evaluation of DSe and DSp is the initial step and critical for appropriate decisions 
regarding the use of diagnostic tests. Testing strategies cover a wide range of designs 
according to the units of sampling, testing, and interpretation, and the access to multiple 
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tests and concerns associated with the classification uncertainty (clinical and economic 
consequences). 
 
45X'(6@%:$;79='N"><76'.6"%<;"''
 
1.3.1 Historic and modern challenges 
 
 Numerous review articles provide a detailed and extensive source of information 
regarding infectious salmon anaemia (ISA) (Cipriano, 2002; Mjaaland et al., 2002; 
Rimstad & Mjaaland, 2002; Kibenge et al., 2004; Martin, 2007; OIE, 2009b). A good 
indication of the importance of ISA is reflected by the frequency of peer,reviewed 
publications addressing this specific disease. Since the first known occurrence of the 
disease in 1984 in Norway (Thorud & Djupvik, 1988), ISA has been increasingly studied 
with sporadic publication peaks corresponding to the progression or new geographical 
occurrence of the disease (Fig. 1.3). A detailed review of the information relevant to 
diagnostic use and evaluation for ISA will be the focus of this section.  
 ISA is frequently a lethal disease of farmed Atlantic salmon, Salmo salar L., 
caused by an orthomyxovirus (Falk et al., 1997). A member of the genus Isavirus, it is 
related but distinct from Influenza viruses (Kawaoka et al., 2005). Infectious salmon 
anaemia virus (ISAV) is described as an enveloped, spherical particle of approximately 
90,140 nm diameter (Hovland et al., 1994) and containing 8 genomic segments of single,
stranded negative,sens RNA (Mjaaland et al., 1997). More conserved and providing 
higher amplification success, the 8th segment is targeted for amplification in nucleic acid  
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 D;A5'45X5' 796$'#%&'E%"&'7@'#9C>;=!%8'&%@%&%6:%='@7&';6@%:$;79='
="><76'"6"%<;" (ISA). Red arrows indicate the year of first record 
of ISA according to the indicated country. 
 
 
 D;A5' 45[5' (6@%:$;79=' ="><76' "6"%<;"' 8;=$&;C9$;76 <"#' C"=%8' 76'
?WW¥L?WW]'&%#7&$=. 
Adapted from OIE, WAHID website: 
http://www.oie.int/wahis/public.php?page=disease_status_map&disease_ty
pe=Aquatic&disease_id=160&sta_method=semesterly&selected_start_year
=2008&selected_report_period=1&selected_start_month=1&page=disease_ 
status_map. 
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detection (NAD) methods, while the 6th segment is used for virus typing by sequencing 
the highly polymorphic region (HPR) (Rimstad et al., 2001). Recently, the 5th segment is 
also used to increase the resolution of the genotyping (Nellie Gagné, pers. com.). The 
viral genome has been described as coding for at least 10 proteins (9 structural and 1 non,
structural) (Kibenge et al., 2004). Among these proteins, two are surface glycoproteins 
which compose resembling mushroom,shaped projections that are of particular interest 
for diagnostic tests. A hemagglutinin,esterase (HE), coded by segment 6 (Rimstad et al., 
2001), is responsible for receptor,binding (hemagglutinin) and receptor,destroying 
(esterase) activity, and a fusion protein (F), coded by segment 5 (Aspehaug et al., 2005), 
is putatively responsible for the fusion between the viral and cellular membranes.  
 The antigenic properties of the surface proteins induce a protective immune 
response in exposed hosts associated with the production of anti,ISAV specific 
antibodies (Falk & Dannevig, 1995). The presence of antibodies against ISAV suggests 
attractive applications for both direct and indirect detection methods (Falk et al., 1998). 
The physical and chemical properties of these proteins elucidate the virus 
pathophysiology and further explain the limited host range of the virus (i.e. salmonids) 
(Cipriano, 2002). For instance, the thermolability of the virus to higher temperatures (i.e. 
> 25°C; Falk et al., 1997) disproves the hypothetical infection of homeothermic 
vertebrates, including humans.  With no zoonotic potential, ISAV mainly represents an 
economical threat for salmon farming due to mortalities, depopulation losses and 
surveillance costs. In 1999, the annual economic impact of ISA was estimated at US$ 14 
million in Norway, US$ 11 million in Eastern Canada, and around US$ 15 million in 
Scotland (Hasting et al., 1999). Among the Atlantic salmon production areas, some 
  50
countries remain ISA,free (e.g. Australia and New,Zealand) and other are considered 
currently free (e.g. Faroe Islands) (Fig. 1.4). Given international trade concerns, 
specifically significant production losses and potential for introduction to free areas, ISA 
was listed as a concern by OIE in 1990 (Mjaaland et al., 2002) and became officially 
reportable in 2003 (Martin, 2007). In Canada, ISA has been present on the Atlantic coast 
since 1996 (Mullins et al., 1998), but the Pacific coast (British Colombia) is officially 
free of viral infection (WAHID OIE website). For this reason, the Canadian National 
Aquatic Animal Health Program (NAAHP) is responsible for maintaining barriers to the 
spread of ISA between the two coasts through coordinated surveillance programs by 
assessing and controlling practices contributing to the risk of transfer.  
 Control and intervention strategies are limited for a viral disease such as ISA. 
Scotland was apparently able to eradicate the disease using aggressive culling based on 
an intensive surveillance program (Stagg et al., 2001). Recently, however, Scotland 
experienced new clinical outbreaks of ISA in the Shetland Islands (WAHID OIE 
website). Development and evaluation of detection methods has been identified as critical 
for the efficient control of ISA (RSE, 2002).  
 
1.3.2 Organ of choice for testing for ISA 
 
 Tissue collection is a key element to the successful detection of a pathogen (OIE, 
2009b). For ISAV detection, the targeted organ depends on the test method, the intended 
purpose of the test, and the stage of infection in the targeted animals. Organs should be 
  51
chosen for optimal detection methods based on information about the pathogenesis and 
route of host exposure. 
 
-79$%'7@';6@%:$;76, The main route of transmission for ISAV appears to be 
horizontal (Melville & Griffiths, 1999). Past failure to experimentally infect fish per os 
(Totland et al., 1996) suggested that infection by coprophagy or cannibalism is less 
likely, although not ruled out completely (Mikalsen et al., 2001). Gills were suggested to 
be the most likely natural route of entry (Totland et al., 1996). Sea lice parasites and their 
associated skin lesions may play a role (Nylung et al., 1994). With a strong tropism for 
leucocytes and endothelial cells (Hovland et al., 1994), the virus starts replicating locally 
in the gills vascular endothelium, and by infecting deeper cell layers, penetrates lamellae 
and filament capillaries. According to the surveillance program in the Faroe Islands 
(Christiansen & Ostergaard, 2008), A;>>= are the organ of choice to screen salmon for low,
virulence genotypes (e.g. HPR,0), suggesting that this genotype might have a specific 
tropism for gills and might not spread further within the organism. 
'
^;&"%<;"'"68'=E=$%<;:'=#&%"8L'Once in the circulatory system, the virus has been 
shown to replicate in erythrocytes, leucocytes and endothelial cells (Hovland et al., 1994; 
Moneke et al., 2005; Workenhe et al., 2007) and spreads systemically. ISAV is described 
as a vascular disease where mortality and morbidity are due to severe internal 
haemorrhaging blood loss and subsequent hypovolemic shock. It takes an average of 7 to 
13 days for the virus to induce repercussions on the vascular system, depending on the 
infective dose and the virulence of the agent. _>778 has been identified as a potentially 
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non,lethal sample as supported by studies comparing this sample type with other tissues 
(Giray et al., 2005). Following the circulatory system of the salmon, ISAV is believed to 
spread rapidly into well perfused organs, namely heart, kidney, spleen, intestines, and 
liver. Due to the extensive network of endothelium comprising the !%"&$ stroma, this 
organ is currently considered the most appropriate target for early detection using 
sensitive methods such as RT,PCR (Mikalsen et al., 2001; Snow et al., 2003). 
 In the >;B%&, infection of the vascular endothelium affects vascular 
integrity resulting in reduced blood distribution, generating severe congestion. With 
limited blood supply and oxygenation, the degeneration of hepatocytes is triggered 
resulting in multifocal to confluent regions of necrosis (Spielberg et al., 1995). 
Subsequently, increased portal venous pressure may cause the impediment of the 
sinusoidal and returning blood flow to the heart, often leading to the accumulation of 
ascites (Evenson et al.1, 1991). Ascites, however, may also be secondary to 
hypoproteinaemia caused by extensive liver damage, and severe nephropathy inducing 
decreased production of plasma protein (Simko et al., 2001). Severe nephropathy may 
similarly be associated with hypoproteinaemia (Simko et al., 2001).''
 In the K;86%E, virus affects mainly the posterior (excretory) component rather 
than the anterior (haematopoietic) segment of the organ (Simko et al., 2001). Interstitial 
vascularisation is affected, with the appearance of multifocal, sometimes coalescing to 
diffuse, haemorrhages (Byrne et al., 1998). As with the liver, this internal haemorrhaging 
will lead to both blood flow and oxygenation problems, as reflected by necrosis of 
tubular epithelium in some cases. Although possessing a similar blood supply, the 
anterior kidney seems to be less affected. Tubular lesions may be associated, caused by 
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peritubular haemorrhages. Necrotic foci have been observed in the hematopoietic tissues 
and are suspected to involve cells targeted by the virus, such as macrophages (Byrne et 
al., 1998). While prominent pathological changes were observed in the liver in Europe, 
kidney lesions were the primary lesions in early North American cases which erroneously 
led to the differentiation of the two pathologies: ISA in Norway, and haemorrhagic 
kidney syndrome (HKS) in Canada (Mjaaland et al., 2002). In practice, the kidney has 
been the sampling organ of choice.  
 Fixed macrophages are actively involved in the phagocytic activity in the renal 
portal endothelium and in other reticuloendothelial tissues, such as the =#>%%6'and kidney. 
Splenic lesions usually include diffuse congestion with degrees of erythrophagocytosis 
(Simko et al., 2001). Snow et al. (2003) experienced difficulty detecting the pathogen in 
spleen samples, suggesting that the splenic endothelium is not the primary location of 
virus replication. Depending on the individual fish, pathologic findings may also be 
observed in the intestines, pyloric caeca and stomach mucosa. Pathologic changes to 
these tissues can range from minor congestion and haemorrhaging within the lamina 
propria to severe mucosal necrosis and sloughing with marked intralumenal hemorrhage 
(Simko et al., 2001, Godoy et al. 2008). 
 
+I:&%$;76'#!"=%L After 7 days post,infection (dpi), the fish begins shedding virus into 
the surrounding environment (Gregory et al., 2009) through a variety of external 
products, such as mucus, faeces and urine (Totland et al., 1996). Two to three days before 
mortality (approximately 14 dpi), the shedding is maximal, associated with increased 
probability of transmission to surrounding fish (Gregory et al., 2009). At this late stage, 
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Griffiths & Melville (2000) identified A;>>'<9:9= as more likely to be positive for virus, 
compared to serum, using RT,PCR as a non,lethal detection method. 
 
T7=$'&%=#76=%'$7';6@%:$;76, A progressive decrease of the viral load was observed after 
15,20 dpi, while a minimum of 25 dpi is required before the first evidence of a host 
immune response is apparent (Milkalsen et al., 2001). Resistance to re,infection was 
shown in fish previously infected or after passive immunization (using serum from 
recovering salmon), suggesting the presence of an adaptative humoral immunity against 
ISAV (Falk & Dannevig, 1995). Evidence of two types of antibody responses has been 
reported (Kibenge et al., 2002). Specific antibody responses were observed in recent 
acute infections, while cross,reacting antibody responses were suggested in chronic 
infections or resistance to ISAV. Subsequent production of ;<<967A>7C9>;6 in response 
to ISAV infection represents an indirect analytical target for detection of infection in 
serum samples (Kibenge et al., 2002). Degrees of protection were also reported in salmon 
vaccinated with inactivated ISAV (Jones et al., 1999, Brown et al., 2000, Salonius et al., 
2003) and may lead to false positive results. 
 
 Although, proper tissue selection and sensitive detection of ISAV is challenging 
in the early stages of infection, the exponential replication of the virus and the subsequent 
development of systemic infection generates several options for specimen collection. In 
case of suspicion, subsequent visits to the production site should increase the chance of 
detecting the virus if present. Persistently low levels of infection would be surprising for 
virulent genotypes of ISAV. Asymptomatic (i.e. HPR0) or healthy carriers of the virus 
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may, however, exist and represent greater challenges with the test methods currently 
available. 
 
1.3.3 Developed ISAV diagnostic methods 
 
 Although Norway experienced ISA episodes as early as 1984 (Thorud & Djupvik, 
1988), the viral agent was first visualized by electronic microscopy (Hovland et al., 1994) 
and grown in cell culture (Dannevig & Falk, 1994) in 1994. Prior to this time, diagnosis 
of ISA was conducted using gross pathology, haematology and histopathology (Evensen 
et al., 1991). Virus isolation (VI) was thereafter developed and standardized by Dannevig 
et al. (1995a) in well established cell line salmon head kidney 1 (SHK,1) and later in 
other salmonid cell lines, including: Chinook salmon embryo (CHSE,214; Bouchard et 
al., 1999), Atlantic salmon kidney (ASK; Devold et al., 2000), salmon head kidney 
leukocytes (TO; Wergeland & Jakobsen, 2001), Atlantic salmon (AS; Sanchez et al., 
1993), and epitheliocytes of carp (EPC, Godoy et al., 2008). Identification of ISAV 
propogated by cell culture is achieved using adjunct assays. Initially confirmed by 
electron microscopy, the presence the viral agents was followed later by verification 
using mouse monoclonal antibodies against the HE surface protein in an indirect 
immunofluorescent antibody test (IFAT) (Falk & Dannevig, 1995).  
 Currently, monoclonal antibodies against ISAV are also used to detect and 
localize viral particles in tissue sections using immunohistochemistry (Falk et al., 1998), 
or in commercial field test kits (Aquatic Diagnostics Ltd., Stirling, Scotland). VI 
remained the main method of detection until 1997 when a nucleic acid amplification test 
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(NAAT) method was developed using reverse transcriptase,polymerase chain reaction 
(RT,PCR) targeting the RNA segment 8 of the viral genome (Mjaaland et al., 1997). 
Subsequently, alternative versions of RT,PCR were developed, including: one,tube 
(Melville & Griffiths, 1999), nested (Løvdal & Enger, 2002) and real,time (Munir & 
Kibenge, 2004). RT,PCR has also been used as an adjunct method to identify ISAV in 
CPE positive cell cultures. The sensitivity and resolution of localizing viral particles in 
infected tissues was later improved using riboprobes for in situ hybridization (ISH) 
(Gregory, 2002; Moneke et al., 2003). Finally, indirect diagnostic methods have recently 
been developed to detect antibodies against ISAV in infected and/or vaccinated salmon 
sera with direct or indirect competitive enzyme,linked immunosorbent assay (ELISA) 
(Kibenge et al., 2002).  A summary of ISAV detection methods is presented in Table 1.5. 
 
1.3.4 Past evaluations of ISAV diagnostic tests 
 
 Justified by the importance to accurately detect ISAV for control and surveillance 
programs, the “field” efficacy of common ISAV detection assays has been evaluated in 
several studies. McClure et al. (2005) evaluated the performances of histopathology, VI, 
IFAT and RT,PCR using a standard of reference, while Nérette et al. (2005a, 2008b) did 
not include histology and Gustafson et al.(2008) focused on IFAT and RT,PCR using 
advanced analytical methods without reference standard information (i.e. a  latent class 
model). 
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Behavioural changes* na Mortality Dis. Gustafson et al.2005  
Clinical signs*  
Eye, skin, fins, vent, gills Hemorrhagic lesions Dis. 
NORWAY Thorud & Djupvik1988, Thorud1991, Evensen et al.1991 
CANADA & USA Mullins et al.1998, Byrne at al.1998, Bouchard et al.2001 
UK, FAEROE ISLAND Rodger at al.1998,Anonymous2000 
CHILE Godoy et al.2008  
 
 >;6;:">LC"=%8'8;"A67=$;:'<%$!78='      
Gross pathology* Peritoneal walls, liver, spleen,  intestinal wall, kidney, skeletal 
muscle 
Hemorrhagic lesions, 
congestion, necrosis Dis. Hovland et al.1994, Falk & Dannevig1995, Spielberg et al.1995, Byrne et al.1998 Opitz et al.2000 
Haematology* 
Blood 
Hematocrite, Corticol, 
Lactate, Glutathione, Total 
plasma protein. 
Hyperglycaemia 
Dis. Hjeltnes et al.1992, Olsen et al.1992, Speilberg et al.1995, Simko et al.2001 Opitz et al.2000 
Smears*  Blood  Dis.   
Microscopic pathology* (histology) Gills, liver, spleen, kidney, heart  Dis. Evensen et al.1991, Speilberg et al.1995, Byrne et al.1998, Mullins et al.1998, Simko et al., 2000 Opitz et al.
2000, Snow et al., 2003, 
McClure et al.2005 
Electronic microscopy*    Inf. or Dis. Hovland et al.1994, Nylung et  al.1995, Speilberg et al.1995, Koren & Nylund1997, Workenhe et al.2007 Nylung et  al.1995 
.6">E$;:">LC"=%8'8;"A67=$;:'<%$!78=      
Virus isolation* Gills, liver, spleen, kidney, heart Active viral particleDIR Inf. or Dis. Dannevig et al.1993, Dannevig & Falk1994 ; SHK,1Dannevig et al.1995a,b, Dannevig et al., 1997; CHSE,214 Bouchard et al.1999, Lovely et al.1999, Kibenge et al.2000a ; ASK 
Devold et al.2000, Rolland et al.2003 ; TO Wergeland & Jakobsen2001; AS Sanchez et 
al.1993; Sommer & Mennen1996 & 1997 ; Rtgill,W1 Bols et al.1994, Falk et al.1997; EPC 
Godoy et al.2008 
McAllister1997, Falk et al.1998, 
 Kibenge et al.2000a,b, Opitz et al.2000, 
Grant & Smail2003, Moneke et al.2003, 
Rolland et al.2003, Snow et al.2003, Munir 
& Kibenge2004,  McClure et al.2005, 
Rolland et al.2005, Nérette et al.2005a,b,2008b 
Indirect fluorescence antibody test* Kidney smear, adjunct to VI (confirmatory) Hemagglutinin Esterase
DIR Inf. or Dis. Falk & Dannevig1995, Mjaaland et al. 1997, Falk et al.1998, Blake et al.1999, Bouchard 
et al.1999, Rimstad et al.1999, McBeath et al.2006 
Opitz et al.2000, Snow et al.2003, 
McClure et al.2005 
 Nérette et al.2005b, 2008b,  
Gustafson et al.2008 
Lateral flow immnoassay Fresh kidney tissue NucleoproteinDIR  Aquatic Diagnostics Ltd. ( http://www.aquaticdiagnostics.com/)  
Immunohistochemistry*  Histology embedded tissue section Hemagglutinin EsteraseDIR Inf. or Dis. Falk & Dannevig1995, Falk et al.1998, Wilson et al.2002, OIE2009b  
In situ hybridization Histology embedded tissue section Messenger RNADIR Inf. or Dis. Gregory, 2002; Moneke et al., 2003, Moneke et al.2005, MacWilliams et al.2007  
Reverse transcriptase,polymerase chain 
reaction(RT,PCR)* Gills, liver, spleen, kidney, heart, adjunct to VI (confirmatory) Genomic RNA
DIR Inf. or Dis. 
Mjaaland et al.1997, Blake et al.1999, Bouchard et al.1999, Melville & Griffiths1999, 
Rimstad et al.1999, Devold et al.2000, Kibenge et al.2000a,b, McBeath et al.2000, 
Mikalsen et al.2001, Løvdal & Enger2002, Mjaaland et al.2002 
Opitz et al.2000, Snow et al.2003, 
McClure et al.2005, 
Nérette et al.2005a,b, 2008b,  
Gustafson et al.2008  
Quantitative RT,PCR* Gills, liver, spleen, kidney, heart Genomic RNADIR Inf. or Dis. Munir & Kibenge2004, Plarre et al.2005, Snow et al.2006, Starkey et al.2006, Snow et al.2009 Workenhe et al.2008 
Loop mediated isothermal amplification Gills, liver, spleen, kidney, heart Genomic RNADIR Inf. or Dis. McCarthy et al.2006  
Isothermal rolling circle amplification  Gills, liver, spleen, kidney, heart Genomic RNADIR Inf. or Dis. McCarthy et al.2007  
Haemadsorption Adjunct to VI Hemagglutinin EsteraseDIR Inf. or Dis. Smail et al.2000  
Virus neutralization Blood serum Antibody anti,ISAVIND Inf. or Dis. Joseph et al.2003, Kibenge et al.2004  
Enzyme,linked immunosorbent assay* Blood serum Antibody anti,ISAVIND Inf. or Dis. Kibenge et al., 2002, Falk Pers. Com. Cipriano2009 
*listed in OIE Manual (2009b) 
na: non applicable 
DIR direct 
IND  indirect 
Inf.: infection 
Dis.: Disease 
SHKG1: Salmon Head Kidney                   AS: Atlantic salmon 
CHSEG214: Chinook Salmon Embryo      TO: Salmon head kidney leukocytes 
ASK: Atlantic Salmon Kidney                   RtgillGW 1: Rainbow Trout gill 
EPC: Epithelioma papulosum cyprini 
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According to international standards, the precision of a test method is defined as the 
agreement between independent test results obtained under prescribed conditions (ISO 
5725,1, 1994). Precision does not necessarily account for the true value but rather reflects 
the distribution spread of random error of the test. Obviously, ISO definitions are more 
adapted for methods that measure continuous outcomes. For these methods, precision is 
usually expressed by estimates of the standard deviation (variability of repeated 
measures) or maximum expected difference between two measurements under specific 
conditions with 95% confidence.  
Dichotomous tests yield binary outcomes (positive or negative) and the distinction 
between random and systematic error is not as straightforward. With a continuous test, a 
method can be precise (consistent measurements) and not true (biased). However, when 
results from two binary test results disagree, one must be true and the other false. 
Therefore, when a dichotomous test is not true, it is considered to be imprecise. For 
binary test results, (dis)agreement combines measures of (in)accuracy (systematic error), 
(im)precision (random error) (Van der Bruel et al.,  2007) and dependence among sub,
samples from a same specimen. A dichotomous test that does not yield consistent results 
experiences some degree of variation in its DSe and DSp. The degree of variation is 
closely associated with the conditions under which the test was run. Within this 
discussion, the terms “test runs” or “runs” are used for a set of results obtained using the 
same test method and set of samples under specified testing conditions defined in the 
study design. Here, we will refer to agreement as the comparison of results from the same 
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method under differing conditions.  Estimation of agreement between different tests is 
beyond the scope of this section, although it follows similar principles. 
 
1.4.1 Study design and associated bias 
 
1.4.1.1 Design 
The major consideration in the design of a study to evaluate result agreement is to 
clearly describe the test protocol. For instance, Nérette et al. (2005b) evaluated the 
consistency of an ISAV RT,PCR assay across 3 laboratories. Each laboratory used the 
same general technique but with different protocols (i.e. different amplification primers) 
which seriously impacted the comparability of laboratories and instead resulted in a 
comparison of separate methods. Therefore, the protocol of the studied test should be as 
precise and standardized as possible to only compare applications of the same protocol.  
The second main design consideration is to define the conditions under which the test is 
run and compared. Indeed, agreement is evaluated under two sets of conditions: (i) runs 
of test were repeated under identical conditions within a laboratory (repeatability); (ii) 
and runs of test were repeated under similar conditions between laboratories 
(reproducibility). Sources of variation due to the laboratory can be chronologically 
separated in 3 phases; briefly, the sampling procedure (e.g. targeted organ, pooling); the 
testing process (e.g. operator); and the test result interpretation (e.g. decision threshold) 
(OIE, 2009b). One important OIE objective is to, ultimately, ensure that a prescribed test 
can be transferred to a wide range of users with minimal change in performance (e.g. test 
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kits). In addition to repeatability and reproducibility, OIE guidelines require several other 
measures of agreement under specified conditions and design summarized below: 
 
1, Test robustness. In the optimization phase of test development, the robustness 
of the method is estimated by the consistency of test results across a wide range of testing 
conditions within the same laboratory. This evaluation should be customized to fit the 
technical specificities of the method and focus on factors likely to influence the 
performance of the assay in question.  
2, Analytical repeatability. The evaluation of analytical repeatability requires 
estimates of within,run agreement using at least two replicate blinded samples, and 
repeated at least 20 times (between,run agreement) on at least 5 separate days (between,
day agreement) and with at least 2 different operators (between,operator agreement). The 
allocation of the 20 runs among days and operators is not specified. However, a logical 
allocation would be that each operator runs two sets of tests per day for five days. 
3, Analytical reproducibility. Following of the analytical evaluation, a preliminary 
evaluation of analytical reproducibility with a small set of highly characterized samples is 
recommended. However, this phase primarily serves to obtain the provisional assay 
recognition at the end of the analytical evaluation (see section 1.2.1.2.1). 
4, Field reproducibility and repeatability. Stage 3 of the evaluation is specifically 
dedicated to the evaluation of field reproducibility and extension to the field repeatability 
(also referred to as “field” evaluation of test precision). Using blinded aliquots, field 
samples are tested in duplicates at each of the participating laboratories (at least 3). Also 
referred to as test ruggedness, the influence laboratory factors (also called “user” factors, 
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Crowther et al., 2006) on test result agreement can be estimated by comparing within,
laboratory variation with the variation among,laboratories. 
 5, Internal and external proficiency testing. To maintain assay validity, the 
proficiency of the laboratory (test) must be monitored and controlled through the 
implementation of internal and external quality control programs. Internally, repeatability 
of control samples is continuously monitored to detect temporal trends. Externally, 
biannual proficiency testing (e.g. ring test) is conducted to monitor the reproducibility 
across laboratories. 
 6, Comparability Assessments. When changes occur in either the structure of the 
target (e.g. new pathogen strain), assay reagents, or in the technology used for detection, 
it is necessary to demonstrate comparable performances instead of re,validation. 
Comparison of the previous and modified methods in parallel over at least 20 runs is 
recommended providing an evaluation of agreement between the two protocols. 
 
In summary, the design to study dichotomous test agreement requires numerous 
aliquoted specimens tested repeatedly by blinded operator(s) under specified conditions. 
Depending on the factor of interest, replicated samples can be randomly allocated within 
run to reduce systematic bias. For instance, within a test plate, the samples can be 
randomly allocated to avoid effect such as plate margins. 
 
1.4.1.2 Sampling considerations 
 The sampling strategy to evaluate test precision depends on numerous factors 
associated with the target population, disease of concern and test technique. Although it 
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is difficult to provide a generic sampling protocol applicable in all situations, OIE 
imposes some requirements regarding the sample size and the origin of the samples. 
 
1.4.1.2.1 Number of samples 
At least 6 estimation exercises involve evaluation of agreement to validate a 
dichotomous test. 
'
1, Test robustness. OIE does not impose a minimum sample size to evaluate 
robustness. However, the power of this evaluation depends on the strength of association 
of specific factors with the technique consistency. Therefore, the required sample size 
depends on the method and the factor of concern. 
2, Analytical repeatability. OIE requires a minimum of 3 samples representing the 
analyte activity within the linear range of the assay (OIE, 2009b). Duplicate samples 
must be tested in a minimum of 20 runs, assuming each of 3 samples is aliquoted at least 
40 times. There is no specific requirement that any of the 3 samples be analyte,free (i.e. 
negative controls). The choice of the three samples’ concentrations is usually made 
subsequent to the estimation of the analytical sensitivity (limit of detection). Non,infected 
samples can be alternated with infected samples to enable agreement for non,infected 
samples to be estimated, and to investigate potential cross,contamination using “sentinel” 
samples. 
3, Analytical reproducibility. OIE guidelines lack detail for requirement for this 
characteristic except to mention the need for a small panel of samples. Since it is a 
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preliminary evaluation, the same samples employed for the previous evaluation of 
analytical repeatability are often used. 
4, Field reproducibility and repeatability. OIE requires a minimum of 20 field,
derived samples be tested twice in at least 3 laboratories (OIE, 2009b). Each sample must 
be aliquoted at least 6 times and there is no specific requirement that any samples be 
analyte,free (i.e. proportion of infected samples). It would be useful to include half non,
infected and half infected samples. The infected samples must represent the natural range 
of infection stage in the population. Within each run, samples can be randomly allocated 
or alternated between infected and non, infected specimens. 
5, Internal and external proficiency testing. OIE does not provide guidelines to 
conduct quality control programs. Internal programs are normally conducted by close 
monitoring of results from control samples (one non,infected and one, or two, infected 
controls) included when running routine samples over time. Complementarily, external 
quality programs, or ring tests, are conducted periodically (e.g. twice a year) using the 
same template as the field evaluation for reproducibility and repeatability estimation. 
6, Comparability Assessments. No specific sample size is required in each of the 
20 runs where both methods are compared. The evaluation of comparability must be done 
using samples submitted in routine operations and tested by both methods. 
 
In general, sample size calculations are directed by the expected magnitude and 
the degree of precision of the estimate. If agreement is expressed as a simple proportion 
of paired test results that agree, the sample size calculation for an expected proportion P0 
(between 0 and 1), estimation error range L (half of the expected confidence interval) and 
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type I error α (complement to confidence level), using a normal approximation, is (Dohoo 
et al., 2009): 
 
n = Z2(1G α/2) P0 (1GP0) / L2        (30) 
 
where Z is the z distribution value associated with a confidence level associated with the 
coverage probability 1, α/2 (usually 97.5% for α = 5%). 
 
1.4.1.2.2 Nature and origin of samples 
 
The principal objective when selecting samples for test evaluation is that the 
samples are as close as possible to the ones that will be submitted during routine use. 
Both control and reference materials are used during the analytical evaluation of 
agreement, comprising robustness, ASe, analytical repeatability & reproducibility, and 
internal proficiency testing. The nature of reference samples (standards) varies from 
natural isolates to synthesized oligonucleotides (e.g. recombinant plasmid) (Wong & 
Medrano, 2005). The complexity of the sample matrix has a strong influence on the 
operating characteristic of the assay (Hiney & Smith, 1998). OIE recommends the use of 
field samples derived from the target population (i.e. the population in which the test will 
be used). Samples of various concentrations (e.g. low level of virus) may not be readily 
available from the field requiring the utilization of serial dilutions that may impact the 
structure and complexity of the sample matrix. The addition of a complementary fraction 
of a neutral solution (e.g. molecular graded water) to a concentration of analyte will 
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artificially dilute the matrix without adjusting for host and/or environmental material. 
Thus, OIE requires diluting highly infected samples with analyte,free matrix from hosts 
in the target population (OIE, 2009b). Spiked samples are not recommended since they 
do not represent biological reality, albeit they may be useful when infectious material is 
not available.  
Samples included in the evaluation should be representative of the spectrum of 
infection (and biological factors associated with the expression of the disease) 
encountered in the current or future target population. For accessible populations, there 
are a wide variety of sampling strategies used to collect real specimens, each potentially 
associated with different degrees of selection bias. These strategies are the same as for 
samples used in test accuracy evaluation and therefore reviewed further below (see 
section 1.5.1.2.2). Although similar samples may be used for the two types of studies for 
field reproducibility and repeatability estimation, a pool of samples with a medium range 
prevalence of infection (e.g. 50%) is recommended to limit problems during Kappa 
estimation (Chapter III for further explanations). 
 Once collected, the main concerns about reference and control materials are the 
homogeneity among sub,aliquots and the stability of the specimen (i.e. storage) (Van der 
Veen & Pauwels, 2000). Indeed, to fit repeatability and reproducibility conditions, it is 
critical for replicated samples to be identical. For instance, Nérette et al. (2005b) used 
separate tissue samples dissected from the same salmon kidney sent to 3 different 
laboratories for testing. It was, thereafter, argued that observed discrepancy in test results 
among laboratories may have been due to heterogeneous distribution of ISAV particles 
among sub,samples and not due to laboratory performances. Although agreement may 
  
2 This section was adapted from the webpage “Statistical methods for rater agreement” edited by John 
Uebersax in 2007: www.john,uebersax.com/stat/agree.html.  
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have been underestimated, the random allocation of the sub,samples ensured that one 
laboratory was not systematically favoured over another. The development of sample 
processing techniques, such as tissue homogenization, is needed to ensure qualitative 
reference materials for test precision and proficiency studies. Albeit essential for 
evaluation of test precision, methods to assess the homogeneity and stability of control 
samples is beyond the scope of this discussion and are covered in detail elsewhere (Van 
der Veen et al., 2000; 2001a&b). When replacing reference samples (or reagents), it is 
advised to overlap the use of both materials (i.e. original and replacing materials), for a 
number of runs to ensure comparability (ISO/IEC 17025, 2005). 
 
1.4.1.3 Bias 
 
For repeatability studies, duplicate samples are used. It is important that the 
operator is blinded to avoid any information bias. For test accuracy studies, Ransohoff & 
Feinstein (1978) referred to this bias as the review bias. Duplicate samples should be 
coded to remove source identification and randomly allocated to the testing order. 
Mislabelling or contamination should be suspected when a large majority of the 
laboratories detected target from supposed non,infected samples (Crowther et al., 2006). 
 
1.4.2 Analysis methodology2 
 
 This section reviews the different ways to express and compute agreement 
including the statistical methods available to compare agreements.  
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1.4.2.1 Agreement parameters (Proportion of agreement / Kappa) 
 
There are numerous ways to report test result variation. For tests with binary 
outcomes, the concept of test result variation is traditionally expressed as an estimation of 
agreement between test runs. Cleophas et al. (2008) suggested that precision for binary 
tests can also be expressed using predictive intervals (random variation) of DSe, DSp or 
Ef. However, OIE guidelines explicitly require measures of agreement (OIE, 2009b). 
Conventionally, agreement is expressed as proportion of agreement (Pa) (i.e. proportion 
of test results that agree), or as Cohen’s Kappa values (κ) (Dohoo et al., 2009), but other 
more refined parameters exist. For instance, the $%$&":!7&;:':7&&%>"$;76 is another 
described way of measuring agreement. Developed by Pearson (1900), this statistic 
makes 6 assumptions that cannot be tested with only two test runs (Uebarsax, 2007). 
Therefore, this measure is rarely used. 
 To illustrate agreement parameters, we will use the example of two test runs (1 & 
2) from paired samples reported in a classical 2X2 contingency table: 
'
'
'
'
O&7#7&$;76'7@'"A&%%<%6$'(Pa) – Also called observed agreement, Pa represents 
the overall proportion of paired test results that agree and is computed as:  
 
  Test run 2  
  Positive  Negative   
Test run 1 Positive a b a + b Negative c d c + d 
  a + c b + d n =a + b + c + d 
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Pa = (a + d) / (a + b + c + d) = (a + d) / n       (31) 
 
The standard error of Pa (SEPa) is calculated as any other proportion (SEPa = √[Pa*(1G
Pa)/ n] ) and confidence intervals can be computed using a normal approximation, an 
exact binomial distribution or bootstrap or Jackknife approaches. Pa has the advantage of 
being simple to compute and interpret. However, it does not distinguish between 
agreement for positive versus negative test results and does not correct for the proportion 
of results that agree only by chance (random classification). 
O7=;$;B%'"68'6%A"$;B%'"A&%%<%6$'(Pa+ & Pa,, respectively) – Also called 
proportions of specific agreement, Pa+ and Pa, are computed as follow: 
 
Pa+ = 2a / (2a + b + c)        (32) 
PaG = 2d / (2d + b + c)        (33) 
 
In Eq. (32), a replaces d from Eq. (31) to only count for agreement on a positive result. 
Eq. (33) is the reciprocal. Asymptotic standard errors may be calculated using 
Mackinnon’s formulae, bootstrapping or Jackknife estimation (Uebersax, 2007). 
Confidence intervals can be obtained by normal approximation, bootstrap or Jackknife 
approaches (not binomial). Assuming infected samples increase Pa+ and non,infected 
samples decrease Pa+, the difference between Pa+ and Pa, reflects the prevalence of 
infected samples in the tested pool, and therefore this difference gives an idea of the 
inflation of agreement due to chance. For instance, if the infection prevalence is very low 
in the sample pool and inflation of agreement due to chance is present, Pa, will be very 
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large (i.e. more inflated) compared to Pa+. Assuming independence, agreement due to 
chance is exacerbated in extreme prevalences and tends to overwhelm the intrinsic 
agreement due to the test. To obtain an unbiased estimation of agreement, Cohen (1960) 
developed a Kappa index that accounts for agreement due to random classification. 
 
  7!%6M='a"##"':7%@@;:;%6$'(κ) – κ is defined as the ratio of the actual agreement 
beyond chance over the potential agreement beyond chance. The actual agreement (the 
numerator) is the difference between the observed agreement (Pa) and the expected 
agreement (due to chance). The potential agreement is the difference between the 
maximal agreement (i.e. 1) and the expected agreement. The components of the κ 
computation are illustrated in Appendix 3. The expected agreement corresponds to the 
agreement by chance alone and is computed using the marginal probabilities from the 
2X2 table assuming conditional independence between tests: 
 
Expected agreement =[(a+b)*(a+c) / (a+b+c+d)] + [(c+d)*(b+d) / (a+b+c+d)] (34) 
 
This computation of agreement by chance alone assumes that the two test runs are 
statistically independent. However, this assumption is rarely true and the computed 
expected agreement may not be valid. Therefore, κ is not really considered as a chance,
corrected measure of agreement (Guggenmoos,Holzmann, 1996). Nonetheless, κ 
measures dependence between test runs (or the deviation from independence) (Gardner et 
al., 2000). Significant evidence of κ being > 0 confirms that observed agreement exceeds 
agreement by chance and that the test runs are conditionally dependent. Conversely, if 
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there is no significant evidence of κ being different from 0, it is confirmed that the 
observed agreement is not different from the agreement by chance and that the runs are 
conditionally independent. In the κ calculation, the computed agreement by chance 
corresponds to the agreement of conditionally independent test runs and is reciprocal. 
Test runs are considered completely dependent when κ = 1. The computation of κ can be 
simplified as (Dohoo et al., 2009): 
 
κ = 2 (a d – b c) / [(a+b)*(c+d) + (b+d)*(a+c)]     (35) 
 
Procedures to compute the standard error, confidence interval and test of significance are 
reviewed elsewhere (Fleiss et al., 2003).  
 Several variations of Cohen’s κ exist (e.g. Fleiss’s Kappa) and are described 
elsewhere (Uebersax, 2007). Most the statistical packages compute the different variants 
of κ. 
 Utilization of κ is associated with numerous controversies and should not be used 
as the only estimation of agreement (Maclure & Willet, 1987). Factors influencing κ 
include DSe and DSp of each test run, sensitivity and specificity covariance between test 
runs, and the prevalence of infection (Gardner et al., 2000). The strong dependence on 
prevalence is one of two paradoxes of κ (Feinstein & Cicchetti, 1990). Similar to Pa, κ 
depends on prevalence but is not a prevalence,weighted average of a specific κ in D+ and 
D, individuals (i.e. not a linear function of prevalence). With extreme prevalences, κ 
tends to drop towards 0 (Byrt et al., 1993). It is therefore not recommended to evaluate 
agreement for extreme prevalences (< 20% and > 80%, Dohoo et al., 2009), but instead to 
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use a set of samples with a medium range prevalence. The second paradox describes the 
fact that κ is overestimated when the proportion of positive test results (marginal 
proportions) differs between test runs (Feinstein & Cicchetti, 1990). Before κ estimation, 
a test of marginal homogeneity (e.g. McNemar’s χ2, see below) is required to investigate 
the presence of a bias. Estimated κ values between test runs with significantly different 
proportions of positive test results are biased and of little interest. 
 
1.4.2.2 Statistics: McNemar’s / Symmetry / Marginal homogeneity test 
 
Computation of κ is only worthwhile if there is no obvious evidence of 
disagreement between test runs (i.e. proportion of positives differing strongly). Several 
procedures exist that are equivalent or synonymous in the 2x2 setting (i.e. 2 runs/2 
outcomes). Usually referred to as McNemar’s test, the hypothesis of the two runs 
yielding equal proportions of positives (H0) can be approached as the test of marginal 
homogeneity or the test of symmetry. In the follow 2x2 contingency table: 
  Test run 2  
  Positive  Negative   
Test run 1 Positive p++  !"#  $"#Negative  "!# pGG  $!#
   "$#  !$# 1 
 
the marginal probabilities (in grey) are the proportions of respective results when each 
test run is considered separately. The symmetrical cells (in bold) correspond to the 
proportions of disagreement symmetrically distributed across the diagonal of agreement 
cells (not bold). For 2x2 settings, the symmetry condition implies marginal homogeneity 
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and vice versa (Pendergast et al., 2005). McNemar’s test can therefore be conducted both 
ways, either by computing the McNemar’s χ2 statistic (marginal homogeneity) or the 
exact binomial statistic (for symmetry) (Dohoo et al., 2009). The McNemar’s χ2 is 
computed as follows (Dohoo et al., 2009): 
 
McNemar’s χ2 = (bGc)2 / (b+c)        (36) 
 
The P,value is obtained from the corresponding cumulative probability of χ2 distribution 
with 1 degree of freedom. The exact binomial test is based on the null hypothesis that if 
the marginal probabilities were equal (H0), the disagreement cells should be equal and the 
probability to be in one or the other should be also equal (i.e. 50%), Therefore, the null 
hypothesis can be tested by computing the probability of the observed number of 
disagreeing samples in one cell (k) out of the total disagreeing samples (n) assuming that 
the binomial probability of either cells was 50%: 
 
Prob(X:k | p=.5) = Cnk 0.5k 0.5nGk       (37) 
 
This probability corresponds to the probability to accept H0 when it is not correct (P,
value). The alternative hypothesis supports that a significant difference exists between the 
proportions of positives between test runs. If this is the case, then serious disagreement 
exists between runs, making the estimation of κ of little value (Dohoo et al., 2009). 
Estimates of agreement can be obtained under different conditions (e.g. 
repeatability) and these agreements can be compared (e.g. repeatability in different 
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laboratories). Agreement comparisons involving the paired test runs (same samples tested 
under different conditions) are specifically addressed in this section. However, simpler 
procedures, such as a comparison of multinomial distributions, can be used when test run 
results are independent (not paired). The results from each agreement estimation yields 4 
different combinations of test results (4 inner cells of the 2X2 table) summarized in a 
cubic 4X4 contingency table as follows: 
 Result 
combination 
Condition 2  
+/+ +/G G/+ G/G 
Condition 1 
+/+ p+/+,+/+  "%!&"%"#  !%"&"%"#  !%!&"%"# p.,+/+#
+/G  "%"&"%!# p+/G,+/G  !%"&"%!#  !%!&"%!# p.,+/G#
G/+  "%"&!%"#  "%!&!%"# pG/+,G/+#  !%!&!%"# p.,G/+ 
G/G  "%"&!%!#  "%!&"%"#  !%"&!%!# pG/G,G/G# p.,G/G 
  p+/+,.# p+/G,.# pG/+,.# pG/G,.# 1 
 
Although less informative, an alternative approach is to group the resulting combinations 
into two categories: agreeing results (+/+ & ,/,) and disagreeing results (+/, & ,/+). The 
resulting 2X2 table can then be analysed and tested with the McNemar’s test. In this 
instance, only the magnitudes of agreement are compared regardless of the nature of the 
result. Alternatively, when specific agreement proportions are of interest, the resulting 
combinations can be rearranged in three categories (agree on a positive result, agree on a 
negative result and disagree). A test of symmetry can be conducted to compare 
symmetrical cells (bold). Asymptotic and exact computations of the symmetry χ2 statistic 
exist and include all pairwise comparisons of symmetrical cells. However, marginal 
homogeneity does not prove symmetry in a cubic table larger than 2X2 (Pendergast et al. 
2005). Tests for marginal homogeneity of several categories can also be implemented, 
with Stuart,Maxwell being the most commonly used (Stuart, 1955; Maxwell, 1970). 
More advanced procedures using quasi,symmetry model comparisons exist and are 
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described elsewhere (Agresti, 2002). However, it is not legitimate to compare two 
agreement estimates involving the same test run. For instance, when comparing 
reproducibility among 3 laboratories (3 pairwise comparisons among laboratories), the 
results of the comparison between 2 laboratories can be deduced from the 2 others 
pairwise comparisons. Therefore, the 3 pairwise estimates of reproducibility are not 
independent and cannot be tested. 
 
In summary, the precision of a dichotomous assay reflects the consistency of the 
test classification. If a test is not sufficiently robust or rugged, the respective evaluation 
of repeatability and reproducibility are of little value. Nonetheless, a test can be 
repeatable and reproducible even when it is inaccurate. The next evaluation stage requires 
assessing the efficiency of the test to properly classify samples. Later on, continuous 
monitoring of agreement will ensure consistent performance over time (internal quality 
control) and demonstrate equivalency with other methods or laboratories (external quality 
control). 
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Often mistaken with accuracy, the trueness of a test is defined as the closeness of 
agreement between the average value obtained from a large series of test results and an 
accepted reference value (ISO 5725,1, 1994). Trueness relies on the true value and 
reflects the test measurement bias or systematic error (difference between the expected 
test results and an accepted reference value). The combination of precision (complement 
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of random error) and trueness (complement of systematic error) results in the estimation 
of accuracy defined as the closeness of agreement between a test result and the accepted 
reference value (ISO 5725,1, 1994). Better adapted to tests with continuous outcomes, 
the definition of trueness could be refined for dichotomous tests as the proportion of 
values obtained from a large series that agree with the accepted reference status. As 
describe previously (see section 1.2.1.2.2), this proportion corresponds to the efficiency 
(Ef) of the test. However, Ef depends on prevalence and may vary substantially across 
tested populations (Alberg et al., 2004). Other parameters that express overall trueness 
have been considered (e.g. Youden index (J), diagnostic odds ratio (DOR)), and they can 
be computed from diagnostic sensitivity (DSe) and specificity (DSp) (infection/disease 
status specific parameters) (see section 1.2.3). This section will focus on the evaluation of 
DSe and DSp as indicators of the trueness of a diagnostic test. The validity of the 
estimation of DSe and DSp lies primarily on the study design and can be affected by 
many variables, particularly when applying such studies to field situations. 
 
1.5.1 Study design and associated bias 
 
The approach and the study design for diagnostic test evaluation are context 
dependent and cannot always fit in a rigid standard framework. However, the default 
design of test trueness studies requires that the candidate (or index) test be compared to at 
least one reference (or relative) test, both run on the same samples (paired design). The 
only cases of studies where a minimum of two methods is not required are %I#%&;<%6$">'
;6@%:$;76':!">>%6A%=. This type of study does not represent the natural range of infection 
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stages (spectrum bias; Ransohoff & Feinstein, 1978) expected in a true population 
(selection bias, Greiner & Gardner, 2000b) and therefore tends to over,estimate DSe and 
DSp (Greiner & Gardner, 2000b). As for agreement studies, OIE recommends to not use 
this approach (OIE, 2009b) for similar reasons. A range of designs exist associated with 
different evaluation objectives related to the intended utilization of the test (Fig. 1.5). 
 
1.5.1.1 Design 
 
 The first consideration to address in diagnostic study design is the evaluation of 
efficacy and usefulness of a candidate test (Fig. 1.5). Partly addressed by the concept of 
“fitness for purpose”, the evaluation of a diagnostic method may not require the exclusive 
estimation of absolute parameters (DSe/DSp) and may be based on the assessment of 
relative criteria associated with test usefulness and efficiency. For instance, the success of 
the implementation of the assay can be estimated by the clinical outcome (e.g. survival of 
a disease) or by the cost,effectiveness (e.g. control program cost) of the test (Van den 
Bruel et al., 2007). When the choice of available techniques is limited, the operator can 
choose by default the method that gives the least compromised consequences. Model 
estimations using information from comparative studies (e.g. clinical field trial) may 
identify the tests associated with the best outcome. In these settings, the patient is only 
tested with one assay and the comparison between two testing strategies involves two 
different sets of individuals (unpaired design). Except in this particular case, diagnostic 
evaluations usually use a paired design where the compared methods are tested on the 
same individuals. For instance, a new test proposed to replace an existing one can be 
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 D;A'45¥5'2%:;=;76'$&%%'$7'=%>%:$'%=$;<"$;76'#&7:%89&%='@7&'$%=$'$&9%6%== (adapted from Reitsma et al., 2009). 
Potential source of bias are presented in italics for each estimation procedure.
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evaluated based on its relative classification performance (i.e. agreement). This 
agreement approach is mainly used to demonstrate test comparability where the 
candidate test is expected to be at most as accurate as the reference test. The relevance of 
a new test could therefore be justified on its reduced invasiveness, processing time, or 
cost.   
 Candidate tests may perform better than the reference test, and in such 
situation, the relative values of DSe and DSp can be estimated using a latent class model 
based on results of samples from populations with different prevalences (Bertrand et al., 
2005). In this case, relative estimates of DSe and DSp are of interest for test comparisons. 
Overall, absolute estimates of DSe and DSp appear to be the most commonly used 
criteria to evaluate and interpret a test, and the international community and institutions 
adopted them as standards for test evaluation, validation and certification (OIE, 2008).  
 
The second design consideration for trueness estimation is the type of standard 
information available to compare the candidate test (Fig. 1.5). In this discussion, standard 
refers to the reference test(s) or information used to identify the true infection/disease 
status of the sampled individuals used in the study. 
 The first standard to consider is the A7>8'=$"68"&8'(GS). By definition, the GS 
provides the correct classification of the studied specimen. A GS test is deemed perfect 
(100% DSe and DSp). When a GS is available, the estimation of DSe and DSp of the 
candidate test is straightforward (see section 1.5.2.1) and follows the original definitions 
(Yerushalmy, 1947). However, the existence of perfect standard tests raised concerns 
among experts (Greiner & Gardner, 2000b) considering that such standard is not truly 
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gold but instead “silver, bronze or even tin” and might have led to biased estimations 
(McKenna & Dohoo, 2006). 
 When the reference test does not perfectly classify samples (;<#%&@%:$'&%@%&%6:%'
=$"68"&8, IRS), adjustment for information bias is possible (Greiner & Gardner, 2000b) 
based on known estimates of the IRS DSe and DSp, if available (Dohoo et al., 2009). 
This estimation procedure assumes that the two tests are conditionally independent and 
requires that all samples were tested by both tests (Enøe et al., 2000). The assumption of 
independence might not always be satisfied and, if rejected, requires more complex 
approaches (Hui & Zhou, 1998).  
 Not all samples are verified by supplementary tests in practice due to the invasive 
nature of the procedure or to the high associated cost. Therefore, only a fraction of 
specimens are tested twice, especially in clinical settings, which results in verification (or 
workGup) bias (Ransohoff & Feinstein, 1978), requiring corrective procedures. If the 
protocol of partial verification was conducted such that specimens were verified 
independently of their candidate test result (i.e. randomly selected), the estimation can be 
8;&%:$>E'"8P9=$%8 (Begg & Greenes, 1983; Zhou, 1994). If the proportions of verified 
samples are different in positive and negative result samples to the candidate test, the 
verification is dependent and requires complex <9>$;#>%';<#9$"$;76 procedures to adjust 
the estimation (Zhou, 1993; Zhou, 1998; Harel & Zhou, 2006). For instance, for a study 
population with a low prevalence of infection, the few positive results are usually all 
verified with the reference test while only a fraction of the negatives are randomly 
retested (Reitsma et al., 2009). Since, no formal method exists to test for verification 
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independence unless it was pre,specified, utilization of multiple imputation estimation is 
the default method of choice (Reitsma et al., 2009).  
 An alternative is to test thereafter unverified samples using a second reference 
standard test that is either less invasive or less expensive. In the very unlikely case of 
both reference tests being perfect, direct estimation of a trueness parameter can be 
conducted using estimation procedure used for a GS. However, if the second or both tests 
are imperfect, but the respective DSe/DSp are known, estimation can be conducted by 
combining the GS and/or imperfect test estimation procedures. Finally, if both reference 
tests are imperfect with unknown operating characteristics, a pseudo,gold standard 
approach is warranted, as described later. Overall, it is not recommended to use partial 
verification study designs. 
 When the operating characteristics of the reference test are unknown, it may be 
possible to use a #=%987LA7>8'=$"68"&8 (PGS) (Fig. 1.5). The PGS classifies the 
specimen based on a combination of information usually obtained from at least two 
imperfect tests (Dohoo et al., 2009). All samples are thereafter considered correctly 
classified, and parameter computations are the same as for estimation with a GS. Three 
approaches have been described for defined PGS criteria. The first two use a preset 
framework using supplementary test results and the third relies on additional information. 
 The 8;=:&%#"6$'(or discordant) &%=7>9$;76 is a two,stage process to classify 
samples (Miller, 1998a). All samples are first subjected to the candidate test and the 
reference test, assuming they are conditionally independent. Only the samples that yield 
discordant results (combinations of positive/negative test results) are tested in a second 
stage using a third test to resolve the discrepancy. If the first reference test is assumed 
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100% specific, only samples with positive candidate results and negative reference results 
are retested. Conversely, if the reference test is assumed 100% sensitive, only samples 
with negative candidate results and positive reference results are retested. In this second 
stage, it is possible to use several tests sequentially to increase the degree of confidence 
(Hadgu, 1996). Even with a perfect test used in the second stage, the DSe and DSp are 
always overestimated (Miller, 1998b). This is explained by the fact that, in the first stage, 
the candidate (imperfect) test is involved in the classification of the samples where the 
specimen status is deemed true when both tests agreed. However, some tested samples 
with agreeing results on both tests may in fact be false. Discrepant analysis combines 
incorporation bias (inclusion of the candidate test in the sample classification, Ransohoff 
& Feinstein, 1978) and information bias (misclassification of the samples for estimation). 
In its statistical guidance for diagnostic studies, the US Food and Drug Administration 
does not use discrepant resolution, justifying that “it does not solve a bias problem and it 
is a more complicated, incorrect solution” (FDA, 2007). 
 The second approach is referred to as :7<#7=;$%'&%@%&%6:%'=$"68"&8 (CRS) 
where the sample classification relies on a predefined combination of several test results 
that do not include the candidate test (Alonzo & Pepe, 1999). Usually at least two 
references tests are used and according to their expected characteristics and conditional 
(in)dependence, the interpretation of the combined results are done either in parallel or in 
series (see section 1.2.3.9). The combination of the references tests is therefore believed 
to increase the classification performances more than when used individually. Briefly, if 
the intent is to optimize specificity of the CRS, only samples testing positive with the first 
reference test are retested by the second test (or resolver test). Then, only samples that 
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yield two positive tests are deemed positive (i.e. series interpretation). If the intent is to 
optimize sensitivity of the CRS, only samples testing negative with the first reference test 
are retested by the second test. Thereafter, only samples that yield two negative tests are 
deemed negative (i.e. parallel interpretation). Sequential testing (i.e. only a fraction of 
samples tested by the resolver) is not a design requirement but is, in this instance, 
recommended for optimization of analysis cost. More than two tests might be used to 
define a CRS according to the objective of classification. However, improvement of the 
classification is ensured only if the tests are conditionally independent, and perfect 
classification may still not be achieved, implying information biased estimates. In the 
evaluation of three ISAV tests, Nérette et al. (2008b) used CRS to estimate DSe and DSp. 
The authors compared two of the tests and used the third one as a resolver. Interpreting 
the results of the supplementary tests in parallel, the estimation of DSe was heavily 
dependent on the resolver positive results, with estimates changing as much as 23%  
depending on which test was considered the resolver (Nérette et al., 2008b). The test with 
the best assumed DSp was selected as the reference test (i.e. VI) and the test with best 
assumed DSe was considered the resolver test (i.e. RT,PCR). Concerns about conditional 
dependence among tests were expressed, but not addressed, by the authors. 
 The last approach for PGS procedures is referred to as the =$98E'#=%987LA7>8'
=$"68"&8 (SPGS), which groups any available information, including test results (or not), 
for the ad,hoc definition of a standard that is specific to the study (Dohoo et al., 2009). 
Clear and rational explanations are required to justify the criteria of classification. When 
the standard definition includes results from the candidate test, incorporation bias may be 
a concern. In their study, Nérette et al. (2008b) used a SPGS based on results from three 
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ISAV tests to define the infection status of samples. In this instance, to be deemed 
infected at least two of the three tests had to be positive. In addition to incorporation bias, 
the authors suspected an overestimation of DSe and an underestimation of DSp due to 
misclassification. Nonetheless, both CRS and SPGS approaches provided similar 
estimates of test characteristics (Nérette et al., 2008b). In an earlier study, McClure et al. 
(2005) used a SPGS based on clinical evidence and not on detection assays to evaluate 
four ISAV tests. Infection status was identified according to the history of the cage of 
origin of the sampled salmon. A fish was deemed non,infected if it was collected from a 
site where none of the cages experience an ISAV outbreak, whereas a fish was deemed 
infected if it came from a cage experiencing increased mortality that was officially 
declared infected by the regulatory authorities (McClure et al., 2005). Although fish from 
a cage with a negative ISAV history had considerable evidence that they were not 
infected, it is questionable that all fish from an outbreak cage were infected (i.e. 100% 
prevalence). However, because the data originally came from surveillance records, all the 
fish that were sampled from outbreak cages were assumed to be moribund or recently 
deceased, which likely increases the prevalence closer to 100% (McClure et al., 2004). 
The authors recognized the limitations and potential bias of this SPGS expecting some 
overestimation of DSp and DSe since studied fish represent the extremities of the 
gradient of infection stages (either “strong” non,infected or heavily infected) (McClure et 
al., 2005). 
For all PGS procedures, it is assumed that every sample is retested. If this is not 
the case, verification bias is expected and adjustment procedures for partial verification 
should be considered.  
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When standards are not available or their performance estimates are not reliable, 
alternative approaches have been developed to estimate test DSe and DSp F;$!79$'"'
&%@%&%6:%'=$"68"&8'(Fig. 1.5).  
The first approach assumed non,lethal or minorly invasive sampling techniques 
that enabled the investigator to repeatedly test the same individual (Schulzer et al., 1991). 
Although it was expected to increase the confidence of the true status of the animal, it 
requires that the infection status stay the same during the entire sampling period. With a 
slow progression over time, chronic disease might be more suitable for this type of 
design. In addition, &%#%"$%8'="<#>%= may be used in experimental infection challenges 
to investigate the performance of the tests during the progression of the infection. 
Without measurable markers to identify the beginning and the end of the infection, the 
status of each individual is still unknown at a specified time. In addition, dependence 
among test results from the same individual should be accounted for in the analysis to 
avoid point and variance estimation bias (Greiner & Gardner, 2000b). Recently, an 
analytical approach was developed to evaluate tests using repeated samples when no gold 
standard is available (Engel et al., submitted). 
Another alternative when no reliable standard is available employs the opinion of 
diagnostic experts and is referred to as 2%>#!;'%=$;<"$;76. This method does not require 
any sample collection or testing. A detailed questionnaire is submitted to a selected panel 
of experts requesting their opinion on the performances of defined tests under specified 
conditions. The first round of answers is then summarized before resubmitting the same 
questions a second time with the addition of the summary of the first set of answers. The 
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Delphi method was previously used to assess the accuracy of screening tests for two 
aquatic viral diseases (Infection Pancreatic Necrosis Virus and Infectious Hematopoietic 
Necrosis) (Bruneau et al., 1999). Although useful when no other information is available, 
this estimation method relies on the subjective opinion of the panel (i.e. information 
bias). For instance, diagnostic experts are often assumed to be test developers or 
operators from laboratories who may not have clinical, epidemiological or population 
perspectives. Due to the important subjectivity and reduced precision of this method, 
Delphi estimation is only used when evidence,based approaches are not available. 
 The last method to evaluate diagnostic tests without reference information was 
developed by Hui & Walter (1980) using >"$%6$':>"=='<78%>'(LCM). This method relies 
on an alternative statistical approach that does not consider tested samples separately (i.e. 
binary outcome: D+ or D,) but as part of a larger cluster or population (i.e. probability to 
be infected/disease based on prevalence). Therefore, study specimens are required to 
come from at least two separate populations with different prevalences, and to be tested 
by at least two tests. Since the existence of reliable reference standard tests is a recurring 
challenge, latent class models are progressively becoming the preferred method for 
diagnostic test evaluation. Guidelines adapted to the veterinary context were developed to 
facilitate the application of this complex procedure (Mintiens et al., submitted). However, 
LCM requires several populations to estimate one set of DSe and DSp and these are 
closely associated with the mixture distribution of covariate factors from a specific 
population. Therefore, pooled estimates of DSe/DSp are expected to be biased (i.e. case 
mix bias, Begg, 1987). In addition, LCM uses the information from the candidate to 
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estimate DSe/DSp, and therefore some degree of incorporation bias is suspected. The 
design and requirements for this estimation procedure are explained in section 1.5.2.2.2. 
 
 Evaluation parameters and standards for comparisons are of primary concern, and 
the identification and collection of appropriate samples in sufficient number represent a 
further challenge for diagnostic evaluations. 
 
1.5.1.2 Sampling considerations 
 
1.5.1.2.1 Number of samples 
 
Different approaches have been described to calculate the sample size according 
to the objectives of the study (Obuchowski, 1998; Branscum et al., 2007), including:  
1. estimating the DSe and the DSp of a candidate test, 
2. determining, with a specified level of confidence, if the DSe and DSp of a 
candidate test is above a fixed value, 
3. comparing the DSe and DSp of a candidate test to a fixed value, 
4. determining if the DSe and DSp of two tests are equivalent, and 
5. determining if a candidate test is superior (either or both DSe and DSp) to a 
reference test. 
 
When a GS is available, the D+ (cases) and the D, are sampled separately in a 
sampling design referred to as caseGcontrol (see section 1.5.1.2.2). Obuchowski (1998) 
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reviewed the different calculations that could be used when cases and controls are 
sampled separately. When a GS is not available, the D+ and D, are sampled together in a 
sampling design referred to as crossGsectional (see section 1.5.1.2.2). Branscum et al. 
(2007) reviewed the different computations that can be implemented in a Bayesian 
framework when the true health status is unknown.  
For the evaluation of DSe and DSp of a candidate test (1), tentative standards of 
sample sizes have been used without clear justifications. Some previous examples of 
sample size recommendations have been quite unrealistically high, such as 300 D+ and 
1000 to 5000 D, sampled individuals suggested by Jacobson (1998). Conventionally, it 
seemed generally accepted that sample size calculations for estimates of DSe/DSp follow 
the normal approximation of the binomial distribution as previously described for a single 
proportion (given equation Eq. (30), section 1.4.1.2.1) (Jacobson, 1998; Greiner & 
Gardner, 2000b; OIE, 2007; Dohoo et al., 2009). Increasing the sample size to ensure that 
coverage of the exact binomial confidence interval is respected has also been 
recommended (Greiner & Gardner, 2000b). However, modern software can easily 
perform exact binomial calculations (Flahaut et al., 2005). When the health status is 
unknown, Branscum et al. (2008) described calculation procedures for one test in one 
population. 
As a preliminary evaluation, one might want to ensure that the DSe or DSp is at 
least above a certain value (2). For instance, the investigator may want to confirm that the 
assay meets minimum requirements before proceeding to more intensive testing. Using 
the case,control sampling approach, one option would be to use the sample size 
calculation to demonstrate freedom of disease (Dohoo et al., 2009). Assuming that the 
  88
population of D+ (or D,) is infinite, a minimum of five randomly selected samples would 
be necessary to test that the DSe (or DSp) is above 50% with 95% confidence (type I 
error, α = 5%). If one sample tested negative (or positive) the DSe (or DSp) would be 
assumed to be below 50%. For 99% level of confidence, 7 samples per population would 
be necessary.  
Towards a more precise evaluation, the DSe or DSp of the candidate test can be 
compared to a fixed value (3). Reviewed by Obuchowski (1998) and illustrated in Flahaut 
et al. (2005), this approach adapts the sample size calculation formulae to compare two 
proportions (Dohoo et al., 2009). For an expected DSe, the number of D+ samples 
required to estimate, with a probability of 1 – β, that DSe is at least higher than a defined 
value DSemin (i.e. lower bound of the confidence interval) with a minimum confidence 
level of 1 , α (one sided) is: 
 
n = [Z1G α √((DSeGDSemin) (1GDSe+DSemin)) + Z1Gβ √(DSe(1GDSe))]2 / (DSeGDSemin)2 
           (38) 
 
Conservatively, the fixed value is set at 50%. The number of D, samples can be 
computed separately or Flahaut et al. (2005) recommended calculating the number of D, 
(nNI) from the number of infected (nI), based on the prevalence of the study population 
(Pr): 
 
nNI = nI * (1GPr) / Pr         (39) 
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The prevalence is frequently expected to be lower than 50%, resulting in a requirement 
for more D, than D+ samples. Pre,computed sample sizes for several sets of proportions 
are summarized in Appendix 4.  
 When the true health status is known, more complex sample size calculations are 
available  to compare two tests in paired or unpaired designs (i.e. when the two assays 
test the same samples or not) to evaluate equivalence (4) or define if one is superior to the 
other (5) (Obuchowski, 1998). For diagnostic evaluation in absence of a standard test (i.e. 
latent class models), Georgiadis et al. (2005) developed a spreadsheet,based program 
that, for a set level of precision, computes the required sample size for LCM analysis 
involving 2 populations and 2 tests. For more complex situations where conditional 
dependence exists between tests and/or more than 2 populations are sampled, Branscum 
et al. (2007) described a Bayesian approach to compare assays or test equivalency.  
 In addition, when DSe and DSp are not the parameters of interest, sample size 
calculations have been described for likelihood ratios (LR) and area under the Receiver 
Operating Characteristic (ROC) curve (continuous outcome test) (Simel et al., 1991; 
Obuchowski, 1998). 
 While an appropriate sample size calculation can be difficult to implement, the 
representativeness of the samples is also a primary concern to properly evaluate the true 
natural variation of the test performance in the targeted population. 
 
1.5.1.2.2 Origin of samples 
 The case of one target population is addressed in this section, as the reviewed 
principles can be repeated with additional populations when more than one population is 
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included (e.g. LCM). Similar to agreement estimation, it is important that samples 
collected for trueness estimation are as similar as possible to those that are submitted 
during routine practice (i.e. representative of the targeted population). The nature, 
homogeneity and stability of diagnostic study specimens were discussed in detail 
previously (see section 1.3.1.2.2). Also, the direction of the data collection can be defined 
as retrospective, ambispective, or prospective relative to the period when the information 
was gathered about the health status and/or candidate test results (Knottnerus & Muris, 
2003). Several sampling designs were described in past diagnostic evaluation studies with 
various degrees of validity. We group them in four categories: case,control, cross,
sectional, cohort, and clinical field trial. 
 
# '()*!+,-./,0#)(1 02-3$ This design refers to study where D+ and D, are sampled 
separately. The disease status of the specimen is known at the time of the collection 
assuming that the method to determine the status is perfect (gold standard). This approach 
is more intuitive to estimate DSe/DSp and convenient when D+ individuals are rare (i.e. 
low prevalence) (Greiner & Gardner, 2000b). However, to increase the certainty about 
the status of the animal, either highly D+ (advanced clinical manifestation) or highly D, 
(never exposed) individuals are sampled which only represent the extreme ends of the 
natural gradient of infection. Referred to as spectrum bias (a type of selection bias), this 
sampling design is expected to overestimate both DSe and DSp (Ransohoff & Feinstein, 
1978). Three commonly used approaches for case,control sampling that avoid the 
utilisation of a controversial GS test are outlined below. 
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  Disease free populationG To estimate DSp, the investigator may sample 
only animals from a disease,free population. Any specimens that test positive are 
thereafter deemed false, and DSp is directly estimated as the proportion of samples that 
test negative. A population is considered free with an acceptable level of certainty if no 
historical evidence of disease was documented and/or an active targeted surveillance 
program to confirm no disease present. To be valid, the disease,free population should be 
representative of populations that may be tested and fish should be collected randomly. 
  Experimental challengeG Although considered more representative than a 
“spike” sample, specimens from experimentally challenged animals are rarely 
representative of a natural infection episode for which the test will be employed. 
Depending on the infective dose, pathogen source, origin of the animal (e.g. certified 
specific pathogen free), or environmental conditions, the induced disease can be over, or 
under,expressed. Albeit convenient when naturally infected animals are not accessible, 
OIE recommends not using this sample source for evaluating diagnostic tests (OIE, 
2009b). 
  Archived specimensG Archived samples from diagnostic laboratories are 
often used as convenient inputs for diagnostic test evaluations (i.e. retrospective study). 
The true status of the cases is identified according to extensive historical information and 
clinical evidence. Although possible to select obvious cases, the selection from the 
archive should be conducted in a formally random manner. Except for laboratories with 
large caseloads (i.e. many samples from the same population over a short duration), this 
type of sampling is not expected to be representative of the infection spectrum (Greiner & 
Gardner, 2000b). Indeed, the infection severity spectrum of submitted cases may change 
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over time and across origins, and the subsequent combinations of specimens may result in 
an unrealistic profile. Furthermore, depending on the type of samples, the stability over 
time of the specimen should be validated before being included in the study. 
 
# '/,))!)*+.2,-(0#)(1 02-3G This design refers to studies where D+ and D, 
individuals are sampled together. Specimens are sampled randomly from a specified 
population similar to a prevalence or survey type study. This sampling design requires 
that the condition of interest (infection or disease) is common in the targeted population. 
Depending on the type of standard, the samples are thereafter tested simultaneously by 
the different assays involved in the study. This approach is expected to increase the 
likelihood that the study population will be represented properly. 
  Random sampling can be approached in different ways according to the presence 
of a sampling frame and the structure of the population (Dohoo et al., 2009): simple 
random sampling (sampling frame available), systematic random sampling (repeated 
collection in a logical manner), stratified random sampling (collection proportional to 
covariates expected to influence DSe/DSp), clustered sampling (collection of all 
individuals from randomly selected clusters), and multistage sampling (collection of a 
few randomly selected individual from randomly selected clusters). Under aquaculture 
settings, techniques to sample fish in a representative manner (i.e. randomly) may depend 
on the infection of interest and fish production methods. Spread into a three dimensional 
environment, capture of healthy fish is not convenient and the utility of various field 
methods have been reviewed elsewhere (Hammell, 1992; des Clers, 1994; Thorburn, 
1999; Cameron, 2002; OIE, 2009b). Furthermore, Van den Bruel et al. (2006) discussed 
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that to be completely validated, a test evaluation study should be repeated on independent 
but similar populations to ensure external validity. Nonetheless, as discussed with 
retrospective sampling (e.g. archived specimens), infection patterns evolve and change 
over time which supports the concept of a test performance monitoring program over 
time to address concerns regarding single time point estimates. 
 
# ',4,/.#)(1 02-3G A cohort identifies a group of individuals that share a common 
character (Dohoo et al., 2009). In this sampling design, animals are selected based on a 
common symptom and followed through time for an outcome to occur. The data 
collection is prospective and targets the estimation of the prognostic value of the 
candidate test (Lijmer & Bossuyt, 2009). This type of approach is only applicable with 
non,lethal sampling or when infected animals have a distinct disease with clinical 
manifestations (e.g. death). This design has very specific and limited applications (Hui & 
Zhou, 1998).   
#
# '02-2+(0#52*06#./2(0G In this type of study, the health status of the individual is of 
secondary importance. Only the candidate test result is known and the outcome of interest 
is either clinical or economic effects. The design is prospective and targets the evaluation 
of the candidate test’s predictive values for individuals that show minor or non,specific 
clinical evidence (Lijmer & Bossuyt, 2009). Based on the initial test result, refined 
treatment strategies are applied to tested individuals while non,tested individuals receive 
a default treatment. The usefulness of the test is then evaluated based on the animal 
outcome and/or treatment cost savings. Although applied to clinical settings, this type of 
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study selects individuals based on preliminary clinical signs to ensure a substantial 
proportion of D+. The evaluation of the test will therefore only be valid for similar 
conditions of utilization. 
 
 For veterinary applications, a test can be intended for a wide range of purposes 
and the evalutions will require a wide range of designs to reflect this. The sampling 
scheme with minimal bias is usually a cross,sectional sampling of the targeted or similar 
population. Estimation procedures that require samples from more than one population 
(e.g. LCM) may experience difficulties avoiding case mix bias (Begg, 1987).  
 
1.5.1.3 Other associated bias 
 
 For diagnostic trueness studies, some precaution is required when handling or 
testing samples to avoid unknown bias. It is necessary to blind the test operator(s) using 
coded samples to avoid review bias (Greiner & Gardner, 2000b). Review bias refers to 
the potential change in test results when the operator has additional information (e.g. 
clinical sign) associated with a specimen. Ransohoff & Feinstein (1978) furthermore 
differentiated two types of review bias: diagnosticGreview bias is referring to a systematic 
test error arising when sample,associated information is provided before the final 
diagnostic result is available; and testGreview bias is a problem when the operator is 
informed of previous test results. In practice, review bias due to preliminary clinical 
information tends to over,estimate test performances (Loy & Irwig, 2004), but 
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diagnostic,review bias can also under,estimate performances (Ransohoff & Feinstein, 
1978). 
 
1.5.2 Analysis methodology 
 
1.5.2.1 Trueness parameters (DSe, DSp, Ef, J, DOR) 
Direct estimation methods for trueness parameters when a gold standard exists 
(i.e. true health status known) are discussed in this section. A “fourfold” or 2X2 table can 
be generated from the test and health status information (Feinstein, 1975): 
 Positive Test Negative Test  
Infected/Diseased a b a + b 
NonGinfected/NonGdiseased c d c + d 
 a + c b + d n = a + b + c + d 
 
Thereafter, DSe and DSp can be estimated as follows: 
 
DSe = a / (a + b)         (40) 
DSp = d / (c + d)         (41) 
 
Similar to SEPa, the standard errors of DSe and DSp (SEDSe & SEDSp) arae calculated as 
for any other proportion (SEDSe = √(DSe*(1GDSe)/ (a + b)); SEDSp = √(DSp*(1GDSp)/ (c 
+ d))  ) with confidence intervals calculated using normal approximation, exact binomial, 
bootstrap or Jackknife approaches. The program Testview is one of many utilities that 
can be used to simultaneously estimate several validation criteria (Gardner & Holmes, 
1993). 
  96
Ef can also be estimated from the 2X2 table or from DSe/DSp: 
 
Ef = (a + d)  /  n  =  P*DSe + (1GP)*DSp      (42) 
 
Standard error and confidence intervals of Ef follow the same estimation principles for 
proportion statistics. 
Youden’s index (J) is expressed as the average of the “successes” (S) of the test in 
the D+ group and the D, group ((Sdiseased + SnonGdiseased)/2). Success is calculated as the 
proportion of correctly classified individuals minus the proportion of incorrectly 
classified individuals in each disease group. Using the 2X2 table notation, the success of 
the test in the diseased group (Sdiseased) is computed as (a – b) / (a + b); and the success of 
the test in the non,diseased group (Snon,diseased) is computed as (d – c) / (c + d). The index 
J can be directly estimated using the 2X2 table or DSe/DSp: 
 
J = (ad G bc)/ [(a + b)(c + d)] = DSe + DSp G 1     (43) 
 
Standard error of J (SEJ) can also be computed (SEJ = √((ab /(a+b)3) + (cd/(c+d)3))) and 
the confidence interval is approximated using a normal distribution, provided there are 
more than 20 individuals in each infection/disease group (Youden, 1950). To be useful, it 
is expected that the test will, on average, more often correctly classify samples and J will 
therefore range between 0 and 1 (positive discrimination). When J is negative, samples 
are more often misclassified (negative discrimination) meaning that there is more chance 
to be correct by inversing the test results. When there is no evidence of J being different 
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from 0, the test has no discriminatory power and is worthless. The test is perfect when J 
is equal to 1.  
DOR can be estimated using the 2X2 table,  DSe/DSp,  PPV/NPV, or  LR+/LR, in 
the following manner: 
 
DOR =  ad / cb = [DSe/(1GDSe)]/[(1GDSp)/DSp]  
 = [(1GPPV)/PPV]/[(1GNPV)/NPV] = LR+/LRG    (44) 
 
Standard error for DOR (SEDOR) is calculated as any other odds ratio (SEDOR = √ (1/a + 
1/b +1/c +1/d)), and the confidence interval is computed using normal approximation 
when DOR is not close to 0 (Glas et al., 2003). When the DOR is significantly > 1, 
individuals have a greater chance to be correctly classified using the test. The greater 
DOR is above 1, the better the discriminatory accuracy of the test. When the DOR is 
significantly < 1, tested individuals have more chance to be misclassified (negative 
discrimination). With no evidence of DOR differing from 1, the test has no 
discriminatory capability.  
 
1.5.2.2 Estimation procedure without a gold standard 
 
1.5.2.2.1 Using an imperfect standard 
Even if a gold standard is unavailable, it is possible to estimate DSe/DSp when 
the operating characteristics of an imperfect reference standard are known and the two 
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tests are conditionally independent (Dohoo et al., 2009). Based on the following 
contingency table: 
 
 Candidate Test  
Reference test Positive Test Negative Test  
Positive Test a b a + b 
Negative Test c d c + d 
 a + c b + d n = a + b + c + d 
 
the candidate test characteristics can be calculated as follows (Enøe et al., 2000): 
 
DSecand = ((a+c) DSpref G c) / (n DSpref  G (c+d))     (45) 
DSpcand = ((b+d) DSeref G b) / (n DSeref  G (a+b))     (46) 
 
Standard error and confidence interval estimation are described elsewhere (Buck 
& Gart, 1966; Gart & Buck, 1966).This calculation is only possible because the data and 
the parameters are both three,dimensional (3 equations for 3 unknowns: DSe, DSp and 
prevalence). When the tests are conditionally dependent, covariate factors must also be 
estimated and the number parameters to estimate becomes greater than the data 
dimension (i.e. 3 equations for 5 unknowns: DSe, DSp, prevalence, cov+ and cov,).  
 However, the previous evaluation of DSe and DSp of the reference standard 
might not be reliable or valid. Therefore, the estimation of operating characteristics of the 
candidate test may be inherently biased because of the originally biased estimates for the 
reference standard. When no standard tests are available or reliable, statistical methods 
have been developed to evaluate more than 2 tests on the same specimen from at least 2 
populations. 
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1.5.2.2.2 Without reference standard 
 When no standard is available, Hui & Walter (1980) adapted a latent class model 
(LCM) estimation that does not require information about the true status. However, with 
no previous information, this procedure requires a minimum of 2 tests run on the same 
sample from at least 2 populations with different prevalences. The mechanics of the LCM 
procedure based on 2 tests and 2 populations is described in Appendix 5. Three 
assumptions are necessary when using LCM for diagnostic evaluations: 
 
 (i) At least two dichotomous assays should be applied to the same individuals 
from at least two populations (with different assumed prevalences). This assumption is a 
study design requirement to ensure that the model is identifiable when no prior 
information is known about the tests or the source populations. In statistics, the 
“identifiability” refers to the ability of a model to be developed based on all the unknown 
parameters (DSe, DSp and prevalences) and the information available from the data (i.e. 
degrees of freedom, df). For instance, the number of parameters in the 2 tests,2 
populations model equals the data df (i.e. 6). However, no residual df are available to 
evaluate the validity and goodness,of,fit of the model, and therefore more than two tests 
and/or populations are preferred (Dohoo et al., 2009). Evaluations of LCM identifiability 
applied to diagnostic tests have been discussed elsewhere (Jones et al., 2009). LCM 
models can also be run with either fewer tests or fewer populations when prior 
information about the prevalence or test properties exist (Dendukuri & Joseph, 2001). 
However, in some situations, the prior information may have more weight on the 
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estimation than the data itself (Neath & Samaniego, 1997). In these models, the number 
of tests should be increased or the available populations stratified (Toft et al., 2005). For 
instance, for a single sampled population, a minimum of 4 tests are necessary (Dendukuri 
and Joseph, 2001). 
 
 (ii) The tests must be conditionally independent given the infection/disease status. 
Test independence conditional on the health status may not be realistic when several tests 
are used (Brenner, 1996) and can result in incorrect estimation due to information bias 
(Torrance,Rynard & Walter, 1997). Conditional dependence was explained in section 
1.2.3.9, and the methods developed to account for conditional dependence in LCM are 
reviewed elsewhere (Hui and Zhou, 1998; Toft et al., 2005; Branscum et al., 2005; 
Dendukuri et al., 2009).  
 
 (iii) The operating characteristics of the tests must be constant across 
populations. Although generally assumed, constant DSe and DSp for various prevalences 
is actually rare. DSe is expected to increase with prevalence while DSp is expected to 
decrease (Greiner & Gardner, 2000b). When the assumption of constant DSe and DSp is 
not valid, the LCM may result in estimates that pool DSe/DSp from the different 
populations (Toft et al., 2005). The impact on LCM of varying DSe and DSp was 
investigated and discussed elsewhere (Johnson et al., 2009). This assumption is rarely 
verified in LCM. DSe and DSp estimations in the different studied populations can be 
done using pseudo,gold standard procedures (Nérette et al., 2008b). However, no 
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modelling procedure has been developed to relax this assumption without increasing 
substantially the number of parameters, which can jeopardize the model identifiability. 
 
 Two different estimation procedures exist to fit LCM and they include: 
maximization of the likelihood function (maximum likelihood, ML) and Bayesian 
estimations. The ML estimates can be obtained using an Expectation Maximization (EM) 
algorithm and the corresponding standard errors using the Newton,Raphson estimation 
(Dohoo et al., 2009). Confidence intervals are usually obtained by bootstrapping. The 
“Tests in the Absence of a Gold Standard” (TAGS) software was developed to facilitate 
the utilization of this procedure using either an “R” interface or directly on the website 
http://www.epi.ucdavis.edu/diagnostictests/QUERY.HTM  (Pouillot et al., 2002). 
However, ML estimation is not particularly flexible and cannot incorporate prior 
information about parameters. Furthermore, it does not perform properly when the 
sample size is small or when cells from contingency tables include nil or small values 
(Dohoo et al., 2009).  
 The Bayesian framework accommodates the modification of the code to include 
prior information or additional parameters (Hui & Zhou, 1998). Usually Bayesian LCM 
is run in the WinBugs software (Spiegelhalter et al., 2003) and codes for various 
estimation scenarios are available online 
(http://www.epi.ucdavis.edu/diagnostictests/software.html#DiagnosticTestSeSp). 
Associated with Bayesian estimation, post,estimation guidelines to assess Markov Chain 
Monte Caro convergence in the specific context of diagnostic test evaluation has been 
outlined elsewhere (Toft et al., 2007). A friendly interface was recently developed to use 
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LCM with two or more classes from a single population 
(http://www.nandinidendukuri.com) and a version for several populations will soon be 
available (Nandini Dendukuri, pers. com.). As multiple Bayesian outputs (i.e. mean, 
median or mode) are obtained, which one is reported should be clearly stated or all 3 
should be reported, to ease subsequent interpretations and applications. 
In the specific context of ISAV diagnostic test evaluations, LCM models have 
used both ML (Nérette et al., 2005a; Gustafson et al., 2008) or Bayesian estimations 
(Nérette et al., 2008b). Although, the assumption of conditional independence among 
tests was evaluated and accounted for in the estimation procedure (Nérette et al., 2008b), 
variation in DSe and DSp across the sampled populations was acknowledged but not 
addressed. 
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In 1947, Yerushalmy understood that the trueness of a diagnostic test could not be 
summarized as a single parameter (i.e. Ef) that would strongly vary with prevalence of 
D+ in the tested population (Alberg et al., 2004). Therefore, he stratified the proportion of 
correctly classified specimens within D+ and D, individuals, defined as DSe and DSp 
respectively. The concept of relative performance was not considered for agreement 
evaluation. Similarly, repeatability and reproducibility are prevalence,weighted averages 
of agreement within D+ animals and agreement within D, animals. When status,specific 
estimates are substantially different from each other or when the assumed prevalence of 
the targeted population deviates from 50%, the overall agreement varies with prevalence. 
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Albeit agreement studies are focused on test comparability or discrepancy, estimates of 
agreement relative to the health status seem more relevant to interpret and predict 
agreement variation in various populations.  
The health status is certainly not the only factor that influences the classification 
performance of a detection method. Contrary to common understanding, DSe and DSp 
may not be constant parameters across populations. Greiner & Gardner (2000b) 
readdressed DSe and DSp as population parameters that vary within and between 
populations according to the distribution of biological factors that influence the disease 
biology. For instance, age was found to be positively correlated with DSe of bovine 
trypanosomosis serology (Greiner et al., 1997).The validity of diagnostic accuracy 
studies is therefore questionable when the spectrum of covariate factors differs between 
the study population and target population(s). OIE addresses this issue by requiring that 
assay evaluation studies use a large number of realistic and representative samples. 
Nonetheless, the apparent poor stability of reported DSe/DSp warrants more 
consideration to these parameters (Moons & Harrell, 2003). Conversely, the widely 
adopted Standards for Reporting of Diagnostic Accuracy (STARD) recommended to 
keep using DSe/DSp and to address their relativity by reporting various population,
specific estimates (Bossuyt et al., 2003). Nonetheless, this approach does not allow for a 
valid extrapolation of test characteristics to a new, unstudied population. Obtained by 
stratification or modelling, covariate,specific estimates of DSe and DSp are more 
relevant to investigate the impact of specified factors on test accuracy (Shapiro, 1999, 
Janes & Pepe, 2008; Bachmann et al., 2009). Finally, according to the assumed mixture 
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distribution of covariates in the population, DSe and DSp can be predicted across various 
populations by simple weighted averages (Björk et al., 2009). 
The most influential factor impacting DSe is most likely the degree of disease 
severity. Based on histology or morphology, DSe is expected to be greater for large and 
diffuse lesions than for small and focal lesions (Begg, 1987). Moreover, the spectrum of 
virulence and immunogenicity of an infectious disease is assumed to vary across 
populations according to the prevalence (Brenner & Gefeller, 1997). With an increasing 
prevalence, the proportion of severe stages is expected to increase among infected 
animals (Greiner & Gardner, 2000b). Therefore, constant DSe across prevalences is 
unlikely and is expected to increase with prevalence. Furthermore, it is reasonable to 
think that test performance in D, individuals (DSp) is dependent on the pressure of cross,
contamination from infected samples or/and positive controls. As the proportion of 
infected animals in the sampled population (prevalence) and the tested sample pool 
become larger, the pressure and chance of cross,contamination likely becomes greater. 
Therefore, DSp is expected to decrease with increased prevalence. Referred to as “mix 
case” (Begg, 1987), misrepresentation of infection stage may result in biased pooled 
estimations for procedures like LCM that assume constant DSe and DSp across 
prevalence populations (Toft et al., 2005).  
Finally, detection assays that measure a continuous biological marker involve an 
additional level of dependence. The two distributions corresponding to D+ and D, group 
measurements tend to partially overlap each other. The degree of overlapping depends on 
various factors that characterize the target population (e.g. spectrum of severity) (Greiner 
& Gardner, 2000b). According to the mixture distribution and the intended purpose of the 
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test, a cut,point value is selected to discriminate D+ and D, individuals. For the same test 
and with the same objective, the cut,point (and associated DSe/DSp) is expected to 
change across populations. Therefore, the selection of a fixed and standard cut,point in 
continuous outcome tests may not be appropriate. 
'
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 The main objective of this research was to develop methods that account for 
factors that are likely to affect the estimation of test accuracy fro ISAV. Addressed in 
four separate research chapters, the specific objectives were: 
 1. to extend the basic description of test agreement by adding visual tools to 
summarize and illustrate the relative agreement among pairs of tests or runs.  
 2. to estimate agreement related to the true health status with subsequent 
predictions of the overall agreement in other populations, for a specified prevalence. 
 3. to extend the conventional latent class model by adding a third class (subclass 
of infected individuals), and to achieve constant DSe estimates based on the stage of 
infection (i.e. relax the assumption of constant DSe). 
 4. to adapt the selection of cutpoints for the particular case of real,time nucleic 
acid amplification assays based on the intended purpose and the target population. 
'
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As a component of diagnostic test evaluation, the estimation of repeatability and 
reproducibility of an assay is necessary to assess the robustness and the transferability of 
the method among laboratories. Respectively defined as the agreement within and 
between laboratories, repeatability and reproducibility of a qualitative diagnostic test are 
traditionally reported using observed proportion of agreement or Kappa values. Applied 
to a recently designed RT@PCR assay for the detection of infectious salmon anaemia 
virus, repeatability within a national reference laboratory and reproducibility with two 
independent regional laboratories were investigated. Additionally, homogenization of fish 
kidney tissue was conducted to potentially provide more uniform submission material, 
and to assess the effect of homogenization on laboratory comparability. Comparison of 
agreement between non@homogenized and homogenized tissue samples revealed different 
patterns of test results and unexpected alterations of agreement due to homogenization.  
This observation may be explained by cross@contamination of some samples during the 
homogenization process.  One of the laboratories was in clear disagreement with the two 
others and impacted the overall reproducibility of the assay. Agreement levels were 
visually described using a novel tree@shape representation inspired from phylogenetic 
studies. The resulting phylogram illustrated the proximity of test findings between 
repeated samples within a laboratory and between laboratories, and facilitated the 
interpretation of the agreement levels. 
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The Office International des Epizooties (OIE, World Organisation for Animal 
Health) aims to safeguard international trade by publishing standards and guidelines for 
health and self@declaration of disease@freedom for animals and animal products. To 
diagnose infectious diseases and associated pathogens, the OIE recommends use of 
certified or validated diagnostic assays (OIE, 2008). Diagnostic validation is defined as 
the evaluation of a test method based on its fitness for a specific purpose (OIE, 2008). 
Validation is a multiple@stage process that determines the operating characteristics of the 
test including the assessment of its characteristics and performance at the bench level 
(estimation of analytical sensitivity, specificity, and repeatability), evaluation of its 
accuracy (diagnostic sensitivity and specificity), and estimation of its precision 
(“diagnostic” repeatability and reproducibility) at the population level.  
The estimation of the test precision is an important step of the validation process, 
although sometimes overlooked and neglected. Diagnostic repeatability is defined as the 
variation in test results that are obtained with the same method on identical test items in 
the same laboratory by the same operator using the same equipment within short intervals 
of time (within@laboratory consistency). Diagnostic reproducibility is defined as the 
variation in test results that are obtained with the same method on identical test items in 
different laboratories with different operators using different equipment (between@
laboratory consistency) (IS0 5725@1, 1994).  
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The concept of variation in binary outcome diagnostics is associated with the 
concept of agreement between test runs. We defined as “test run” or “run” a set of results 
obtained using the same method under defined conditions relative to the testing 
laboratory and the nature of the sample (identical conditions for repeatability and similar 
conditions for reproducibility). Agreement is traditionally expressed using the proportion 
of agreement (Pa) (proportion of tests results that agree) or using Cohen’s Kappa values 
(κ) (Dohoo et al., 2009). It has been suggested that precision for binary tests can also be 
assessed using predictive intervals of diagnostic sensitivity (DSe), specificity (DSp) or 
overall accuracy (Cleophas et al., 2008). This study was restricted to the evaluation of 
diagnostic repeatability and reproducibility to suit the requirements of international 
standards (OIE, 2008). 
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Phylogenetics is a discipline that investigates the relationship among organisms 
according to their gene similarity. The pairwise comparison of aligned nucleotide or 
amino acid sequences determines the degree of similarity (agreement) between genes. 
The measure of similarity is calculated as the proportion of nucleotides, or amino acids, 
that are identical between two sequences (Vandamme, 2003).  Proportions of similarity 
(or dissimilarity) are usually summarized in a pairwise genetic distance matrix. The 
distance matrix is then used to reconstruct a phylogenetic tree that illustrates the 
evolutionary relationship among compared organisms. Distance matrices are comparable 
to agreement matrices that are reported in diagnostic evaluation studies. Methods using 
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distance matrices for phylogenetic tree inferences are referred to as distance@based 
methods in contrast with character@based methods that integrate additional character 
information. Genes with high sequence agreement will be positioned closer to each other, 
whereas genes with low sequence agreement will not group together. Similarly to genetic 
sequences, laboratory test results can be aligned and analyzed using distance@matrix 
based models to visually represent agreement among laboratories in a tree shape. 
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Infectious Salmon Anaemia virus (ISAV) is an Orthomyxovirus, genus C#&<"*,#@ 
causing a hemorrhagic syndrome in salmonids. Primarily pathogenic for Atlantic salmon, 
E&.D;$#&.&* L., the viral agent, causing high mortality, is a serious threat to the economic 
sustainability of many salmon aquaculture industries worldwide. Originally observed in 
Norway in 1984 (Thorud & Djupvik, 1988), clinical ISA was then chronologically 
reported in Canada (Mullins et al., 1998), Scotland (Rodger et al., 1998), Faroe Islands 
(Anonymous, 2000), USA (Bouchard et al., 2001), and recently in Chile (Godoy et al., 
2008). Absent in some areas of Atlantic salmon production (e.g. Tasmania, Australia; 
British Columbia, Canada), ISAV is listed as a reportable aquatic disease by the OIE 
(OIE, 2009). Consequently, for international trade purposes, diagnostic methods used for 
screening, certification, confirmation, and control require validation. The implementation 
of the National Aquatic Animal Health Program, including national reference laboratories 
and surveillance programs, aims at controlling and preventing the emergence and spread 
of aquatic disease in Canada. Since ISAV surveillance is a goal of the program, it was 
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required that a recently designed Reverse@Transcriptase Polymerase Chain Reaction (RT@
PCR) assay for ISAV (Gagné et al., data unpublished) be validated. 
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A single study previously investigated the repeatability and reproducibility of an 
ISAV RT@PCR assay in three different laboratories (Nérette et al., 2005). The study 
revealed substantial differences in repeatability (Pa ranging from 76 to 98% and κ from 
0.50 to 0.96).  In addition, there was a serious disagreement explained by one laboratory 
with a higher proportion of positive tests although a substantial reproducibility was found 
between the two others (Pa = 91% and κ = 0.79).  The authors proposed that factors 
associated with sample and testing conditions may have affected the assessment of 
reproducibility and repeatability: i) heterogeneous distribution of virus in the organ may 
have resulted in virus quantity inconsistency among replicated samples; ii) differences in 
testing protocols (i.e. different sets of primers and methods) may have compromised the 
comparability of laboratories; and iii) differences in agarose gel interpretation and 
confirmation protocols (i.e. whether a sample with a weak gel band was retested) may 
have also affected interpretation of results differently in the three laboratories.   
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The objective of this study was three@fold.  The first objective was to describe 
qualitative diagnostic precision of a newly designed ISAV RT@PCR (Gagné et al., data 
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unpublished) in three different laboratories using identical standard operating procedures 
for testing and interpretation. Specifically, we estimated the repeatability only within the 
designated National Reference Laboratory for ISAV in Canada (the Aquatic Animal 
Health Section of the Gulf Fisheries Centre, Department of Fisheries and Oceans, 
Moncton, Canada), and the reproducibility by including two other independent 
laboratories in the study. The second objective was to investigate the impact of the 
potential heterogeneous distribution of viral particles among replicate samples by 
assessing agreement of homogenized tissue samples. The third objective was to develop a 
novel visual approach to describe test agreement using distance@matrix based tree 
reconstruction inspired from phylogenetic studies. This new approach was not intended to 
replace former methods but to facilitate the illustration and complement interpretation of 
agreement with a new perspective. 
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Kidney samples from 100 Atlantic salmon were selected from archives of 
different sources to target a prevalence of approximately 50% according to McClure et al. 
(2004); briefly,  45 apparently healthy fish (15 fish from each cage) were from exposed 
cages in 3 different infected sites (expected prevalence of 28.1%), 35 apparently healthy 
fish were from a known infected cage (expected prevalence of 41.5%), and 20 dead or 
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moribund fish (10 fish from two different sites) were from ISA clinically affected cages 
(expected prevalence of 100%). Kidney samples were collected aseptically from each fish 
in replicates of six and stored in RNA.&()* (Ambion Inc., Austin, TX, USA) at @80 °C 
after a 24 hour period at 4 °C. 
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Each sample was coded with a random identification number to blind laboratory 
operators and to avoid test@review bias (Ransohoff and Feinstein, 1978).  Sample 
distribution and testing objectives are summarized in Fig. 2.1.  From each salmon, 
duplicate samples (t1, t2) were sent on dry ice to the reference laboratory (lab A) to 
estimate repeatability, and single samples (t) were transported on dry ice to two other 
laboratories (labs B and C) to estimate reproducibility.  The remaining two samples were 
combined, homogenized and aliquoted with equal volume (250 kL) in four coded 
microtubes.  
Homogenization was performed in lab A by transferring the two samples (h1, h2) 
in a 2 ml microtube filled to the upper limit with RNA.&()* and homogenized using a 
FastPrep® FP120A homogenizer (MP Biomedicals) at 5.5 m/sec for 20 s twice. Two 
aliquots (h) of 250 kl of homogenate from each fish stayed in lab A stored at @80 °C to 
estimate the repeatability, and single aliquots of 250 kl of homogenates were sent frozen 
on dry ice to the other two laboratories to estimate the reproducibility (Fig. 2.1). Each of 
the participating laboratories agreed to test for the presence and absence of ISAV using 
the same RT@PCR protocol provided by the reference laboratory (lab A). 
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3 +' &%#%"$"<FGF$L' "BD' &%#&CDE>F<FGF$L@ (t1): non@homogenized sample, 
duplicate 1; (t2): non@homogenized sample, duplicate 2; (t): non@
homogenized sample; (h1): homogenized sample, duplicate 1; (h2): 
homogenized sample, duplicate 2; (h): homogenized sample. 
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For RNA extraction, a piece of tissue (approximately 30 ± 5 mg) was removed 
and homogenized in 1 ml of TRI reagent (Molecular Research Inc) with a FastPrep 
FP120 (Savant Instruments). For homogenates, microtubes were centrifuged to remove 
the RNA.&()* before adding 1 ml of TRI reagent and homogenization.  Manufacturer’s 
instructions were followed, except for 2 additional washes of the RNA pellet with 75% 
ethanol. RNA pellets were resuspended in 50 kl of sodium citrate buffer 1mM pH 6.4 
containing an RNase inhibitor (Qiagen). RNA was further diluted if necessary, and 
quantified on a spectrophotometer and normalized. A maximum of 1000 ng/kl was used 
for reverse transcription.  
A one@step RT@PCR was used to detect ISAV, using the Qiagen One@step RT@
PCR kit (Qiagen). The mixture comprised 5 kl of Q solution, 0.32 kM of each primer 
(404F : 5’ tgg gca atg gtg tat ggt atg a@3’ and RA3(583R): 5’ gaa gtc gat gaa ctg cag cga@
3’), 1 kl of enzyme, 5 kl of buffer, 1 kl of dNTP, 11.2 kl of H2O and ≤ 1 kg of RNA, for 
a total volume of 25 kl. PCR conditions consisted of an initial hold at 50 °C for 30 min, 
and 95 °C for 15 min, followed by 10 cycles of touchdown PCR starting with  94 °C for 
40 s, 72 °C for 40 s, and 72 °C for 60 s,  and lowering by 1 °C the annealing temperature 
after each cycle. Then 40 cycles at 94 °C for 40 s, 62 °C for 40 s, and 72 °C for 60 s were 
added, and a final extension of 72 °C for 10 min, and holding at 20 °C completed the 
program. PCR products (10 kl) were electrophoresed in 6% acrylamide, visualized with 
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ethidium bromide, and compared to positive controls and a DNA ladder. A band at the 
same expected size (179 bp) as the positive control was considered positive. For quality 
control, extraction blanks (no sample) were included every 15th tube during extractions, 
and blanks (water) were added at the RT@PCR step. Electrophoresis gels were examined 
carefully, and PCR was repeated on samples where a very weak intensity band at the 
expected size was observed initially. If the second PCR result was positive again, the 
final result was positive; if not, it became negative. 
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  Test results from each laboratory were collated and first analyzed using Stata SE 
10.0 (Stata Corp., College Station, TX, USA, 2007). The first agreement statistic 
computed was the observed proportion of agreement (Pa), giving the proportion of paired 
test results that agreed either on a positive or on a negative test result between two test 
runs. Exact confidence intervals (CIs) for observed agreement were computed. An 
average Pa was also computed as a mean of Pa estimates from all possible pairs of test 
runs within lab A (overall repeatability), and among the three laboratories (average 
reproducibility of homogenized and non@homogenized samples, and overall 
reproducibility). CIs were computed using 5% and 95% percentile values from 
bootstrapped estimates resampled 1,000 times. 
  The second agreement statistic computed was Cohen’s Kappa (κ), commonly 
used for subjective rating. Ranging from @1 to +1, this value represents the level of 
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agreement beyond agreement expected due to chance (Dohoo et al., 2009). The κ was 
also computed for agreement among three laboratories data together (Fleiss et al., 2003). 
CIs for the κ statistic were computed using an analytical method for comparison of two 
test runs (Fleiss et al., 2003) and a bootstrap method for three runs (Lee and Fung, 1993). 
Prior to each paired κ estimation, a McNemar’s test (exact binomial test for correlated 
proportions) was performed to assess if proportions of positive results differed between 
test runs. Evidence of proportion disagreement between runs would constitute 
disagreement between runs and reduce the interest in κ estimation (Dohoo et al., 2009). 
  Due to violation of the assumption of independent observations (test results 
obtained from the same fish), two Pa from different conditions (i.e. repeatability of non@
homogenized vs. homogenized samples) could be compared using a McNemar's test by 
defining agreement/non@agreement (e.g. comparing two runs) as a binary outcome. 
However, this method does not consider proportion of agreement on a positive and on 
negative result. The contingency table can contain more than two categories (e.g. agree 
on a positive result, disagree and agree on a negative result). The effect of 
homogenization on agreement was then assessed by testing symmetry and marginal 
homogeneity in contingency tables.  The symmetry test compares symmetrical cells 
around the agreement diagonal of the contingency table, whereas the marginal 
homogeneity test compares the marginal distributions of the positive test results (Table 
2.1). Agreement among all test results from non@homogenized samples was compared to 
agreement among all test results from homogenized samples using the exact test for 
symmetry and Stuart@Maxwell test for marginal homogeneity ( !""#$%! command; 
Stata Base Reference Manual, 2007). In addition, following the approach outlined in 
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Agresti (2002), a quasi@symmetry model for the contingency table was fit, and marginal 
homogeneity was tested using a likelihood ratio test of symmetry in this model. The same 
approach was used to compare agreement in homogenized and non@homogenized samples 
within@ and between@laboratory data. 
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A summary matrix of observed agreement (Pa) and disagreement (i.e. proportion 
of results that disagree between the two test runs: 1 @ Pa) was generated for all possible 
pairwise comparisons. In phylogenetic methods, the observed disagreement is also called 
;-#)*<)/$/"#(&0%) or '8/"#(&0%) (Van de Peer and Salemi, 2003). Thus the distance 
matrix summarized the relative distance of the runs to each other based on their test 
results.  Smaller distance values indicate closer result findings between two laboratories.  
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A pseudogold standard (PGS) was created to provide a consensus reference baseline for 
the test results alignment. Adapting the PGS definition of Nérette et al. (2008), ISA 
positive and ISA negative classification criteria were arbitrarily based on the combination 
of six test results for each fish, excluding the duplicate sample results in lab A (3 
laboratories testing a non@ and a homogenized samples each).  “Infected” fish were any  
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N&CH'$!%'NCE&'$%=$= (2 tests in reference lab A and one test each in participating lab B & 
C)a,b. The number (#) of positive test result “0” and “4” correspond to complete 
agreement among all samples and laboratories on a negative and on a positive test result 
respectively, while intermediate categories correspond to the number of positive test 
result among the four sub@samples regardless of the sample and the laboratory.  
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a 2LHH%$&L'$%=$ compared symmetrical cells around the agreement diagonal (in bold) 
b :"&IFB"G'!CHCI%B%F$L'$%=$ compared the marginal distributions of non@homogenized and homogenized 
samples (italicized) 
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fish with more than three positive tests out of the six (> 3/6). “Non@infected” fish were 
any fish with three or less positive tests out of the six (≤ 3/6).  
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Initially formatted with individuals in rows and runs in columns, tests results were 
transposed so individuals were in columns and test runs in rows. Negative results, “3”, 
were recoded with an “&” (corresponding to adenine) and positive results, “7”, were 
recoded with a “>” (corresponding to  guanine) in a FASTA format to suit the DNA 
sequence alignment editor software BioEdit version 7.07 (Hall, 1999) requirements. Test 
results were edited and displayed as a sequence alignment where only results in 
disagreement with the PGS are highlighted, and test results in agreement were 
symbolized by a “.” as a placeholder. 
 
2:2:F:B$Distance@matrix based tree reconstruction model$ 
To conduct tree reconstruction, the FASTA alignment was transferred into the 
MEGA format using the package MEGA version 4 (Tamura et al., 2007). The alignment 
was considered as a non protein@coding nucleotide sequence and phylograms were 
obtained using the distance@based Neighbor@Joining (NJ) method. The model used 
distances based on the number of differences, and missing data were handled by pairwise 
deletion. Statistical support for tree topologies were bootstrap@resampled 1,000 times 
(Felsenstein, 1985). Bootstrap support values (proportion of resampled trees that include 
the node of interest) were reported in percentage on the nodes of the original tree. 
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Phylograms were edited using the TreeExplorer software appended to the MEGA 
package. 
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Results were obtained for all eight test conditions with all 100 samples, except 
that lab C had insufficient material for one homogenized sample (only 99 results for 
homogenates). Among the 100 non@homogenized samples, duplicates t1 and t2 of lab A 
detected respectively 42 and 44 positives, and lab B detected 43, while lab C detected 58. 
Among the 100 homogenized samples, duplicates h1 and h2 of lab A detected 
respectively 53 and 57 positives, and lab B detected 48, while lab C detected 62 (out of 
99 results). Agreement statistics of interest (Pa and κ) and CIs are summarized in Table 
2.2.  
Overall repeatability revealed slightly lower Pa than overall reproducibility (0.81 and 
0.82, respectively), although the overlapping of CIs provided little evidence of significant 
difference (Table 2.2). Tests from pairwise comparisons involving lab C showed serious 
disagreement with the two other laboratories regardless of the sample type (significant 
McNemar’s test). Estimates of κ ranged from 0.57 to 0.73 and concurred with Pa results 
(Table 2.2). 
The average proportion of positive results for non@homogenized samples was 
46.8%; and the average proportion of positive results for homogenized samples was
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G"<C&"$C&F%='>CH#"&F=CB@ t1: reference laboratory A, tissue sample, duplicate 1; t2: reference laboratory A, tissue sample, duplicate 2; h1: 
reference laboratory A, homogenized sample, duplicate 1; h2: reference laboratory A, homogenized sample, duplicate 2; tB: laboratory B, 
tissue sample; tC: laboratory C, tissue sample; hB: laboratory B, homogeized sample; hC: laboratory C, homogenized sample. 
 
 !"##$#%&'(#)#( *#+#,&,-.(.&/ ' ' *#+"0123.-.(.&/  
4,$+(#'&/+#  
50%6
70$0!#%.8#1  90$0!#%,&# 
'
50%670$0!#%.8#1  90$0!#%,&#  
:,-';0$+,".<0%' &='>'&?' 7='>'7?' ' &='>'&@' &='>'&;' &@'>'&;' 7='>'7@' 7='>'7;' 7@'>'7;' 
! " !  #$  %&   &'  %$  #!  #!  %'  %&  
' " '  %&  #&   %(  %$  #'  #'  #(  #&  
' " !  )  *   (  %  +  '+  (  +  
! " '  $  '+   )  '$  ')  )  '(  ')  
A0&,(',-./012' '!!  '!!   '!!  '!!  '!!  '!!  $$  $$  
B, ,342 
CDEF'
,!5)&"!5$!2   
CDEC'
 ,!5)'"!5*)2 
' CDEG'
,!5)$"!5$%2 
CDGE'
,!5($"!5*(2 
CDE='
,!5)+"!5**2 
CDE='
,!5)+"!5**2 
CDGE'
,!5(*"!5*&2 
CDE='
,!5)+"!5**2 
B,',)#",!#',$0%!'"2%<H'
,342' CDE=',!5)&"!5*(2'
' CDE?',!5)("!5**2 CDEC',!5)#"!5*(2 
CDE?',!5))"!5*(2'
I35#$,"J<'A#<& , "678/92 !5('! !5%)! 
 
!5)*! !5!!!:: !5!!!:: !5+&! !5!%%:: !5!!!:: 
K,++, ,3.;90<=2  CDLG' CDLC' ' CDGM' CDNG' CDL?' CDL?' CDNN' CDLM'
34  !5&% " !5*+ !5## " !5)&  !5(! " !5*) !5#+ " !5)+ !5#) " !5)) !5#) " !5)) !5#! " !5)' !5#* " !5)) 
M6"#+(.3,&#'K,++,  %,  %,  
'
CDLF CDLC 
34 ,>..1=1?7@A'!!!2  07  07   !5&+"!5)(  !5#)"!5)'  
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** Significant McNemar’s test (J < 0.05): significant difference of proportion of positive results between the two test runs; thus 
corresponding Kappa value is less revelant 
na: not applicable 
Pa: observed proportion of agreement 
CI: confidence interval 
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56.4%. Table 2.1 shows the contingency table of number of positive test results 
comparing non@homogenized and homogenized samples. Both symmetry and marginal 
homogeneity tests showed a significant difference (J < 0.05) in overall agreements, 
repeatabilities and reproducibilities between non@homogenized and homogenized sample 
results. As an example, for overall agreement, we observed more complete agreements 
(all four tests agree for a given sample type) on positive results (n =40) than on negative 
results (n= 28) in homogenized samples whereas non@homogenized samples showed the 
opposite pattern (33 vs. 35) (Table 2.1). Intermediate marginal proportions (two to three 
tests that agree) were, however, quite comparable (Table 2.1). Quasi@symmetry modelling 
procedure showed a good fit to the data and the hypothesis of marginal homogeneity was 
significantly rejected against that model for overall agreement, repeatability and 
reproducibility data (all J < 0.05). 
Table 2.3 represents a summary matrix of observed agreement (Pa) and disagreement (1 @ 
Pa) of all possible pairwise comparisons. The minimum disagreement or distance (0.09) 
was observed between lab A, duplicate 2, and lab B with non@homogenized sample; and 
the maximum was observed between non@homogenized sample in lab A and 
homogenized sample in lab C (0.25). Additionally, significant McNemar’s test revealed 
serious disagreement despite high Pa for several pairwise comparisons (Table 2.3). 
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According to the PGS, out of the 100 salmon sampled, 48 were positive and 52 
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*"<G%'?@P'
 ,I&%%H%B$'H"$&FT'UF$!'#&C#C&$FCB'CN'"I&%%H%B$'(lower left corner) "BD'#&C#C&$FCB'
CN'DF="I&%%H%B$'C&'DF=$"B>%'(top right corner in bold)'<%$U%%B'&EB=. (t1): non@
homogenized sample, duplicate 1; (t2): non@homogenized sample, duplicate 2; (t): non@
homogenized sample; (h1): homogenized sample, duplicate 1; (h2): homogenized 
sample, duplicate 2; (h): homogenized sample 
 
Runs  LabA(t1) LabA(t2) LabB(t) LabC(t) LabA(h1) LabA(h2) LabB(h) LabC(h) 
LabA(t1) \ V@AQ V@AP V@??W V@AXW V@AXW V@AY V@?ZW:"T 
LabA(t2) 0.84 \ V@VX:FB V@?VW V@?PW V@AXW V@AY V@?ZW:"T 
LabB(t) 0.87 0.91Max \ V@AXW V@??W V@A[W V@AA V@?YW 
LabC(t) 0.78* 0.80* 0.81* \ V@AX V@AP V@A?W V@AZ 
LabA(h1) 0.81* 0.77* 0.78* 0.81 \ V@?V V@AX V@??W 
LabA(h2) 0.81* 0.81* 0.82* 0.87 0.80 \ V@AAW V@AY 
LabB(h) 0.86 0.86 0.89 0.88* 0.81 0.89* \ V@AXW 
LabC(h) 0.75*Min 0.75*Min 0.76* 0.85 0.78* 0.86 0.81* \ 
* Significant McNemar’s test (J < 0.05): significant difference of proportion of positive results between the 
two runs; thus serious disagreement 
Min Minimum 
Max Maximum 
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negative for ISAV. Assuming that the PGS is correct, the targeted prevalence in the 
submitted samples (~ 50%) was reached which was fortuitous since the estimates within 
each salmon group did not agree with the ones reported in McClure et al. (2004). Using 
the PGS as a reference standard, the alignment of test results from the eight runs (3 
laboratories, 2 sample types, and duplicates in lab A) highlighted the differences among 
test results (Fig. 2.2). 
 The computed unrooted tree represents the relative position among the eight test 
runs (Fig. 2.3A &B). Except for lab C, all non@homogenized samples were grouped 
together and formed a cluster supported by a low bootstrap value (61%). Within the 
cluster, lab A (duplicate 2) and lab B were the closest and associated with a high 
bootstrap value (88%) as previously shown in the agreement matrix (Table 2.3).  Except 
for lab B, all homogenized samples were grouped together, including the lab C non@
homogenized sample, and formed a cluster not supported by a high bootstrap value 
(50%). Within the homogenates cluster, both lab C samples and the lab A homogenate 
(duplicate 2) were grouped based on a low bootstrap value (60%).  The lab C homogenate 
and lab A homogenate (duplicate 2) group was not supported by a high bootstrap value 
(43%) which does not separate them from the lab C non@homogenate. The results of the 
homogenized sample from lab B were consistently different, and therefore separated, 
from the two main clusters.
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'
'
'
'
7FI@' ?@?@' *%=$' &%=EG$' "GFIBH%B$: sampled salmon (in column) were clustered by cage origin and expected 
prevalence level population grouping (moderate level: apparently healthy fish from exposed cage; high level: mix 
of apparently healthy, mortality and moribund fish from infected cage). Negative was recoded as “adenine” (a); 
positive as “guanine” (g); and by column a dot (.) indicates same result as the first row. Greek letters: arbitrary 
cage number. (t1): non@homogenized sample, duplicate 1; (t2): non@homogenized sample, duplicate 2; (t): non@
homogenized sample; (h1): homogenized sample, duplicate 1; (h2): homogenized sample, duplicate 2; (h): 
homogenized sample. 
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7FI@' ?@P,' @' 2$"&' =!"#%D' EB&CC$%D' #!LGCI&"H' &%#&%=%B$FBI' "I&%%H%B$' "HCBI' $%=$'
&EB=@ The distance between two runs is visually assessed by the relative length of 
branches that connect them and are scaled based on the number of differing results out of 
the 100 samples tested. (t1): non@homogenized sample, duplicate 1; (t2): non@
homogenized sample, duplicate 2; (t): non@homogenized sample; (h1): homogenized 
sample, duplicate 1; (h2): homogenized sample, duplicate 2; (h): homogenized sample. 
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7FI@' ?@P9' @' *&%%' =!"#%D' EB&CC$%D' #!LGCI&"H' &%#&%=%B$FBI' "I&%%H%B$' "HCBI' $%=$'
&EB=@ The distance between two runs is visually assessed by the relative length of 
branches that connect them and are scaled based on the number of differing results out of 
the 100 samples tested. (t1): non@homogenized sample, duplicate 1; (t2): non@
homogenized sample, duplicate 2; (t): non@homogenized sample; (h1): homogenized 
sample, duplicate 1; (h2): homogenized sample, duplicate 2; (h): homogenized sample. 
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Although no minimum threshold has been set as suitable for validation of 
qualitative diagnostic tests, it is accepted that greater repeatability and reproducibility is 
preferred, provided that the McNemar’s test is non@significant. Kappa values (κ) are 
usually used to compare test agreement beyond expected agreement (Dohoo et al., 2009). 
However, κ was estimated for all test runs at a same prevalence level of approximately 
50%, and therefore, expected agreement due to chance would be consistent for all 
agreement estimates. Accordingly, we decided to base most of the discussion on Pa with 
little reference to κ values. 
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' Based on the set of samples tested, the overall RT@PCR repeatability in the 
reference laboratory was approximately 81% (proportion of agreement). One could 
interpret this value as one in every set of five samples tested does not provide the same 
result when tested a second time (or 19% of the samples do not repeat the same result). 
When two results from the same individual disagree, based on a dichotomous outcome, 
one of the results has to be incorrect. Consequently, qualitative diagnostic tests that lack 
repeatability also lack accuracy. In this particular case, 9.5% (1/2 * 19%) of the 
combined results are either false positive or false negative.  
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Greater frequencies of false negative results imply decreased diagnostic 
sensitivity (DSe) that can be explained by several factors. The most likely reason for false 
negative results is a limited analytical sensitivity. Defined as the minimum threshold of 
detection, the analytical sensitivity of a RT@PCR depends on several method@specific 
factors including primer stringency (i.e. design of primer, nature and freshness of 
reagents), reaction preparation (i.e. ratio of target and primers), and thermocycling 
protocol (i.e. annealing temperature). It is possible that samples with a low concentration 
of target and/or a complex molecular matrix might not be detected if the primers do not 
bind to the target during the first cycles of the reaction. Thus, for infected samples with a 
concentration of RNA targeted close to the limit of detection, the target is sometimes 
detected or not, and the repeatability decreased. Among the 19% of non@repeatable 
results, some may be due to low concentration of target; hence the estimate of 
repeatability depends strongly on the nature of the sample tested. During routine 
surveillance, the pathogen load of screened apparently healthy individuals is likely to be 
low and the frequency of false negative results is expected to be high, whereas for 
confirmatory purpose, the pathogen load of clinically suspected individuals is likely to be 
high and the frequency of false negative results is expected to be low.  
Greater frequencies of false positive results imply decreased diagnostic specificity 
(DSp) that can be explained by several factors. The most likely reason for false positive 
results with RT@PCR is cross@contamination (Wilson, 1997). Among the 19% of non@
repeatable results, some may be due to contamination. Agreement among false positive 
results was not complete indicating that contamination was most likely random and not 
systematic. In theory, the probability of contamination should be associated with the 
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prevalence of infection in the sample pool tested. During routine surveillance, the 
prevalence of infected samples is usually low and the frequency of false positive results is 
expected to be low, whereas for confirmatory purpose, the prevalence of infected samples 
is likely high and the frequency of false positive results is expected to be more common. 
As discussed previously (Begg, 1987; Greiner & Gardner, 2000), test operating 
characteristics depend strongly on the targeted population. Thus, the specific purpose and 
use of the diagnostic method must be clearly defined to reflect the assay’s performance 
(OIE, 2008). 
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The overall reproducibility of 82% proportion of agreement was estimated to be 
slightly higher than the overall repeatability of 81% (Table 2.1). In theory, it is expected 
to observe a larger variation in results between than within laboratories. Factors 
influencing the reproducibility include the ones influencing the repeatability plus factors 
differing among laboratory practices such as technician habit and training, equipment, 
facilities structure and organisation. For example, false positive or false negative results 
could arise from the subjective reading and interpretation of bands in electrophoresis 
gels. Laboratory technicians must choose the dichotomous result (i.e. positive or 
negative) according to the test protocol, their own training, and experience. Although 
mostly expected to influence the assay reproducibility, gel interpretation may also affect 
the repeatability due to human error and multiple laboratory staff.  
A major source of decreased reproducibility is the discrepancy among laboratory 
operators in identifying a weak intensity band. Based on the subjective interpretation of 
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the operator, the sample will be retested or not. The subsequent interpretation in series of 
the repeated sample result (if the second test result is negative the sample is declared 
negative) may impact the agreement with laboratories that do not retest weak band 
samples. Retesting samples with weak bands aims to remove some false positive results 
and to increase DSp. This procedure may, however, also interpret as negative some truly 
low infected samples that are poorly repeatable. In this case, it would subsequently 
decrease DSe. If not standardized among laboratories, the retest of weak band samples 
and the interpretation of the second result would likely impact the reproducibility. 
Overall, it seems that these factors had little influence in this study since the overall 
agreements within and between laboratories were similar. However, these values reflect 
an average and do not reflect particular pairwise agreements.  
Regardless of sample type, lab C had significantly higher proportions of positive 
results, suggesting serious disagreement with other laboratories (Table 2.1). This can be 
explained either by a higher DSe or by lower DSp in lab C. Assuming that the PGS is 
correct, lab C tended to have more false positive results (Fig. 2.2). Mostly with 
homogenates, lab B had overall a lower proportion of positive results. This can be 
explained by a lower DSe or a higher DSp in lab B. Assuming again that the PGS is 
correct, lab B seemed to have more true results than the two other laboratories (Fig. 2.2). 
There is evidence of variation in laboratory performance associated with low 
reproducibility. 
In general, no international or standard guidelines are available to define 
acceptable levels of reproducibility. When two proportions of agreement are similar, the 
proportion of tests that agree on a positive result and the proportion of tests that agree on 
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a negative result can still differ. As an example, McNemar’s test detected significant 
differences in proportions of positive results on homogenized tissue samples between lab 
B and C and not between lab A and B for identical Pa (Table 2.1). More sophisticated 
modelling, using multilevel logistic regression models, could alleviate the assumption of 
independent observations to simultaneously explore the effects of laboratories and 
homogenization on agreement levels (Chapter III).$
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The second objective of this study was to assess the effect of homogenization by 
comparing agreement between non@homogenized and homogenized samples. On average, 
homogenized samples had a higher proportion of positive results than non@homogenized 
samples (56.4% vs. 46.8%), which implies that homogenization impacted the test 
performances with either increased analytical sensitivity and DSe, decreased DSp, or 
both. Homogenized samples revealed slightly lower repeatability and reproducibility as 
non@homogenized samples (Table 2.1). We expected a strong improvement of agreement 
with homogenized sample as the supposedly heterogeneous distribution of ISAV particles 
in the salmon kidney was one suggested explanation for the low RT@PCR reproducibility 
in Nérette et al. (2005). Furthermore, significant symmetry and marginal homogeneity 
tests suggested a shift in testing pattern with homogenized samples. The marginal 
distribution of overall agreement revealed that the proportion of complete agreement (all 
test results agree for a given sample type) was higher with positive than with negative test 
results for homogenized samples while it was the opposite with non@homogenized 
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samples (Table 2.2). Although it was expected that higher complete agreement was 
observed for positive results with homogenized samples, a decrease of complete 
agreement for negative results was totally unexpected, in particular with the assumed 
dilution effect of homogenization (see below).  
Reviewing the homogenization protocol and the fact that 12 fish with some 
positive results for homogenized samples were negatives for the four tests in non@
homogenized samples (Table 2.2), it is feasible that cross@contamination occurred during 
homogenization. The use of pipette tips that lacked a filter might explain the potential 
false positives among the homogenates. Homogenization protocols, in particular of solid 
tissue, must be optimized and standardized in order to reach the maximal homogeneity in 
the sub aliquots. Even in a scenario of contamination, we would have expected all 4 
homogenised aliquots to be contaminated. Random contamination with few viral RNA 
copies might thus explain a decreased repeatability or reproducibility with homogenized 
samples.  
Repeatability and reproducibility estimates of tissue samples depend on the 
assumption that sub@samples from the same fish are identical and that the detection 
threshold of the assay is constant. Both can be either associated or independent. For 
example, in the initial phase of the infection, only clusters of low numbers of viral 
particles may be present in the salmon kidney to be tested. At this stage, homogenization 
would dilute already low levels of virus and produce more false negative results and 
lower agreement. Further, the progression of the infection would produce clusters of high 
numbers of viral particles as a result of viral replication. Homogenization would 
harmonize viral concentration among sub@samples at a detectable level despite dilution. 
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Finally, later stages of infection are expected to result in high numbers of viral particles 
throughout the organ. Homogenization would then provide little advantage since all 
tissue samples will contain high virus load. Although unrealistic according to the ISAV 
histopathology (Byrne et al., 1998), another scenario would be a spread of low numbers 
of viral particles throughout the organ. Homogenization would then provide limited 
benefit since each tissue sample would already have similar levels of particles. 
Agreement level would diminish mainly due to inconsistent detection of low virus load. 
Overall, homogenization was of limited value in this precision evaluation; we 
suspect that occasional non@systematic error (cross@contamination) affected the samples’ 
comparability and the agreement estimation. Tissue homogenization has diverse 
application (sample pooling, certified reference and control material, laboratory 
proficiency testing) and is greatly needed but an appropriate evaluation of its influence on 
test comparisons requires close monitoring and protocol optimization.  
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The approach offered in this study of using column (individual fish) and row (test 
run) to represent the test results similar to a genetic sequence alignment has not been 
previously published. This is a convenient and intuitive way for the reader and the 
investigator to screen and visually compare test results (Fig. 2.2), whereby each result is 
compared within a fish (column) to the first aligned test, in this case the PGS. No 
alignment algorithm is needed as each test result corresponds to a defined fish (or 
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column). From the alignment, it is possible to generate a matrix of pairwise comparisons 
among sequences, also called a distance or similarity matrix. 
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 The phylogram graphically represents the matrix of agreement and facilitates the 
visualisation of the relative position among test runs. Distance@based phylograms are 
generated from the matrix of pairwise genetic distances. A matrix of pairwise genetic 
distances is very comparable to a matrix of tests disagreement (1@Pa) (Table 2.2). Due to 
variable pressure of evolutionary changes, it is common in phylogeny to correct the 
estimates of genetic distance for multiple events per site (Van de Peer and Salemi, 2003). 
Since the probability that test results will be first positive then negative then positive 
again is extremely low, an evolutionary correction in the distance computation was 
judged not necessary. Future development of this approach may benefit from 
incorporating different weights for results changing from negative to positive and from 
positive to negative. Indeed, depending on the diagnostic test method being assessed, the 
probability of a false positive result (e.g. contamination) might be higher than the 
probability of false negative result (e.g. target decay during transport). More knowledge 
on the assay performances is, however, required to implement this refinement.  
The distance matrix obtained from the alignment was identical to the initially 
computed disagreement matrix. Distance@matrix based tree reconstruction differentiates 
methods that are character@based and non character@based (Van de Peer and Salemi, 
2003). The reconstruction generated by this study used only two arbitrary characters 
(adenine and guanine for negative and positive result, respectively) with equal weights of 
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substitution, giving no value to the character chosen. The phylogram construction was, 
however, rerun with the 12 possible combinations of two nucleotides from the four 
existing (adenine, guanine, cytosine, thymine) and confirmed the non@importance of 
character used as expected (data not shown).  
Also referred to as pairwise distance methods, non character@based methods 
include cluster or minimum evolution analyses (Van de Peer and Salemi, 2003). The 
latter was preferred to the former because cluster analysis only assumes constant 
evolution (existence of a molecular clock) and would position all test runs in the tree 
equidistantly from the baseline or root. The commonly used method to estimate the 
minimal evolution tree is the Neighbor@Joining (NJ) method (Saitou & Nei, 1987). We 
selected only pairwise deletion in cases of missing data to avoid losing all the information 
from a fish when only one test result was missing. The obtained tree is a unrooted 
phylogram scaled for distances (set as the number of differing results) among test runs 
(Fig. 2.3A &B).  
Bootstrap analysis is commonly used to evaluate the robustness of nodes that 
support tree branches. The magnitude of the bootstrap values is intimately correlated to 
the numbers of variable sites (or fish in this instance) that are informative in the 
alignment. A variable site is informative if there are at least two different characters that 
are represented at least twice at the given site. All bootstrap values, except for one node, 
were lower than 70% (Fig. 2.3A &B). The low resolution of the tree suggests some 
caution in its interpretation. With only 100 fish, the number of fish that discriminate the 
test runs might be limited and a higher number of salmon might provide a better tree 
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resolution. However, poor tree resolution will also be expected when test runs greatly 
agree (high consistency and precision). 
The obtained phylogram illustrates the relative agreement among test runs (Fig. 
2.3A &B). The distance between two runs is visually assessed by the relative length of 
branches that connect them. Non@homogenized samples were clearly clustered and 
showed some testing consistency; although lab C was separated, confirming poorer 
reproducibility. Within this cluster, non@homogenized samples of lab A (duplicate 2) and 
lab B were grouped separately from lab A (duplicate 1) which supported previous 
observations of similar repeatability and reproducibility on non@homogenized samples.  
The cluster of homogenates, excluding lab B but including non@homogenized lab 
C, was poorly supported by bootstrapping (50%).  This weak separation presumed a 
tendency of homogenized samples to test differently. The wide distribution of 
homogenates in the tree, however, supported a serious inconsistency in the testing pattern 
compared to non@homogenized samples. The homogenization protocol appeared to be 
inadequately refined or standardized to harmonize the testing pattern. Lab C revealed a 
distinct testing pattern with a reasonable repeatability regardless of the sample type and 
more closely resembling homogenized samples. However, lab C clearly decreased the 
overall assay reproducibility and must standardize its testing procedure to be comparable 
to the other laboratories.  
The distance@matrix based tree reconstruction approach helps the investigator and 
the reader to visualize the relative proximity among test runs and to understand the 
distinctive testing patterns reflected by each of them. 
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Utilisation of basic phylogenetic reconstruction techniques provides a convenient 
and descriptive method to compare and assess agreement among test runs. The 
interpretation and validation of repeatability and reproducibility estimates, particularly 
using natural field samples, are complicated by the fact that no international standards 
and guidelines are established. Until guidelines are provided, we recommend considering 
as evidence of acceptable agreements results that show (i) fairly large κ estimates with 
(ii) a fairly narrow confidence interval obtained from (iii) a medium range prevalence, 
and (iv) conditional on a non@significant McNemar’s test. Repeatability and 
reproducibility levels and the associated test accuracy appear to vary strongly with the 
intended use of assay. Appropriate assessment of consistency of test performance is 
critical to the interpretation of surveillance and control results and requires further 
development to model agreement across a range of population covariates (e.g. infection 
prevalences, infection stages) (Chapter III).
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 Traditional assessment of precision of binary outcome diagnostic tests focuses on 
descriptive estimates of agreement from a particular pool of studied samples. However, 
agreement for binary tests is intrinsically associated with precision (random error) and 
accuracy of the assay (systematic error). When two test results disagree, one is correct 
and the other incorrect. Assay operating characteristics are potentially strongly influenced 
by the test population and laboratory covariate factors that may result in agreement 
variations. Using test result information from a previous descriptive study on agreement 
within and between laboratories (repeatability and reproducibility, respectively) of an 
RTBPCR assay for infectious salmon anaemia virus (ISAV), the influence of submission 
factors (tissue homogenization, infection prevalence and pathogen level) on agreement 
was further investigated. Multilevel logistic regression models were constructed 
separately for nonB, lowB or highBinfected salmon (classified using a study pseudogold 
standard) to predict probabilities of testing positive under different testing conditions. For 
given prevalences and infection stages of infected fish, agreement and kappa values were 
computed from the predicted values using probability formulae and category weighting. 
Repeatability and reproducibility varied greatly with prevalence, and the influence of 
infection stages on agreement was lowered by homogenization which supported a 
heterogeneous distribution of ISAV in early infected salmon kidney. This predictive 
approach provided a better expectation of assay agreement and increased the capacity to 
apply and extrapolate estimates of repeatability and reproducibility to other 
circumstances of use. 
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3.1.1 Diagnostic precision 
 
Evaluation of diagnostic assay precision and accuracy are critical components of 
the multiBstage validation procedure recommended by the World Organisation for Animal 
Health (OIE) to certify methods that either diagnose disease or detect the presence of an 
associated pathogen (i.e. infection) (OIE, 2008). Assay precision is conventionally 
assessed by estimating repeatability and reproducibility. According to International 
Standards definitions (IS0 5725B1, 1994), the repeatability is defined as the variation in 
test results obtained with the same method on identical test items in the same laboratory 
by the same operator using the same equipment within short intervals of time. 
Reproducibility is defined as the variation in test results obtained with the same method 
on identical test items in different laboratories with different operators using different 
equipment. For a dichotomous assay (i.e. binary outcome), variation in test results is 
estimated by the agreement between two test runs. We define here “test run” or “run” as a 
set of results obtained using the same method under defined testing conditions that may 
differ within a laboratory for repeatability, and between laboratories for reproducibility. 
Traditionally, estimates of withinB and betweenBlaboratory agreement are expressed as 
proportion of agreement (proportion of tests results that agree) (Pa) or as Cohen’s Kappa 
values (κ) (Dohoo et al., 2009).  
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3.1.2 Diagnostic agreement relativity 
 
 Albeit agreement is commonly assumed to be a measure of test precision, the lack 
of result consistency is in fact a combination of imprecision (random error) and 
inaccuracy (systematic error) (Van der Bruel et al.,  2007). When test results from two 
identical samples do not agree, one has to be correct and the other not. Alternatively, 
when two test results agree on a positive, they are either both right (substantial diagnostic 
sensitivity, DSe) or both wrong (poor diagnostic specificity, DSp) depending on the true 
status of the sample. Equally, when two test results agree on a negative, they are both 
correct (substantial DSp) or both incorrect (poor DSe). Agreement therefore depends 
directly on DSe and DSp. Interestingly, strong agreement in infected/diseased samples 
results from either both very high DSe (both results positive) or very low DSe (both 
results negative). Reciprocally, strong agreement in nonBinfected/nonBdiseased samples 
results from either both very high DSp (both results negative) or very low DSp (both 
results positive). Therefore, at the animal level, agreement depends primarily on the 
magnitude of DSe and DSp, and also on their stability. Agreement relies also on the 
degree of dependence between subBsamples collected from a same individual. Cleophas 
et al. (2008) prefer to report assay precision using predictive intervals of DSe, DSp or 
overall accuracy. To match international requirements for test validation (OIE, 2008), we 
restricted the evaluation of test precision to the estimation of repeatability and 
reproducibility.  
 Even if DSe and DSp were appreciable and stable, estimates of agreement may 
also vary greatly with prevalence of infected/diseased animals in the tested population 
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(population level). If agreements within infected/diseased and nonBinfected/nonBdiseased 
individuals differ, overall agreement reflects the average of both statusBspecific 
agreements weighted on the proportion of each status in the tested sample pool (i.e. 
prevalence). Consequently, overall agreement estimates may vary substantially across 
prevalences of infected/diseased individuals. To limit extrapolation error from specific 
population estimates, the Standards for Reporting of Diagnostic Accuracy (STARD) 
recommended reporting variation of diagnostic performances across populations (Bossuyt 
et al., 2003). Therefore, evaluation of test precision should include infection statusB
specific estimates and a description of agreement variation across a range of 
infection/disease prevalences. Assuming that agreement for each infection/disease 
category are known and constant, it is possible to compute (and predict) agreement across 
a range of prevalences using simple category weighting, as suggested by Björk et al. 
(2009).  
 The operating characteristics of an assay may vary greatly with testing conditions, 
such as sample preparation or processing laboratory. Collection technique, storage, buffer 
solution, and homogenization are sampling factors that are associated with test accuracy 
and might change the agreement within an infection/disease category. Intrinsic laboratory 
factors such as instrument, operator, and facility design are also associated with test 
accuracy and might also influence agreement within an infection/disease category. It is 
therefore essential to refine the prediction of agreement by investigating variations of 
agreement associated with submission covariate factors. 
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3.1.3 ISAV RT;PCR repeatability and reproducibility 
 
 Infectious Salmon Anaemia virus (ISAV) (family Orthomyxovirus, genus 
Isavirus) is the causative agent of an important infectious disease, particularly of Atlantic 
salmon (Salmo salar L.). Targeting endothelial cells of salmonids, the viral pathogen is 
found in Northern Europe (Thorud and Djupvik, 1988; Rodger et al., 1998; Anonymous, 
2000), and in North and South America (Mullins et al., 1998, Bouchard et al., 2001, 
Godoy et al., 2008). Responsible for high cumulative mortality when present in salmon 
farms, ISAV is listed as a reportable aquatic disease by the OIE (OIE, 2009a), requiring 
intensive surveillance and control programs.  
ISAV surveillance was identified as part of the Canadian National Aquatic 
Animal Health Program (NAAHP), and required that a recently developed ReverseB
Transcriptase Polymerase Chain Reaction (RTBPCR) assay (Gagné et al., data 
unpublished) be evaluated, validated and certified. The targeted use of the assay in 
Atlantic salmon aquaculture and wild fish samples is to demonstrate freedom of infection 
(not disease) in a seaBcage, farm site, bay, or region in Canada. The assay is able to detect 
the presence of a portion of RNA from the 8th segment  of the viral genome in a kidney 
tissue sample which is assumed to be correlated with the presence (or absence) of 
“active” viral particles in the fish. Following the bench validation phase, the first stage of 
this field evaluation focuses on the estimation of the assay’s repeatability and 
reproducibility. 
Two previous studies reported estimates for ISAV RTBPCR repeatability and 
reproducibility using different protocols and evaluation designs. The first study, 
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published by Nérette et al. (2005), examined ISAV RTBPCR agreement within and 
among three different laboratories and revealed poor reproducibility and substantial 
differences in repeatability.  The authors, however, described factors associated with the 
study design that may have biased the comparability of test results. First, different kidney 
tissue samples from the same fish were submitted for detection in the different 
laboratories. These samples were though to be hypothetically heterogeneous for the 
distribution of viral particles in the organ. If the subBsamples differed, then they may have 
compromised the requirement of “identical test items” for agreement evaluation. Second, 
different amplification protocols (i.e. different set of primers, reagents and methodology) 
were used in different laboratories and may have compromised the requirement of using 
the “same test”. Third, different result interpretations and confirmation protocols (i.e. 
sample with a weak gel band retested) may also have compromised the comparability of 
laboratories. In a subsequent study, presented in Chapter II, described the repeatability 
and reproducibility of a different ISAV RTBPCR assay in three different laboratories 
while specifically addressing the design limitations described in Nérette et al. (2005). 
Homogenized kidney subBsamples were submitted for testing in parallel to reduce the 
impact of withinBtissue variability. In addition, all participating laboratories agreed to use 
the same detailed test protocol to detect ISAV. Lastly, gel band interpretation and 
retesting strategies were harmonized among the three laboratories. Regardless of the 
sample type (homogenized or nonBhomogenized), the descriptive analysis of the test 
results revealed only a moderate repeatability in the reference laboratory and a slightly 
lower overall laboratory reproducibility. It is believed that this was weakened by the 
strong disagreement of one participating laboratory compared to the other two 
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laboratories.  Due to substantial study design and testing protocol discrepancies, the two 
study estimates can not and have not been directly compared. 
 In addition, both Nérette et al. (2005) and the Chapter II only reported overall 
agreement estimates specific to respective study sample pools. The Chapter II discussed 
the difficulty in generalizing their estimates due to the close relationship between 
agreement and accuracy and the need to explore agreement variation across population 
covariate factors such as prevalence.  Chapter II further suggested that DSe, and 
associated agreement in infected fish, would be strongly dependent on pathogen load in 
the tested samples. Referred to as “spectrum” (Ransohoff and Feinstein, 1978) or “caseB
mix” (Begg, 1987), the varying proportions of infection stages associated with viral load 
would potentially influence agreement within infected individuals, regardless of the 
prevalence. Variation of agreement should also be investigated across a range of infection 
stages in infected fish.  
 
3.1.4 Study objectives 
 
  Recognizing that repeatability and reproducibility are proportionBweighted 
averages of agreements specific to infection stage, the objective of this study was to 
predict test agreement across a range of infection stages and prevalences for ISAV in 
salmon. The modelling approach used also allowed us to assess the effect on agreement 
of submission factors, including sample preparation (i.e. homogenization) and testing 
laboratory. 
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3.2.1 Data, complementary testing, and a pseudogold standard 
 
3.2.1.1 Data 
 
The data used in this study were derived from a previous study on the descriptive 
analysis of repeatability and reproducibility of a recently designed RTBPCR for ISAV 
(Chapter II). Kidney samples from 100 Atlantic salmon, Salmo salar, were collected in 
six replicates from each fish. Duplicate coded tissue samples were tested by the reference 
laboratory (lab A) and single samples were tested by two other laboratories (lab B & C).  
The remaining two tissue samples were combined, homogenized and aliquoted into four 
coded microtubes. Two of these homogenates were tested in lab A and single 
homogenates were tested by the other two laboratories. Full descriptions of sample 
allocation and testing protocol are reported in Chapter II. 
 
3.2.1.2 Complementary testing (Real;time Reverse;Transcriptase Polymerase Chain 
Reaction) 
 
Two hundred RNA extracts, obtained from the duplicate tissue samples originally 
analyzed by conventional RTBPCR in the reference laboratory (lab A), were recoded, 
randomly ordered and tested again using the realBtime version of the previous RTBPCR 
protocol. Reverse transcription was done with the High Capacity Reverse transcription kit 
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(Applied Biosystems). RNA (≤ 1000 ng/hl) and water were mixed, denatured at 95°C for 
5 min and transferred to ice. The enzyme mix containing 2 hl of random primers was 
added to the tubes, for a total of 20 hl per tube, and incubated according to the 
manufacturer’s instructions; 20 hl of H2O was added after the reaction. RealBtime PCR 
was performed with the Taqman Universal PCR Master Mix (Applied Biosystems), on a 
Mx3000P thermocycler (Stratagene). PCR was done in 25 hl volumes comprising 2 hl of 
cDNA, 0.48 hM of each primers, and 0.2 hM of probe. Primers were 404F_ISA8: 5' tgg 
gca atg gtg tat ggt atg aB3’ and RA3 (583R)BISA8: 5' gaa gtc gat gaa ctg cag cgaB3’; the 
FAM labelled probe (491_ ISA8) sequence was 6BFAM cag gat gca gat gta tgcBMGB 
(quencher). Cycling conditions consisted of an initial hold at 50 °C for 2 min, then 95 °C 
for 10 min, and 45 cycles at 95 °C – 30 sec, 60 °C – 30 sec, 72 °C – 30 sec, with 
fluorescence reading at the end of each cycle. For quality control, extraction blanks (no 
samples) were included every 15th tube during extractions, and blanks (water) were added 
for the reverse transcription and the PCR steps; positive controls were included during 
the PCR step. Any obtained cycle threshold (Ct) values were reported as positive results; 
all blanks and negative controls yielded no Ct values. 
 
3.2.1.3 Pseudogold standard 
 
ISAV replication was assumed to be sigmoid across time with three successive 
infection stages characterized by increasing viral load: low, intermediate and high 
infection. The duration of the intermediate stage is limited and therefore underB
represented in an infected population. Consequently, we only considered lowB or highB
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infection stages in this study. Each of the 100 salmon was thereafter classified as nonB, 
lowB or highBinfected according to an established pseudogold standard (PGS). Salmon 
were first classified as infected and nonBinfected using the criteria of Chapter II based on 
the combination of the six previous results from the conventional RTBPCR (excluding 
duplicate results in lab A). A fish was classified as “nonBinfected” (NI) if it yielded three 
or less positive tests out of the six (≤ 3/6). Alternatively, a fish was classified as 
“infected” if it yielded more than three positive tests out of the six (> 3/6). “Infected” fish 
were further dichotomized into lowB or highBinfected using additional realBtime RTBPCR 
duplicated results. Obtained Ct values from the tested samples ranged from 17.41 to 
42.98, and by extrapolation, we considered that Ct values from any ISAV infected 
salmon would universally range from 15 to 45 cycles. Thereafter, we arbitrarily selected 
the range midBpoint (30 cycles) as the cutoff to subBclassify infected fish as lowB or highB
infected. “LowBinfected” (LI) fish were infected salmon with the lowest obtained Ct 
value equal to or higher than 30 cycles. “HighBinfected” (HI) fish were infected salmon 
with the lowest obtained Ct value lower than 30 cycles. Six salmon classified as NI had 
one duplicate sample test positive to realBtime RTBPCR; and 2 salmon classified as 
infected had both duplicate samples test negative to realBtime RTBPCR (no Ct) and were 
thus classified as LI. Test results from conventional and realBtime RTBPCR were aligned 
for visual comparison using PGS as the reference using the approach described in 
Chapter II (Fig. 3.1). 
 Two alternative PGS definitions were further developed to investigate the 
influence of the classification criteria on the analysis outcome. The first alternative PGS 
(StrictBPGS) used more restrictive criteria to classify fish as infected such that a salmon  
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were defined as fish with 3 or less positive test results out of the 6 conventional RTBPCR assays run from the two sample types (i.e. (t): nonBhomogenized 
sample, (h): homogenized sample) in the 3 participating laboratories (lab A, B & C) without including duplicates in lab A (i.e. (t2) & (h2)). Within nonBinfected 
salmon, fish were ordered by increasing number of positive test results. Within infected salmon  (fish with more than 3 positive test results), fish were classified 
and ordered as lowBinfected (light “p”) or highBinfected (dark “p”) according to the duplicated  realBtime RTBPCR (qRTBPCR) results reported as cycle threshold 
(Ct) values. LowBinfected were defined as fish with the minimum yield Ctvalue equal or above 30; while highBinfected were fish with the minimum Ct value 
below 30. Strict and LenientBPGS are alternative standards used for comparison, whereby StrictBPGS classified nonBinfected fish as 4 or less positive 
conventional RTBPCR (out of 6), and LenientBPGS classified nonBinfected fish as negative on both qRTBPCR duplicates. The cutoff for lowB and highBinfected 
fish remains constant across the 3 pseudogold standards. 
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had to be positive on the two types of samples in at least two laboratories (i.e. at least five 
positive results out of the six conventional RTBPCR runs) (Fig. 3.1). The empiric cutB
point to subBclassify infected fish was conserved for both additional PGS definitions. The 
second alternative PGS (LenientBPGS) used less restrictive criteria to classify fish as 
infected and only used duplicated results from realBtime RTBPCR. To be classified as 
infected, a salmon had to be positive on at least one realBtime RTBPCR run (Fig. 3.1).  
 
3.2.2 Multilevel logistic models 
 
3.2.2.1 Data hierarchy and model construction  
 For analysis, the dataset was split into three subsets according to the PGS status 
and separate multilevel logistic models were conducted for each infection category (NI, 
LI, HI). MLwiN software v.2.11 (Rasbash et al., 2009) was used for model building and 
as a transfer platform. Across all laboratories and sample types, all nominated HI 
individuals tested positive (Fig. 3.1). Therefore, no model was developed for HI fish 
since their probability to test positive was 1 regardless of the assay conditions. The 
original hierarchical structure included 3 levels: “fish” (100); “samples within fish” (five 
in total: four separate tissues and one homogenate); and “tests within sample” (four for 
homogenized sample and one for nonBhomogenized sample) (Fig. 3.2A). Preliminary 
model construction did not reveal any variation at the “sample” level for both NI and LI 
fish after accounting for homogenization. Therefore, finalized models only included two 
levels: “fish” and “test results within fish” (eight tests for each fish) (Fig. 3.2B).  
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 Multilevel logistic regression models included “fish” as a random effect, and 
homogenization (Hom), laboratories (Lab) and their interaction as fixed effects. Identical 
models were initially built for NI and LI fish: 
 
logit (Pr(test:pos)) = β0 + β1 Hom + β2 Lab B + β3 Lab C + β4 Hom*Lab B + β5 
Hom*Lab C + ufish          (1) 
 
where ufish is the random effect from N(0, σ2fish), a normal distribution with mean 0 and 
variance σ2fish. Regardless of the sample type, all nominated LI individuals tested positive 
in lab C (Fig. 3.1). Since the probability to test positive in lab C was 1, lab C results were 
removed from the LI dataset and the model was developed without the lab C fixed effect. 
In the model from Eq. (1), test results in different laboratories were conditionally 
independent given the random effect (and true sample status); this is a standard way of 
incorporating (conditional) test independence (e.g. Yang and Becker, 1997) 
 
3.2.2.2 Bayesian analysis 
 
For reasons detailed below (see section 3.2.2.3), predictions from model (1) were 
based on the posterior distributions obtained in a Bayesian estimation. From MLwiN, the 
models were transferred to WinBUGS v.1.4.3 software (Spiegelhalter et al., 2003) for 
analysis. MarkovBchain Monte Carlo models were run using Gaussian priors for fixed 
effects regression coefficients (mean =0, variance = 1.EB6) and a uniform prior (0,100) 
for σ2fish, a burnBin period of 10,000 iterations, and a run of 1,000,000 iterations with 
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thinning sampling every 100 iterations for a total of 10,000 posterior samples. Regardless 
of their significance, all fixed factors were kept in the models as the main modelling 
objective was prediction. Three Markov chains were run in parallel with different sets of 
initial values for model parameters to conduct the GelmanBRubin convergence diagnostic 
(Brooks and Gelman, 1998) but no influence on posterior estimates was detected. Model 
convergence was assessed visually with informal examinations (Gelman, 1996) involving 
the convergence diagnostics based on quantiles (RafteryBLewis) and means (BrookB
Draper) provided by MLwiN. Poor autocorrelation along the Gibbs sampler chains was 
confirmed visually. 
 
3.2.3 Agreement computation 
 
  A multilevel logistic regression model, Eq. (1), yields parameters with subjectB
specific (SS) interpretation (Zeger et al., 1988). As test and agreement characteristics 
should be interpreted across the population of samples, a conversion to populationB
averaged (PA) estimates is required (see McClure et al. (2005) for a discussion of the 
context related to test characteristics). Test characteristics such as DSe and DSp may be 
calculated directly based on predicted probabilities from Eq. (1), after an approximate 
conversion of parameters to a PA interpretation (Dohoo et al., 2009). Agreement and 
kappa statistics do not permit a closed formula calculation but involve integrals over the 
random effects distribution. Therefore, we used an integral approximation by averaging 
over randomly sampled randomBeffects terms (i.e. a Monte Carlo approximation to the 
integral) (Smyth, 2005). All test and agreement characteristics were calculated by 
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averaging over random effects sampled for each of the 10,000 posterior samples, using 
the detailed formulae outlined below. The advantage of this approach is that it 
incorporates uncertainty about the parameter estimates by using values across the 
posterior distribution. Subsequent calculations were carried out in standard spreadsheet 
and statistical software. 
 
3.2.3.1 Estimated agreement 
 
 We termed repeatability (r) the estimated agreement between duplicate samples in 
the reference laboratory (lab A). We termed reproducibility (R) the computed average of 
estimated agreements of duplicate samples between labs A and B, A and C, and B and C. 
Generally, estimated agreement (Est. Agr.) between samples analyzed at two defined 
testing conditions c1 and c2 (which could involve the same or different labs) was 
computed by the formula: 
 
Est. Agr.(c1,c2|I,u) = Pr(pos,c1|I,u) * Pr(pos,c2|I,u) + Pr(neg,c1|I,u) * Pr(neg,c2|I,u) = 
Pr(pos,c1|I,u) * Pr(pos,c2|I,u) + (1 ; Pr(pos,c1|I,u)) * (1 ; Pr(pos,c2|I,u))  (2) 
 
where I refers to the infection stage (NI, LI, HI) and u to a particular posterior random 
sample from respective models. Conditional probabilities are computed from the linear 
predictors (β) on the logit scale and the inverse logit transformation (logitB1 (β) = 1 / (1 + 
eBβ)) (Dohoo et al., 2009). The dependence on the random effect is addressed by 
averaging the estimates over the 10,000 posterior samples. For instance, the PA estimate 
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of agreement between condition c1 and c2 in the infection category I is obtained as 
follows:  
 
Est. Agr.(c1,c2|I) = (1/10,000) Σi [ Pri(pos,c1|I,ui) * Pri(pos,c2|I,ui) + Pri(neg,c1|I,ui) * 
Pri(neg,c2|I,ui)]         (3) 
 
where ui is the random value sampled from N(0, σ2i); and σ2i and βi inherent in Pri are 
the parameters of the ith sample of the posterior . For a mixture population with a 
prevalence (θ) and a proportion (π) of LI among all infected fish, the conditional 
estimated agreement was computed as: 
 
Est. Agr.( c1,c2|θ, π, u) = θ * (π * Est. Agr.(LI,u) + (1; π) * Est. Agr.(HI))+ (1 – θ) * Est. 
Agr.(NI,u)          (4) 
 
where Est. Agr.(LI,u)and Est. Agr.(NI,u) are estimated agreements in LI and NI, 
respectively. Note that for simplicity of notation, we used the same symbol u to denote 
both random effects, although the values for LI and HI models were sampled from 
different distributions (hence different iteration) and randomly combined. For HI fish, 
Est. Agr.(HI) = 1, as described above. Similar to Eq. (3), the PA estimates were 
computed by averaging over the 10,000 conditional estimates. 
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3.2.3.2 Chance agreement and Cohen's kappa 
 
 Cohen’s  kappa (κ) value involves the agreement beyond chance, i.e. the expected 
agreement computed if no correlation between test results is assumed (Dohoo et al., 
2009). We first describe how the model (1) was used to compute the chance agreement. 
In the absence of information about other test results, the probability to test positive (or 
negative) under a given testing condition depends on the corresponding test 
characteristics (DSe and DSp) as well as on the prevalence (θ) and the proportion (π) of 
LI fish:  
 
Pr (pos|θ, π, u) = θ * (π * DSe(LI,u) + (1; π) * DSe(HI))+ (1 – θ) * (1 – DSp(u)) (5) 
Pr (neg|θ, π, u) = θ * (π * (1 ; DSe(LI,u)) + (1; π) * (1 ; DSe(HI)))+ (1 – θ) * DSp(u)(6) 
 
where u refers to a particular posterior random sample from respective models. For HI 
fish, DSe(HI) = 1, as described above. Similar to Eq. (3), the PA estimates of DSe(LI) 
and DSp for a specific condition (c) were computed by averaging the predicted 
probabilities of testing positive in LI fish (DSe(LI)) or negative in NI fish (DSp) over the 
10,000 posterior samples. 
Thereafter, the chance agreement between two testing conditions (c1 and c2) was 
computed as: 
 
Ch. Agr. (c1,c2|θ, π, u) = Pr (pos,c1|θ, π, u) * Pr (pos,c2|θ, π, u) + Pr (neg,c1|θ, π, u) * 
Pr (neg,c2|θ, π, u)         (7) 
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where Pr (pos,c1|θ, π) refers to the probability of testing positive under testing condition 
c1. Finally, Cohen's kappa (κ) between testing conditions (c1 and c2) was computed by 
averaging the Kappa calculation formulae as follows: 
 
κ (c1,c2|θ, π, u) = (Est. Agr. (c1,c2|θ, π, u) ; Ch. Agr. (c1,c2|θ, π, u)) / (1 ; Ch. Agr. 
(c1,c2|θ, π, u))          (8) 
'
Similar to Eq. (3), the PA estimates was computed by averaging over the 10,000 
conditional estimates of κ. 
'
3.2.4 Alternative approach to modelling 
 
 A convenient alternative approach was used to directly estimate probabilities to 
test positive (or negative) in each infection category (NI, LI, HI) as defined by the PGS.  
For instance, from Fig. 3.1, positive test results for NI fish in lab A relative to replicated 
nonBhomogenized samples were counted (7 positives out of 104 results) and the 
corresponding probability estimated (6.7%). Thereafter agreements were calculated by 
inserting the respective probabilities in Eqs. (2), (5) and (6).  Using simple descriptive 
statistics, these agreement estimates were referred as descriptive estimates. Descriptive 
estimations were used when assessing the impact of the three PGS definitions. 
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3.2.5 Agreement graphical representation 
 
 Three sets of graphics were generated for each agreement type (i.e. estimated, 
chance, and κ) including withinB and betweenBlaboratory comparisons for homogenized 
and nonBhomogenized samples. Each graph represents agreement across a range of 
infection prevalences (from 0 to 100%) and for three proportions of LI among all infected 
fish (0, 50 and 100%). In addition, the agreement profile corresponding to the supposed 
proportions of LI and HI fish among all infected fish (71% LI, 29% HI) was added to be 
compared to the actual observed value of agreement. Minimum and maximum limits of 
the predictive interval (95%) of estimated, chance and κ agreements were calculated 
using the 2.5% percentile and 97.5% percentile (not the average) of Eqs. (2), (7) and (8) 
for each prevalence and submission condition, regardless of the proportion of LI.'
'
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3.3.1 Pseudogold standard and observed values  
 
 
 Among the 100 tested salmon, the PGS identified 52 nonB, 34 lowB and 14 highB
infected (NI, LI and HI, respectively) fish. Assuming the PGS is correct, the prevalence 
of infected fish was 48% and the proportion of LI fish among all infected was 71% (and 
29% HI). Alternatively, the StrictBPGS identified 44% infected salmon among which 
68% were LI and 32% were HI, while the LenientBPGS identified 52% infected salmon 
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among which 73% were LI and 27% were HI. It was noteworthy that the proportion of LI 
among the infected fish did not change substantially with the three PGS versions (71%, 
68% and 73%, respectively).  Descriptive statistics of this dataset including observed 
agreement proportions (Pa) and kappa values (κ) were reported elsewhere (Chapter II). 
Observed r within the reference laboratory for nonBhomogenized and homogenized 
samples were 0.84 and 0.80, respectively, while the corresponding values of averaged R 
were 0.82 and 0.80. Assuming test independence, observed chance r within the reference 
laboratory for nonBhomogenized and homogenized samples were 0.51 and 0.50, 
respectively, while the corresponding values of averaged chance R were 0.50 and 0.50. 
The observed κ within the reference laboratory for nonBhomogenized and homogenized 
samples were 0.67 and 0.69, respectively; while the corresponding values of κ among the 
3 participating laboratories were 0.64 and 0.60.  
 
3.3.2 Multilevel logistic models 
 
 For each model, posterior distributions of regression coefficients 
(homogenization, testing laboratory and firstBorder interaction) and variance estimates at 
the fish level are numerically summarized in Table 3.1. A direct interpretation of back 
transformed model coefficients would be subjectBspecific (SS) (Dohoo et al., 2009), and 
therefore, for proper populationBaveraged (PA) interpretation, one can adjust regression 
coefficients using a conversion formula:  βPA ≈ βSS / √ (1 + .346 σ2) (McClure et al., 
2005). PA adjusted estimates by conversion were reported in the sections below to 
facilitate the interpretation of model coefficients. For comparison, PA estimates were also  
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Parameters   Non-Infected Fish Model   Low-Infected Fish Model   High-Infected Fish 
Number of records  416 test results used from 52 fish  204 (271*) test results from 34 fish  112 test results from 14 fish 
         
Random Effects  Variances (σ2) C.I.(2.5%,97.5%)   Variances (σ2) C.I.(2.5%,97.5%)    
     Fish  1.108 0.45, 1.85  1.906 0.90, 3.34  na 
         
Fixed Effects  Coefficient C.I.(2.5%,97.5%)  Coefficient C.I.(2.5%,97.5%)   
     Constant (Lab A, tissue)  -3.16 -4.22,-2.25  1.77 0.77, 3.08  na 
     Homogenization  1.38 0.42, 2.44  1.70 0.55, 2.95  na 
     Lab B  -0.82 -2.90, 0.80  0.38 -0.81, 1.62  na 
     Lab C  1.36 0.27, 2.54  na na  na 
     Homogenization x Lab B  -1.36 -3.95, 1.12  0.32 -1.81, 2.77  na 
     Homogenization x Lab C   -0.73 -2.16, 0.65   na na   na 
 
Bold: parameter significantly different from 0  
*record including data from lab C 
C.I.: credibility interval 
na: not applicable since the probability to test positive is perfect (100%) 
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5"=I%'@AH'
2&D="=GIG$G%>'ND&'GCN%?$GDF>'>"IJDC'"C"%JG"'QG&F>'35<2 3'$D'$%>$'C%K"$GQ%'D&'#D>G$GQ%'"??D&EGCK'$D'GCN%?$GDC'>$"$F>R'$!%'>"J#I%'
$M#%' (homogenized or nonBhomogenized)R' $!%' #&D?%>>GCK' I"=D&"$D&M' (lab A, B or C)' "CE' $!%' GCN%?$GDC' >$"K%' (nonB, lowB, highB
infected)A Classification of fish in infection stages originally followed a preset pseudogold standard (PGS). For PGS, the probabilities 
were first computed as population average estimates from averaged model predicted values (Modelling) or by direct description of 
probabilities in each infection category (Descriptive). Descriptive probabilities were added using two alternative pseudogold 
classifications (i.e. StrictB & LenientBPGS) to assess the impact of the pseudogold definition on prediction.  
 
 Probability to test negative 
 in NonBinfected salmon 
 Probability to test positive 
 in LowBinfected salmon 
 Probability to test positive 
 in HighBinfected salmon 
 NonBhomogenized Homogenized  NonBhomogenized Homogenized  NonBhomogenized Homogenized 
 lab A lab B lab C lab A lab B lab C  lab A lab B lab C lab A lab B lab C  lab A lab B lab C lab A lab B lab C 
+DE%IIGCK'
PGS' 0.930 0.960 0.806 0.806 0.958 0.712  0.747 0.788 1.00* 0.902 0.933 1.00*  1.00* 1.00* 1.00* 1.00* 1.00* 1.00* 
-%>?&G#$GQ%'
PGS 0.933 0.962 0.808 0.808 0.962 0.712  0.750 0.794 1.000 0.912 0.941 1.000  1.000 1.000 1.000 1.000 1.000 1.000 
-%>?&G#$GQ%'
StrictBPGS 0.937 0.946 0.750 0.768 0.893 0.661  0.850 0.934 1.000 0.934 0.934 1.000  1.000 1.000 1.000 1.000 1.000 1.000 
-%>?&G#$GQ%'
LenientBPGS 0.958 0.98 0.771 0.702 0.917 0.688  0.711 0.737 0.868 0.816 0.816 0.895  1.000 1.000 1.000 1.000 1.000 1.000 
* not modelled since all samples tested positive, therefore estimated on observed test results
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computed by averaging predictive values over the 10,000 posterior sampled random 
effects (see section 3.2.2.1). The PA estimates of probabilities to test positive (or 
negative) according to the sample type and defined infection stages are reported in Table 
3.2. In NI fish, the probability to test negative corresponds to DSp. In LI and HI fish, the 
probability to test positive corresponds to DSe(LI) and DSe(HI), respectively. 
 
3.3.2.1 Non;infected salmon model 
 
 In NI fish, significant variation of test results was confirmed at the fish level. The 
baseline converted PA probability that nonBhomogenized samples from NI fish test 
positive (1BDSp) in the reference lab A was 6.4%. Testing in lab C significantly increased 
(i.e. almost 3.5x) the probability of testing positive (17.8%), whereas testing in lab B 
slightly decreased this probability (3.3%, not significant). Tissue homogenization 
increased significantly the probability of testing positive (i.e. almost 3.5x) in lab A 
(18.0%) and almost doubled in lab C (27.3%), whereas it did not show any effect in lab B 
(3.3%). 
 
3.3.2.2 Low;infected salmon model 
 
 In LI fish, higher variation in test results was revealed at the fish level. The 
baseline converted PA probability that nonBhomogenized samples from LI fish test 
positive (DSe (LI)) in reference lab A was 72.6%. Testing in lab B slightly increased the 
probability of testing positive (76.6%, not significant). Tissue homogenization 
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significantly increased the probability of testing positive in lab A (87.2%) and in lab B 
(90.9%). Regardless of the sample type, all samples tested positive in lab C and the 
predicted probability of LI fish to test positive was100%. 
 
3.3.2.3 High;infected salmon model 
 Since all 14 HI fish tested positive, regardless of the sample type and processing 
laboratory, no model was required to predict the probability of HI fish to testing positive;  
DSe(HI) was assumed to be 100%. 
 
3.3.3 Agreement prediction 
 
3.3.3.1 Estimated agreement 
 
 Variation of estimated repeatability (r) and reproducibility (R) in nonB
homogenized and homogenized samples across infection prevalences and proportions of 
LI are illustrated in 4 separate graphs in Fig. 3.3. Based on NI fish (prevalence = 0%) 
only, estimated r and R were greater for nonBhomogenized samples compared to 
homogenized samples (0.88 and 0.83 vs. 0.74 and 0.73, respectively). For each sample 
type, estimated R was slightly lower than estimated r. Increased infection prevalence was 
associated with an increase in estimated r and R in homogenized samples, whereas the 
progression of estimated r and R in nonBhomogenized samples depended on the 
proportion of LI fish in the sample pool. An increased proportion of LI in the group 
substantially decreased the estimated r and, to a lower degree, the estimated R for nonB 
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7GKA'@A@A' DJ#F$%E'%>$GJ"$%E'"K&%%J%C$'DN'(;*6'35<2 3. Within the reference laboratory for nonBhomogenized (A) and homogenized sample (B); 
and reproducibility for nonBhomogenized (C) and homogenized sample (D) as a function of prevalence of infection and proportion of lowB (vs. highB) 
infected among all infected fish. Filled circles represent the originally observed estimates under the same testing conditions. 
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homogenized samples. For instance, estimated r and R with only LI fish (0.75 and 0.77, 
respectively) were lower for nonBhomogenized samples than with NI fish. For 
homogenized samples, estimated r and R, based only on LI fish (0.87 and 0.91, 
respectively), were higher than with NI fish. Estimated r and R with only HI were perfect 
(i.e. 100%) regardless of sample type. According to the cone shaped spread of estimated 
values and associated predictive intervals (Fig. 3.3), estimated agreement in homogenized 
samples were little influenced by infection stage compared to nonBhomogenized samples; 
and predicted R seemed to be wider spread than r. The initial observed estimates (filled 
circles) set at the 48% prevalence, according to the PGS, were fairly close to the 
estimates predicted by the model for 71% of LI among infected fish (Fig. 3.3). 
 
3.3.3.2 Chance agreement 
 
 Variation of chance r and R in nonBhomogenized and homogenized samples 
across infection prevalences and proportions of LI are illustrated in 4 separate graphs in 
Fig. 3.4. All curves showed a convex profile with a minimum prevalence around 50%. 
Chance agreements were fairly stable across levels of infection when prevalence was 
lower than 50% and slightly more variable when prevalence was higher. Chance r and R 
with only NI fish (prevalence = 0%) were higher for nonBhomogenized samples 
compared to homogenized samples (0.87 and 0.81 vs. 0.69 and 0.70, respectively). 
However, for nonBhomogenized samples, chance r and R with only LI fish (0.62 and 
0.73, respectively) were lower than with NI fish. For homogenized samples, chance r and 
R with only LI fish (0.82 and 0.89, respectively) were much higher than with NI fish. 
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infected among all infected fish. Filled circles represent the originally observed estimates under the same testing conditions.  
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Therefore, profiles for nonBhomogenized samples looked more symmetrical than for 
homogenized samples (Fig. 3.4). Chance r and R with only HI were perfect (i.e. 100%) 
regardless of sample type. According to the hornBshaped spread of predicted values and 
associated predictive intervals (Fig. 3.4), chance agreements in homogenized samples 
were less influenced by infection stage compared to nonBhomogenized samples, and 
chance R seemed to be also more spread than chance r. The initial observed estimates 
(filled circles) fitted the estimates predicted by the model for 71% of LI among infected 
fish (Fig. 3.4).  
 
3.3.3.3 Kappa values 
 
 Variation of κ within and among laboratories in nonBhomogenized and 
homogenized samples across prevalences and proportions of LI are illustrated in 4 
separate graphs in Fig. 3.5. All curves showed a concave profile. Curve profiles were 
fairly stable when prevalence values ranged from 20 to 80% and κ decreased when 
prevalence values were extreme. According to the spread of the estimates, κ for 
homogenized samples was more influenced by prevalence and less influenced by 
infection stage when compared to nonBhomogenized samples. The initial observed κ 
estimates (filled circles) were fairly close to the κ predicted by the model for 71% of LI 
among all infected fish (Fig. 3.5). 
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7GKA'@ATA' DJ#F$%E' D!%CU>'V"##"'Q"IF%>'DN'(;*6'35<2 3. Within the reference laboratory for nonBhomogenized (A) and homogenized samples 
(B); and among laboratories for nonBhomogenized (C) and homogenized samples (D) as a function of prevalence of infection and proportion of lowB (vs. 
highB) infected among all infected fish. Filled circles represent the originally observed estimates under the same testing conditions.
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3.3.4 Alternative estimation to modeling 
 
  Direct estimation of probabilities to test positive (or negative), from the 
dataset split according to the three PGS definitions, are summarized in Table 3.2 for 
comparison with modelling estimates. Similarly, corresponding agreement estimates 
using the different approaches (i.e. observed, modelling, and descriptive) are also 
summarized in Table 3.3. For comparison of prediction, estimated, chance and κ 
agreement graphs were generated based on descriptive estimates and on PGS, StrictBPGS 
and LenientBPGS definition and are presented in the thesis appendices (Appendix 1 to 9, 
respectively). 
 
@AS'-G>?F>>GDC'
'
3.4.1 Dependence of repeatability and reproducibility 
 
The main objective of this study was to extend the evaluation of the consistency of an 
ISAV RTBPCR test by predicting r and R across a range of prevalences and infection 
stage distributions. Adapting Bachmann et al. (2009) approach, we used modelling to 
predict the probability to yield the same test results from a single farmed Atlantic salmon 
according to the prevalence of infection in its population of origin, and if infected, the 
load of virus in its kidney. The modelling approach permitted us to estimate the influence 
of submission factors on agreement, including the type of sample (i.e. homogenized or 
not), and the testing laboratory. The developed model identified strong interBdependence  
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!DJDK%CGW%E'>"J#I%> between originally observed agreement estimates (from Chapter 
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pseudogold standard classification (PGS) for nonB, lowB and highBinfected fish (NI, LI, 
HI). Descriptive agreement estimates were added from the two alternative pseudogold 
classifications (StrictB & LenientBPSG) for comparison and assessment of the impact of 
pseudogold definition on prediction. 
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between agreement and each of these factors. 
  
3.4.1.1Dependence on homogenization 
 
 For both NI and LI salmon, homogenisation of the kidney samples significantly 
increased the probability to test positive compared to the same fish preBhomogenization 
(Tables 3.1 and 3.2). In NI fish, this led to a higher proportion of false positives and the 
test DSp moving away from perfection (100%) toward a middle range performance 
(Table 3.1). Therefore, homogenization decreased estimated and chance agreements in NI 
fish. The most likely explanation for increased proportion of false positives in 
homogenates was a sequential contamination from previous homogenized infected 
samples to subsequent nonBinfected samples during the homogenization process, as was 
discussed elsewhere (Chapter II). Regardless of the testing conditions (homogenization 
and laboratory), Cohen’s kappa (κ) values were nil for NI because agreement was only 
due to chance (κ measures agreement beyond chance; Dohoo et al., 2009). 
 The increased probability to test positive in LI fish reflects a higher proportion of 
true positive (i.e. DSe(LI) more extreme and closer to 100%) and therefore an increase in 
estimated and chance agreements. Again, κ for LI were close to nil since agreement was 
by chance alone. The higher probability to test positive in homogenates from LI salmon 
might be explained by a better yield of viral RNA during the extraction facilitated by a 
more efficient cell disruption due to the previous homogenization. Further investigations 
should be conducted at the bench level to evaluate if homogenization would improve the 
analytical sensitivity of this assay. 
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 All agreement estimates for homogenized samples revealed a much lower 
variation across different proportions of LI. The apparent improvement of robustness by 
homogenization in LI fish is consistent with the suspected heterogeneous distribution of 
viral particles during early infection stages. Previously discussed in Chapter II, this 
suggests a multifocal distribution of infectious clusters of low numbers of viral particles 
in the kidney of LI salmon. Higher consistency of virus detection in homogenates may 
also be due to over contamination of samples. However, this aspect could not be assessed 
in this study. 
 The decreased DSp in homogenates would support the use of homogenization 
toward a confirmatory diagnostic test and away from a screening use. This may, however, 
be impractical, and homogenization showed encouraging consistency for LI fish which 
are targeted by surveillance programs. Homogenization of tissue samples has diverse 
relevant applications for ISAV control programs (e.g. pooling of samples, production of 
aliquoted reference and control materials, laboratory proficiency testing). Further 
development and standardization of the homogenization process is needed to optimize the 
assay’s performance and consistency. 
 
3.4.1.2 Dependence on processing laboratory 
 
 In this study, R was not reported for separate pairBwise comparisons between two 
laboratories, but as an average of the three pairBwise estimates among the three 
participating laboratories (Labs A, B and C). Pooled R showed less variation than 
particular pairBwise estimates which would be expected to cover wider predictive 
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intervals. Overall, the average R showed less influence from proportion of LI fish than r. 
As an average value, this parameter is less susceptible to variation, but wider predictive 
intervals confirmed that it could take more extreme values. This observation is consistent 
with the concept that R carries additional degrees of variability compared to r due to 
laboratory divergences, even when assessed as an average.  
 Lab C had a significantly higher probability to test positive than the two other 
laboratories, based on samples from NI fish (i.e. lower DSp) (Tables 3.1 and 3.2). This 
reduced performance in NI fish might be explained by increased crossBcontamination 
(Wilson, 1997) in this particular laboratory and might result in a lower r in this particular 
category of salmon (not assessed here). Conversely, the probability to test positive in lab 
C for samples from LI fish was perfect (DSe(LI) = 100%) which might increase the 
overall r (not assessed here). Since the agreement is perfect for infected fish in lab C 
(DSe(LI) and DSe(HI) = 100%), the overall r in this particular laboratory would depend 
only on the proportion of NI of fish in the tested pool (1 B prevalence). As suggested by 
Bland and Altman (1986), the lack of agreement of lab C with the two other laboratories 
may be explained by poor r in lab C. However, considering results from both types of 
samples (homogenized and nonBhomogenized), the observed agreement within lab C was 
acceptable (0.85 in Chapter II). Therefore, the poor observed agreement between this 
facility and the others laboratories described in Chapter II might be explained by 
consistent divergent performances in lab C. Albeit agreement between lab A and B was 
more acceptable (Chapter II), clearly the method was difficult to transfer between 
laboratories without significantly changing test performances. Reasons for poor 
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transferability of this method, including factors associated with laboratory organization 
and staff experience, were discussed in detail elsewhere (Chapter II). 
 
3.4.1.3 Dependence on infection prevalence 
 
R and r within each infection category (infected and nonBinfected) are intrinsically 
associated with test performances (DSe and DSp, respectively). If agreement differs 
across infection categories, the overall agreement would result in a prevalenceBweighted 
average. The establishment of a PGS allowed us to estimate categoryBspecific agreement, 
and confirmed the discrepancy of agreement among infection stages (Table 3.2). Similar 
to overall accuracy or efficiency (Alberg et al., 2004), it was expected that test agreement 
strongly varies when (i) DSe and DSp differ much from each other and/or (ii) the 
prevalence of the targeted population deviates from 50%. By category weighting, 
agreement was predicted across prevalences and revealed substantive levels of variation 
according to the submission factors. Application of these predicted agreements depend on 
the specific utilization of the assay. If the purpose of the test is routine surveillance, the 
infection prevalence in the targeted population is likely to be low, and predicted precision 
would provide better fit to true agreement values. Alternatively, if the intended purpose 
of the test is diagnostic confirmation, the infection prevalence is likely to be high and the 
predicted estimates would strongly change the expectation of test agreement based on the 
proportion of infection stages. 
Across prevalences, estimated agreement showed monotonic linear profiles (Fig. 
3.3), whereas chance agreement and κ values revealed convex and concave profiles, 
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respectively (Fig. 3.4 and 3.5). Chance agreements, regardless of the testing conditions, 
reached a minimum around 50% prevalence which was close to the assumed prevalence 
of the studied pool of samples (according to the PGS). Although initial observed 
agreements appeared low (Chapter II), the interpretation should consider that the actual 
agreement evaluation was evaluated under the most challenging conditions. Representing 
the test result agreement due to chance alone (Dohoo et al., 2009), chance agreement of 
an imperfect test (DSe and DSp < 100%) is the lowest when the test has the highest 
number of misclassifications. For instance, when DSp and DSe are equal, chance 
agreement is minimum (.50) at exactly 50% prevalence. In this study, however, Dsp and 
DSe in LI and HI fish differed and minima were reached at prevalences moving away 
from 50%. Computation of κ from Eq. (10) was mainly influenced by the difference 
between estimated and chance agreement (numerator). In theory, κ reaches a maximum 
approximately when chance agreement is minimal under the assumption that estimated 
agreement is fairly stable (Fig. 3.3, 3.4 and 3.5). The resulting concave profile of κ across 
prevalences was consistent with previous descriptions of κ variations (GuggenmoosB
Holzmann, 1996). This is another example of the fair stability of κ in midBprevalence 
ranges and the strong, almost symmetrical, decrease of κ for extreme prevalences (i.e. 
below 20% and above 80%). In these extreme prevalence ranges, interpretation of κ is 
difficult which supports the recommendation to use samples from population close to 
50% prevalence to evaluate r and R. 
The predictive approach for agreement across different prevalences allowed us to 
extrapolate test consistency to external populations. It assumes, however, that the 
agreement is constant within each infection category. Advanced explorations of test 
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performances tend to indicate that DSp and DSe are not constant parameters and may 
vary according to population factors such as infection prevalence (Greiner & Gardner, 
2000). The impact of particular biological factors on test performances, such as 
proportions of infection stages, were further investigated to assess the possibility that 
agreement could fluctuate within infected fish for a similar prevalence. 
 
3.4.1.4 Dependence on proportion of infection stages 
 
 The probabilities to test positive (or negative) in the three infection categories 
differed substantively (Table 3.2), and resulted in agreement discrepancies among the 
three stages. The perfect test agreement with HI confirms the good performances of RTB
PCR in salmon with high concentrations of ISAV. Encouraging for advanced outbreaks, 
the intended purpose of this assay, however, was also to target detection of early ISAV 
stages during surveillance. Therefore, prediction of overall agreement for surveillance has 
to be adjusted for the proportion of LI fish (assuming that agreement is constant within 
each infection stage).   
 DSe is closely associated with the detection limit of the assay (i.e. analytical 
sensitivity), and therefore the probability of detection in LI fish was expected to be lower 
(low number of viral particles) or less consistent than in HI fish (Fig. 3.1). Indeed, 
probabilities to test positive in LI fish (DSe(LI)), and therefore agreements, were far from 
perfect except in Lab C (Table 3.2). This further supports the hypothetical heterogeneous 
distribution of viral particles (clustered) in early infection stages of ISA. With nonB
homogenized tissue, the operator can also expect lower agreement in LI than in NI 
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specimen (Fig. 3.3). According to Fig. 3.5, similarly to NI, agreement in LI is only due to 
chance (κ =0), regardless of the sample type. Therefore, the RTBPCR performances 
decrease with viral concentration in nonBhomogenized samples. Most binary diagnostic 
tests are based on the dichotomization of individuals according to a continuous 
underlying trait (i.e. target concentration) (Brenner and Gefeller, 1997). It is then 
recommended that test performance (DSe) and agreement be preliminarily investigated 
(at the bench level) across a gradient of analyte concentrations. For instance, a regression 
equation associating agreement and target concentration may be implemented to predict 
agreement within infected individuals.   
 Ultimately, using agreement estimates specific to infection stage (assumed 
constant within stages) and field evidence of the association between prevalence and 
relative proportions of infection stages, agreement can be predicted for different 
configurations to validate the agreement estimation and allow extrapolation to new 
populations.   
   
3.4.2 Validity of the modelling approach 
 
 The implementation of a modelling approach to predict agreement revealed very 
practical applications but also required several assumptions. Briefly, the defined PGS was 
assumed to correctly classify fish into the three infection stages; and stageBspecific 
agreement estimates were assumed to be constant across populations and also across 
infection prevalences. 
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3.4.2.1 Comparison with observed and descriptive estimates 
 
 Following confirmation of MCMC chains convergence (see section 3.2.2.2), 
indication of goodnessBofBfit was assessed visually by the proximity of predicted values 
with originally observed values in each graph (Fig. 3.3, 3.4 and 3.5). Overall, modelling 
tended to slightly overestimate agreement, though these values were still very close to 
each other. Compared to the originally observed estimation of agreement (Chapter II), 
modelling estimation enabled assessment of dependence among observations (e.g. from 
the same fish) and assessment of submission factors (e.g. homogenization) on test 
agreement.  
Tables 3.2 and 3.3 also compared probabilities and agreement obtained from 
different methods, including observed, modelling and descriptive estimates. Descriptive 
estimation is an alternative approach to evaluate probabilities to test positive (or negative) 
directly from the fish results classified according to PGS definition. This descriptive 
approach, however,neglected the dependence of duplicated test results coming from the 
same fish. Estimated probabilities were very similar between modelling and descriptive 
approaches (Table 3.2), and the corresponding agreement estimates stayed close to 
initially observed values, although they could differ slightly from each other (Table 3.3). 
The alternative estimation approach (descriptive) does not provide predictive intervals for 
agreement, thus restricting the assessment of the full range of future values. The 
predicted intervals indicated in Fig. 3.3B3.5 were very wide, in part because of the 
substantial betweenBfish random variation, but also because they corresponded to 95% 
predictive ranges for a sample size of one salmon. If agreement was computed from a 
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larger sample, its predictive bounds would become narrower. Basically, the modelling 
approach requires a modest extra analytical effort but provides valuable additional 
information.  
 
3.4.2.2 Sensitivity of prediction to the pseudogold standard definition 
 
Both predictive approaches (i.e. modelling and descriptive) rely on the definition 
of the PGS to classify fish into infection categories whereby the accuracy of the 
classification may affect the validity of the prediction. For example, the test DSe seemed 
to be lower in lab C than in other laboratories based on the PGS classification of fish, or 
alternatively the assay analytical sensitivity may be greater in this laboratory, allowing 
detection of very low virus levels. Originally, PGS was set that any observation had equal 
weight and the fish classification was based on evidence supported in the data. To be 
classified as infected, a salmon had to be positive in at least two laboratories (excluding 
lab A duplicates), and in the two sample types (nonBhomogenized and homogenized) (i.e. 
at least four positive results out of the six conventional RTBPCR runs) (Fig. 3.1). The 
subsequent classification differentiated lowB and highBinfected fish based on realBtime 
RTBPCR results using a Ct cutpoint set at the midBpoint of the expected range for Ct 
values. We acknowledge that this value is arbitrary and requires further investigation to 
explore ISAV levels existing in salmon at different stages of infection and correlate them 
to Ct values. To explore any major influence of PGS definition on agreement prediction, 
we compared changes in probabilities and agreement estimates using the descriptive 
approach for probability estimation (see section 3.2.5) based on alternative PGS 
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definitions (Tables 3.2 and 3.3). Compared to PGS, StrictBPGS classified less fish as 
infected which resulted in increased DSp  and decreased DSe, while LenientBPGS 
classified more fish as infected and resulted in decreased DSp and increased DSe (Table 
3.2). Graphical prediction of agreement for both PGS alternative definitions revealed 
approximately the same trends compared to the initial PGS (data not shown), while 
comparison with initially observed estimates revealed small differences (slightly larger 
than for PGS) (Table 3.3).  Albeit the PGS criteria may change some salmon infection 
status, the overall agreement trends did not change substantially when the PGS definition 
was changed.  
 
3.4.2.3 Dependence of diagnostic sensitivity and specificity on infection prevalence 
 
 Prediction of agreement assumed that agreement within each infection category 
was constant and that test performances did not depend on the factors varying across 
populations. Although, it is commonly accepted that DSp (or DSe) are constant 
parameters within each infection category and do not vary with population factors such as 
prevalence, various studies have challenged this postulate (e.g. Leeflang et al., 2009) and 
the invalidity of these assumptions may introduce estimation bias for predicted 
agreement. Further discussions on this issue and methods to adjust the estimation 
procedure are proposed in Appendix 15.   
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 Conventional descriptions of r and R have limited extrapolation, in particular 
when test agreement is expected to vary with the stage of infection and therefore to be 
dependent on prevalence. External validity of r and R estimation requires the possibility 
to predict the change in agreement across prevalences and infection stage distributions. 
Utilization of multilevel modelling procedures in a Bayesian framework allowed for 
assessment of the effect on agreement of submission factors as well as accounting for 
dependence among samples from the same fish. Briefly: 
 B Homogenization of salmon tissue samples tended to improve the detection and 
agreement in early infected salmon with ISAV, which supports a hypothetical 
heterogeneous distribution of ISAV in an infected kidney. Higher proportions of positives 
with homogenates, however, might also result from crossBcontamination in nonBinfected 
fish.  
 B ISAV RTBPCR in salmon was not always transferred with success (e.g. lab C) 
and may require further protocol standardization.  
 B r and R increased in a linear fashion with the proportion of highly infected 
salmon and decreased with the proportion of nonBhomogenized lowly infected samples 
for ISAV. RTBPCR agreement was perfect with samples from highly infected salmon. 
 B Kappa profiles revealed concave patterns, with kappa maxima reached 
approximately at 50% prevalence of ISAV infection in salmon, and sharp drops for 
extremes in prevalence (prevalence < 20% or > 80%). Agreement for nonBinfected (0% 
prevalence) and lowly infected fish was mainly due to chance.'
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' More than two classes (diseased and non2diseased) have been previously used to 
address the assumption of conditional test independence when using latent class model 
(LCM) to evaluate diagnostic test performance in the absence of a gold standard. The 
addition of supplementary class was investigated in this study to also address the 
assumption of constant diagnostic sensitivity (DSe) and specificity (DSp) across 
populations. Applied to 5 detection methods for infectious salmon anaemia virus (ISAV) 
using 400 Atlantic salmon sampled from 4 populations, a three class LCM was 
implemented in a Bayesian framework with further adjustment for test dependence. The 
model successfully recognized a third class of fish with substantially differing test 
performances. Only the nucleic2acid amplification assay could detect this additional class 
of fish. The definitive identity of the third class (infected or not) was subject to discussion 
and required further knowledge about the infection dynamics at the fish level. The 
obtained estimates of test DSe and DSp only apply to populations of Atlantic salmon 
farmed in Atlantic Canada. Regardless of the potential applications of multiple class 
estimates, selection of the appropriate assay or testing strategy for ISAV infection 
requires further detailed information of the infection dynamics at the population level. 
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4.1.1 Latent Class Modelling for diagnostic evaluation and underlying assumptions 
 
Conventionally, the evaluation of diagnostic test performances has involved a 
comparison of a candidate test with perfect (gold standard) or imperfect reference 
methods (Dohoo et al., 2009). In the absence of a reference standard, latent class models 
(LCM) have become the analytical tool of choice. Pioneers in the application of LCM to 
diagnostic evaluation, Hui & Walter (1980) presented key assumptions for using LCM: 
(i) at least two dichotomous assays should be applied to the same individuals from at 
least two populations (with different assumed prevalences), (ii) the tests must be 
conditionally independent given the infection/disease status; and (iii) the operating 
characteristics of the tests must be constant across populations.  In a Bayesian 
framework, the requirement for at least 2 populations can be relaxed using a single 
population when prior information about the prevalence and test properties are available 
(Dendukuri & Joseph, 2001). However, the prior of a specified parameter may have more 
impact on the posterior distribution of some parameters than the data itself (Neath & 
Samaniego, 1997). As an alternative, it was recommended to increase the number of tests 
and/or the number of populations or to stratify the one(s) available (Toft et al., 2005). For 
instance, a minimum of 4 tests is necessary for a single sampled population (Dendukuri 
& Joseph, 2001). 
 
202 
 
4.1.2 Validity of the test independence conditional on the infection/disease status 
 
 Conditional independence between two tests means that the probability of one test 
result is not influenced by the result of the other test (Dohoo et al, 2009). Tests that use 
similar techniques and/or measure the same biological trait are expected to be 
conditionally dependent (Gardner et al., 2000). The assumption of test conditional 
independence may not be reasonable (Brenner, 1996; Hui & Zhou, 1998) and may result 
in strongly biased estimations (Vacek, 1985; Torrance2Rynard & Walter, 1997). Several 
methods have been developed to account for conditional dependence (Hui & Zhou, 1998; 
Toft et al., 2005; Branscum et al., 2005).  
  The first method was indirectly developed by Vacek (1985) and it involves 
adding covariance terms to the model (Dendukuri & Joseph, 2001; Georgiadis et al., 
2003). With this approach, one test can depend on two other tests only if these other tests 
do not depend on each other (Nérette et al., 2008a). Later, utilization of log2linear models 
was described by including first degree interaction terms between pairs of tests in the 
model (Espeland & Handelman, 1989; Yang & Becker, 1997). Although interaction 
effects can be included as fixed or random, this assumes that at least one of the 
interactions is significant and the interpretation of the final model becomes complex (Hui 
& Zhou, 1998; Toft et al., 2005). Another approach was described by Qu et al. (1996) by 
extending the LCM with random effects to account for correlation among tests. A major 
assumption of mixed models is that random effects representing dependence between 
tests follow the same normal distribution, which might not be reasonable (Toft et al., 
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2005). Alternatively, Rindskopf & Rindskopf (1986) suggested relaxing the assumption 
of test conditional dependence by including additional classes in the model.  
 Binary tests may be assumed to dichotomize the measure of an underlying 
continuous trait of the degree of infection/disease (Brenner & Gefeller, 1997). However, 
This continuum, however, may be differentiated into three or more categories (Rindskopf 
& Rindskopf, 1986). The inclusion of more than two classes in LCM allows for different 
levels of infection/disease that correspond to different observed testing patterns giving a 
better fit of the data (Formann, 1994). Within each class, the assumption of conditional 
independence may therefore hold. In general, the addition of terms or classes increases 
the number of model parameters which might compromise the identifiability of the LCM. 
  
4.1.3 Validity of the assumption of constant classification across populations 
 
Often incorrectly referred to as accuracy, the trueness of an assay is defined as the 
degree of agreement between the average value obtained from a large series of test results 
and an accepted reference value (ISO 572521, 1994). For binary outcomes, this is 
expressed by the test overall efficiency (Ef) computed as the proportion of specimens that 
are truly classified. Ef is a prevalence2weighted average of the proportion of true positive 
in infected/diseased (D+) individuals and the proportion of true negative in non2
infected/non2diseased (D2) individuals (Alberg et al., 2004).  Classification performances 
of a test are, therefore,  preferentially reported separately for D+ and D2 individuals. 
Conventionally, the diagnostic sensitivity (DSe) refers to the proportion of positive test 
results among D+ individuals (true positive fraction). Similarly, the diagnostic specificity 
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(DSp) refers to the proportion of negative test results given the individuals are D2 (true 
negative fraction) (Yerushalmy, 1947).  
Contrary to common understanding, DSe and DSp may not be constant 
parameters and may vary across populations. Greiner & Gardner (2000) considered DSe 
and DSp as population parameters that vary within and between populations according to 
the distribution of covariate factors that influence the biology of the infection/disease. For 
instance, stage and severity of disease are factors commonly suspected to influence DSe. 
In pathologic screening, DSe is expected to be greater for large lesions than for small 
lesions (Begg, 1987). Also, compared to early stages, the proportion of animals in 
advanced stages of an infectious disease testing positive is expected to be higher in high 
prevalence populations (Greiner & Gardner, 2000), and DSe is expected to increase with 
prevalence. Conversely, DSp is suspected to be highly impacted by the probability of 
cross2contamination (Wilson, 1997). For instance, high prevalence populations are 
expected to generate more opportunities for cross2contamination. Therefore, DSp is 
expected to decrease with prevalence. In theory, it would be recommended to estimate 
DSe and DSp specifically for a targeted population using samples randomly collected 
(i.e. representative of biological covariates) (Johnson et al., 2009). Nevertheless, the 
disease pattern expressed in a population changes over time.  In addition, to be 
identifiable, LCM may require more than 2 populations with different prevalences (no 
prior information available). As the mixture distribution of infection/disease stages varies 
across populations, LCM may result in a biased pooled estimation of DSe (Toft et al., 
2005). In a 22test/22population scenario, the LCM estimate of DSe is an average of the 
two population2specific DSe only when one test has perfect DSp (Johnson et al., 2009). 
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One alternative approach is to increase the number of classes and assume constant DSe 
(or DSp) within each class, as previously suggested by Rindskopf & Rindskopf (1986) 
for conditional independence. The proportion of infected animals in each class would 
vary across the studied populations, while the basic assumptions of constant DSe and 
DSp are maintained within each sub2class.  
 
4.1.4 Application of LCM to infectious salmon anaemia virus detection 
 
 Infectious Salmon Anaemia virus (ISAV) is an Orthomyxovirus, genus Isavirus, 
causing high mortality in Atlantic salmon, Salmo salar L., and except in a few salmon 
production areas (e.g. British Columbia, Canada), represents a serious threat to the 
economic sustainability of aquaculture industries around the world (Godoy et al. 2008).  
ISAV is listed as a reportable disease by the World Organisation for Animal Health (OIE, 
2009a) and by the Canadian National Aquatic Animal Health Program which requires 
that ISAV assays be evaluated and validated. According to the biology of the disease, it is 
expected that DSe of ISAV tests varies across different prevalence level populations 
since prevalence of ISAV has been associated with the severity of infection (i.e. 
proportion of mortalities increased faster than infection prevalence) (Gustafson, 2005). 
Among the numerous evaluations for ISAV diagnostic tests, three studies have been 
conducted using LCM (Nérette et al., 2005; Gustafson et al., 2008; Nérette et al., 2008a). 
Discussing the validity of Hui & Walter assumptions, Nérette et al. (2005) observed 
variation in test performances with a decrease of DSp when ISA prevalence increased. 
This inconsistency in classification was further analyzed and confirmed, and some degree 
of conditional dependence among test pairs was additionally detected (Nérette et al., 
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2008a). Although conditional dependence was accounted for in the final evaluation, the 
variation of DSp across populations was not addressed (Nérette et al., 2008a). 
Furthermore, no investigation of the model assumptions was reported in Gustafson et al. 
(2008).  
 
4.1.5 Objectives 
 
The objectives of this study are twofold. First, this study was conducted to 
evaluate the test characteristics of a recently designed conventional reverse2transcriptase 
polymerase chain reaction (RT2PCR) assay for ISAV in Atlantic salmon. As 
recommended in OIE guidelines (OIE, 2009b), the aim of this evaluation was to 
determine the test’s fitness for a specific purpose. The components of the “purposeD
statusDtest” triangle, as outlined in (Mintiens et al., submitted), were clearly identified 
and defined before commencing the evaluation.  The intended purpose of the test was to 
demonstrate freedom from ISAV (surveillance) in a population (cage, site, bay, region, 
Canada). The targeted status for detection (diagnostic target) was an Atlantic salmon, 
Salmo salar L., infected with any ISAV genotype regardless of disease. Here the concept 
of infection is ambiguous and includes carrier states since active viral particles can be 
detected in a susceptible host before and after the infection per se. Although the test of 
interest was the RT2PCR assay, four additional detection methods, including real2time or 
quantitative RT2PCR (qRT2PCR), virus isolation (VI), indirect fluorescent antibody test 
(IFAT), and lateral flow immunoassay (LFI), were used in parallel on the same fish 
sampled from 4 separate populations to ensure the LCM identifiability. 
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 The secondary objective of this study was to build a LCM for tests for ISAV in 
salmon that included a third class in a flexible Bayesian framework to explore and 
account for expected variation in classification performance across populations and 
address conditional dependence of misclassification error. Adapting the multiple latent 
variable model recently described by Dendukuri et al. (2009), we further measured the 
conditional dependence among tests by including covariance terms in the model. The 
variation of RT2PCR DSp across populations observed by Nérette et al. (2008) could be 
explained by a differing diagnostic objective where only fish carrying virulent ISAV 
were targeted. Explained by a different analytical specificity, RT2PCR can detect RNA of 
avirulent ISAV particles (i.e. HPR0) when other tests may not. Hence, when a sample 
tested positive only to RT2PCR in Nérette et al. (2008) study, the fish was considered 
non2infected by the model when it may be truly infected with avirulent particles. 
Depending on the proportion of this type of samples, the DSp of RT2PCR varied across 
populations. In this study, the diagnostic target was ISAV infection including any viral 
genotype (including HPR0) and instead we expected DSe to vary across populations. 
Therefore, we first assumed that the added class was a supplementary class of infected 
salmon. 
The justification of a third latent class from patterns in the data as well as its 
possible interpretations are investigated and discussed in detail. This reflects our view 
that multiple latent class models may seem attractive for modelling but need to be well2
founded in the data in order to obtain meaningful results. For instance, the relative 
presence of the third class in the data would increase its ability to be detected. Thus we 
believe our study could serve as a case study for further applications of the methodology. 
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4.2.1 Target and study populations  
 
 The target population for this study was farmed Atlantic salmon, Salmo salar L., 
grown in sea cages in the province of New Brunswick, Canada. Other farmed salmon 
exposed to similar environmental and viral genotype conditions, such as those in Nova 
Scotia and Newfoundland, are considered a first degree external population. Wild 
Atlantic salmon might be included as a second degree external population, assuming 
external validity. 
 The studied populations consisted of farmed Atlantic salmon of 2004 and 2005 
year class, grown in polar circle cages in the Bay of Fundy, New Brunswick, Canada. 
Four populations were identified with different infection prevalence and representing a 
range of infection stages according to clinical and historical information (McClure et al., 
2004): (i) a near2zero prevalence population included apparently healthy fish from non2
exposed cages at non2infected sites but from a region historically infected (Pop I); (ii) a 
low prevalence population included apparently healthy fish from exposed cages at 
declared infected sites (Pop II); (iii) a moderate prevalence population included 
apparently healthy fish from infected cages after an ISA outbreak (Pop III); and (iv) a 
high prevalence population included a mixture of apparently healthy, dead and moribund 
fish from infected cages during an ISA outbreak (Pop IV).  
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4.2.2 Subject recruitment and sample collection 
 
 A total of 400 fish represented multiple origins: 100 from Pop I (50 fish from two 
different cages, different sites); 130 from Pop II (20, 50 and 60 fish from three different 
cages, respectively, different sites); 70 from Pop III (20 and 50 fish from two different 
cages, respectively, different sites); and 100 from Pop IV (10, 14, 31 and 45 fish from 
four different cages respectively, different sites). Except for Pop IV, salmon were 
collected using systematic random sampling during the harvest.  For Pop IV, 10 fish were 
slow swimming salmon from a declared infected cage conveniently dipped from the side 
of the cage; 45 fish (14+ 31) were fresh mortalities and moribund fish collected 
purposively during an outbreak; and the last 45 fish were sampled randomly during the 
culling of an outbreak cage. 
 Following removal from the cage, fish were preserved on ice until kidney samples 
were taken. For each fish, abdominal organs, including the swim bladder, were removed 
and the membranous capsule of the kidney was aseptically detached. A series of 122 mm 
cubed sections of the kidney were collected into sterile 2 mL microtubes containing 1 mL 
of RNAlater (Ambion Inc., Austin, TX, USA) and the remaining tissue was collected and 
stored into sterile tissue bags. Microtubes were subsequently stored at 280 °C after a 24 
hour period at 4 °C, and tissue bags were directly archived at 280 °C.  Multiple 
impression smears of kidney were made on slides. Slides were heat2 and then acetone2
fixed for 10 min before being stored at 280 °C. Samples were sent to the testing 
laboratories on dry ice to ensure that the impact of transport on specimen quality was 
minimized. 
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4.2.3 Data collection and management   
'
4.2.3.1 Testing protocols and interpretation 
 
To avoid review bias (Ransohoff & Feinstein, 1978), kidney samples were 
randomly coded to blind operators. Samples and test allocations for ISAV are illustrated 
in Fig. 4.1. 
 
4.2.3.1.1 Conventional reverseDtranscriptase polymerase chain reaction (RTDPCR) 
 The assay of interest for this study was a one2step RT2PCR, and the detailed 
protocol for it was described in Chapter II. From RNAlater2preserved kidney tissue, the 
assay detected the presence or absence of a 120 base fragment (analytical target) of the 
8th RNA segment of the viral genome. Ultimately, the diagnostic purpose of the assay 
was to detect infection in the tested fish (presence of active viral particles). Therefore, it 
was assumed that strong positive correlation exists between the presence of the targeted 
RNA fragment and the presence of segment 8, the presence of segment 8 and the 
presence of viral genome, the presence of viral genome and the presence of viral particles 
(both active or inactive), the presence of viral particles and the presence of active viral 
particles, and the presence of active viral particle in the kidney sample and the true 
infection status of the tested salmon (sampling effect as discussed in Thurmond & 
Johnson, 2004). Evaluation of the operating characteristics of a test includes sampling 
and transport procedures, the detection process, and interpretation of the test outcomes  
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Studied assays included: reverse2transcriptase polymerase chain reaction (RT2PCR), real2time 
RT2PCR (qRT2PCR), virus isolation (VI), indirect fluorescent antibody test (IFAT), lateral flow 
immunoassay (LFI). 
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(OIE, 2009b). The test targeted a conserved region of segment 8 and could in theory 
detect any sub2type of ISAV, regardless of its virulence (i.e. including HPR0). 
 
4.2.3.1.2 RealDtime or quantitative ReverseDTranscriptase Polymerase Chain Reaction 
(qRTDPCR) 
The real2time version of the RT2PCR used the same pair of primers in addition to 
a Taqman probe. The detailed protocol of this assay was described in Chapter III (p.). 
This assay was performed on the same RNA extracts as conventional RT2PCR (Fig. 4.1), 
thus the same serial assumptions of positive correlation between the presence of the 
targeted RNA fragment (analytical target) and infection in the tested fish (diagnostic 
target) is made. The outcome of the qRT2PCR was given by the amplification cycle at 
which the fluorescent signal was measured above a specified threshold (cycle threshold, 
Ct). For any sample that yielded a Ct value before the end of the reaction (45 cycles 
total), the test result was deemed positive. Using an additional probe, qRT2PCR was 
believed to be more specific (analytical and diagnostic) than RT2PCR, albeit it also 
detects any sub2type of ISAV.  
 
4.2.3.1.3 Virus isolation (VI) 
 The approach to ISAV isolation used in this study was developed by Rolland et 
al. (2005) and uses two cell lines in parallel. Using frozen kidney samples conditioned in 
tissue bags, duplicate cell cultures of salmon head kidney 1 (SHK21) and Atlantic salmon 
kidney (ASK) were seeded simultaneously. If, within 28 days, at least one of the wells 
showed cytopathic effects (CPE), the culture was sub2seeded in new duplicate cultures of 
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both cell lines.  If CPE was confirmed in the second passage, the supernatant was tested 
with an adjunct test (i.e. RT2PCR) for identification. The results of the combined VI were 
interpreted in parallel (i.e. if at least one cell line tested positive, the sample was deemed 
positive) (Dohoo et al., 2009). This interpretation in parallel was intended to increase 
DSe but assumed some degree of  conditional dependence between the two VI 
procedures. This assay targeted the presence or absence of active virulent ISAV particles 
(analytical target) in the tested sample. To fit the diagnostic target of detecting infection 
in the tested salmon, it was assumed that a series of strong positive correlations exist 
between the detection of active viral particles in kidney sample and the true infection 
status of tested fish. However, VI only detects virulent ISAV genotypes capable of 
replication in the cell culture (i.e. not HPR0) which may affect the validity of comparing 
it with RT2PCRs. 
 
4.2.3.1.4 Indirect fluorescent antibody test (IFAT) 
The IFAT protocol to detect ISAV from kidney imprints was initially developed by 
Falk & Dannevig (1995) and was fully described by Nérette et al. (2005). The IFAT uses 
a monoclonal antibody that binds to the surface glycoprotein hemagglutinin2esterase 
(HE) of the viral particle (analytical target) (Falk et al., 1998). Similar to other tests, it 
was necessary to extrapolate the diagnostic target (detection of infection in the tested 
salmon) from the detection of the HE in the kidney smear by assuming a series of 
positive correlations. The IFAT results were reported using a grade scoring system 
according to frequency of observed fluorescent areas (0 to 4+), and any samples that 
generated at least 1+ score were deemed positive. The monoclonal antibody used has 
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been shown to bind to all of the North American genotypes of ISAV known, and there is 
no evidence suggesting that the antibody does not bind to the avirulent genotype HPR0 
(Dr. Knut Falk, pers. com.). 
 
4.2.3.1.5 Lateral flow immunoassay (LFI) 
 The LFI is a commercially available assay (Aquatic Diagnostics Ltd., Stirling, 
Scotland) that uses a mix of two monoclonal antibodies targeting the nucleoprotein 
(analytical target) coded by the 3rd RNA segment of the viral genome. Although the test 
was developed for fresh kidney samples, frozen tissues conditioned in tissue bags were 
used for this evaluation. A series of positive correlations were assumed between the 
presence of the nucleoprotein and the ultimate diagnostic target. Both monoclonal 
antibodies are believed to bind to all North American genotypes of ISAV and, no 
evidence suggests that they do not bind to the avirulent genotype HPR0 (Dr. Kim 
Thompson, pers. com.). 
 
4.2.3.2 Data alignment and test agreement 
 
 Visual screening and agreement of the 5 assay results was conducted using the 
descriptive approach developed in Chapter II. Separate alignment of the test results was 
generated (fish in column, test in row) for each population using the DNA sequence 
alignment editor software BioEdit version 7.07 (Hall, 1999). Agreement among the 5 
tests was represented with an agreement tree reconstructed using the phylogenetic 
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analysis package MEGA version 4 (Tamura et al., 2007). Analysis parameters for the tree 
reconstruction are detailed in Chapter II.  
 
4.2.3.3 Suspected conditional dependence 
 
 Diagnostic tests that target a similar biologic trait (i.e. same analyte and/or stage 
of the infection) are expected to be dependent conditional on the infection status (Gardner 
et al., 2000). Therefore, the two nucleic2acid amplification tests (NAAT) (i.e. RT2PCR & 
qRT2PCR) and the two antibody based assays (ABA) (i.e. IFAT & LFI) were expected to 
be conditionally dependent. Although these two pairs of tests were particularly targeted, 
statistical procedures were used to investigate test dependence for any test pairs. 
 
4.2.4 Latent Class Modelling 
 
 Allowing for more flexibility, LCMs were coded and run in a Bayesian 
framework using WinBugs software (Spiegelhalter et al., 2003). The code for the final 
model is available in Appendix 17.  
 
4.2.4.1 Parameters and identifiability 
 
  Test results were collected from P = 5 assays for each of the N = 400 sampled 
salmon clustered in K = 4 different prevalence populations. To investigate the assumption 
of constant DSe across populations and test conditional independence, we considered C = 
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3 categories (or latent classes) of infection: the class of non2infected (LA), and two sub2
classes of infected fish (LB and LC). LB is assumed to be an intermediate stage between LA 
and LC. Similar to Dendukuri et al. (2009), we set a model where Yip denotes the result of 
the ith fish on the pth test, and Yi = (Yi1, Yi2, Yi3, Yi4, Yi5) and denotes the result vector for 
the ith salmon. Yip is dichotomous (negative or positive; 0 or 1, respectively). Assuming 
that the 5 tests are conditionally independent within each latent class, the probability to 
observe Yi in population k was expressed as: 
 
Pk(Yi)  = Pk(Lc) Pk(Yi1, Yi2, Yi3, Yi4, Yi5|Lc) 
   = Pk(Lc)   Pk(Yip|Lc)      (1) 
 
where Pk(L) denotes the prevalence of class L in the kth population; and Pk(Yip|Lc) denotes 
the probability that the ith fish yields a result Yip (0 or 1) on the pth test in class c of the kth 
population. In the two classes of infected fish (LB, LC), the probability to test positive 
correspond to the DSe, while in the class of non2infected (LA), it corresponds to the 
complement of DSp (12DSp). These parameters were assumed to be population 
independent and therefore constant across the 4 populations. In each population, the 
probability of non2infected fish (P(LA)) can be expressed as the complement of the 
prevalence of infection (i.e. 1D (P(LB)+P(LC))). Within each population k, the result 
vector Yi is a count that follows an independent multinomial sampling distribution. 
 Under the assumption of independence of test results within each of the 3 classes, 
23 unknown parameters were included in the model (CP + K(C21), modified from 
Dendukuri et al., 2009); in detail, one DSp and two DSe (DSeLB and DSeLC) for each of 
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the 5 tests, and two infection prevalences (LB and LC) in each of the 4 populations. The 
dataset degrees of freedom were 124 (K (2P21); Hui & Walter, 1980).  
 
4.2.4.2 Prior information 
 
  Non2informative beta priors (1, 1) were set for DSp and DSe. Prevalence 
of the 3 classes in each population were set to follow a Dirichlet distribution (whereby 
the 3 proportions add to 1) and were parametrized using 3 gamma distributions, as 
described in the WinBugs manual (Spiegelhalter et al., 2003). Initially, the gamma 
distributions were given the same shape parameters (1, 1, 1), leading to a non2informative 
Dirichlet prior, in all 4 populations. However, to avoid identity switching between the 
two sub2classes of infected, a weak prior distribution was set for the prevalence of LA fish 
in Pop I. In a previous ISAV prevalence study, the proportion of non2infected fish (class 
A) in non2exposed cages in an infected area was estimated at 95% (McClure et al., 2004). 
Using the BetaBuster freeware (http://www.epi.ucdavis.edu/diagnostictests), distribution 
parameters were calculated for a prevalence distribution corresponding to a mode at 95% 
and a 5% percentile at 50% (i.e. beta(4.8, 1.2)). The beta prior was converted into a 
Dirichlet prior by distributing the non2class A proportions equally on classes B and C (i.e. 
gamma(4.8, 0.6, 0.6)). 
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4.2.4.3 Model refinement for conditional dependence among tests 
 
Although conditional dependence was assumed to be addressed by adding an 
extra class, test dependence within each class was further explored, one test pair at a time, 
using the methods described by Nérette et al. (2008a). Models corresponding to the 10 
possible combinations of test pairs were compared using the deviance information 
criterion (DIC) (Spiegelhalter et al., 2002) and Bayesian P2values (Nérette et al., 2008a). 
DIC reflects the combination of 2 parameters: pD+ describing the model complexity (i.e. 
number of effective parameters), and D describing the goodness2of2fit. Models were 
considered significantly different when DIC differed by more than 3 units. In addition, 
Bayes P2values were estimated to select models based on their goodness2of2fit using a 
code adapted from Nérette et al. (2008a). Only covariance terms between the two NAATs 
and the two ABAs were significant and included in the final model. Further model 
refinements were pursued and only significant covariance terms conditional on the 
infection class C were conserved in the final code. From Eq. (1), the probability that the 
ith fish yields a result Yip (0 or 1) on the pth test in the class C included the covariance 
terms and was expressed as follow: 
 
P(Yi1, Yi2, Yi3, Yi4, Yi5|Lc) =  P(Yi1, Yi2|Lc) * P(Yi3|Lc) * P(Yi4, Yi5|Lc) 
 
When Yi1=Yi2, 
P(Yi1, Yi2|Lc) =  P(Yi1|Lc) * P(Yi2|Lc) + γ12  
and  when Yi1 ≠ Yi2, 
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P(Yi1, Yi2|Lc) =  P(Yi1|Lc) * P(Yi2|Lc) D γ12 
 
where γ12 is the covariance term between test 1 and 2 (NAATs) in class C. Similar 
formulae apply to the conditional probabilities involving tests 4 and 5 (ABAs) (P(Yi4, 
Yi5|Lc)), with a covariance term (γ45) between tests 4 and 5 in class C. 
 
4.2.4.4 Assessment of MCMC chains convergence 
 
 For all models, a burn2in period of 10,000 iterations and 40,000 additional 
iterations were run for posterior sampling estimation. Proper convergence and mixing of 
Markov Chain Monte Carlo were assessed by following Toft et al. (2007) guidelines. A 
brief overview of the steps in this process includes the following: (i) visual assessment of 
time series trace plots using Gelmann (1996) empiric criteria; (ii) Gelman2Rubin 
convergence diagnostics (Brooks & Gelman, 1998) to assess the influence of the starting 
values on the chains convergence; and (iii) autocorrelation plots to assess the presence of 
correlation among posterior samples. To reduce some observed autocorrelation along the 
Gibbs sampler chains, a total of 400,000 iterations were run with thinning sampling every 
10 iterations to ultimately obtain 40,000 posterior samples. In addition, chain 
convergence assessment was complemented with quantile stability diagnostics (Raftery2
Lewis, 2.5% and 97.5%; Brooks2Draper, mean) and the Effective Sample Size (i.e. 
sample size for a completely uncorrelated sequence that would yield the estimated MC 
standard error for the mean) using the “column diagnostic” function in MLwiN software 
v.2.11 (Rasbash et al., 2009). Markov chains were run in parallel using three random sets 
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of initial values for test parameters (i.e. DSeA, DSeB and DSp). Some convergences failed 
due to a shift between the two sub2classes of infected fish relative to the initial values. 
New sets of initial values were arbitrarily set based on the overall interpretation of the 
two sub2classes of infected fish (i.e. DSeB lower than DSeA). 
 
4.2.4.5 Model validity 
 
The goodness2of2fit of the model was assessed using the Bayesian P2values as 
described in Nérette et al. (2008a). In addition, the robustness of the model estimation 
was investigated with respect to the influence of various parameters on the analysis. First, 
the influence of the third class on the LCM procedure was assessed by running a 
conventional two2class LCM (2LCM) for comparison. Next, the influence of conditional 
dependence between NAATs and ABAs was studied by breaking the dependent pair of 
tests and running 2LCM and 3LCM models with 3 tests only, including combinations 
using one NAAT and one ABA simultaneously. Covariance factors were conserved when 
the selected pair of tests was present in the model.  
To investigate the potential impact of a particular test, the model was run with 
four tests at the same time.  Robustness of the model was evaluated by monitoring the 
variation of estimated parameters across different cut2point values for ordinal or 
continuous outcome tests. The analysis was repeated for different qRT2PCR Ct cut2off 
value and IFAT score cut2off values (1, 2, 3, 4). Finally, the influence of the informative 
prior (prevalence of class A in Pop I) was explored by running the model with first a non2
informative prior (gamma(1, 1, 1)), or with a weaker prior distribution (gamma(1.3, 0.5, 
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0.5)) with the mode at 95% and the 5% percentile at 10%), or finally with a stronger prior 
distribution (gamma(10.8, 0.75, 0.75)) with the mode at 95% and the 5% percentile at 
70%) (Fig. 4.2).  
 
>?N'3%<DG$<'
 
4.3.1 Test result alignment and agreement tree 
 
 For each population, the test results were aligned and were presented in Fig. 4.3. 
Three different testing patterns were observed. The first pattern was fish yielding 
negative results to all 5 tests and was found in all populations, but largely dominated in 
Pop I and II. The second testing pattern was salmon with at least 3 positive tests and was 
exclusively found in Pop IV (infected cages). The third pattern was observed mainly in 
Pop III, and included fish positive to either both NAATs and negative in the 3 other 
methods. The observation of 3 distinct testing patterns supported the addition of a third 
class in the analysis. A table of test result frequencies is presented in Appendix 15. 
 The distance2based tree reconstruction generated a visual representation of the 
agreement among the 5 assays (Fig. 4.4). The tree is scaled with the number of test 
results that differ between assays. As the branch distance between two tests becomes 
greater, the number of disagreeing results becomes more important. The two antibody2
based assays (ABAs) clustered together and revealed the best agreement with only 8 
discrepancies out of the 400 fish (2%). The two nucleic2acid amplification tests (NAATs) 
also clustered together. However, they revealed much stronger disagreement (9.25%), 
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The distribution used was beta(4.6, 1.2) (mode at 0.95 and the 5% 
percentile at 0.50). Alternative priors were tested: a beta(1.3,1) (mode at 
0.95 and the 5% percentile at 0.10); and a beta(10.8, 1.5) (mode at 0.95 
and the 5% percentile at 0.70). 
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/EI?'>?N?'1%<$'&%<DG$'"GEIAH%A$*'<"H#G%C'LE<!'OEA'=BGDHA<Q'R%&%'=GD<$%&%C';M'="I%'B&EIEA'"AC'#&%K"G%A=%'G%K%G'#B#DG"$EBA< (Population I: 100 apparently 
healthy fish from non exposed cages; Population II: 130 apparently healthy fish from exposed cages; Population III: 70 apparently healthy fish from post 
outbreak cages; Population IV: mixture of apparently healthy, mortality and moribund fish from outbreak cages). RT2PCR: reverse2transcriptase polymerase 
chain reaction; qRT2PCR: real2time reverse2transcriptase polymerase chain reaction; VI: virus isolation; IFAT: indirect fluorescent antibody test; LFIA: lateral 
flow immunoassay; “n” codes for negative; “p” codes for positive; a dot indicates the same result as the first row (RT2PCR). When positive, cycle threshold 
values were reported for qRT2PCR, and intensity score (0 to 4) for IFAT. Greek letters are arbitrary cage numbers. Note that the same cages were sampled for 
moderate and high prevalence populations.  
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&DA<?  
The percentages reported at the branch node are the bootstrap support 
values (proportion of resampled trees that include the node of interest) and 
the distance between two tests is visually assessed by the relative length of 
branches that connect them and are scaled based on the number of 
differing results out of the 400 samples tested. RT2PCR: reverse2
transcriptase polymerase chain reaction; qRT2PCR: real2time reverse2
transcriptase polymerase chain reaction; VI: virus isolation; IFAT: indirect 
fluorescent antibody test; LFI: lateral flow immunoassay. 
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particularly in Pop III. The VI branched with the ABAs cluster, suggesting a similar 
testing pattern but sufficiently different to be separated. The respective cluster of the 2 
ABAs and the 2 NAATs suggested that some degree of dependency was to be expected 
within each these pairs of tests.  
 
4.3.2 Model building and refinement 
 
 Compared to the model with conditional independence, significant improvement 
in the model DIC and goodness2of2fit were observed when dependence between the 2 
NAATs and the 2 ABAs were accounted for (Table 4.1). Further refinement of the model 
revealed that dependence within the two pairs of tests was only conditional on class C 
and covariance terms in the two other classes could be excluded without changing 
substantively the model’s DIC (Table 4.2). 
 
4.3.3 Final threeDclass LCM (3LCM) 
 
The final model included 3 classes with 400 salmon from 4 different populations 
tested by 5 tests and accounting for test dependence between the NAATs and the ABAs, 
and required thinning. The model showed satisfactory goodness2of2fit (Bayesian P2value 
= 0.56) and a DIC of 145.95. Posterior distributions of the test result probabilities were 
presented in separate graphs for each class (Fig. 4.5A, B & C), and detailed estimates 
from the distributions (mean, median and mode) and their corresponding 95% credibility 
intervals were reported in Table 4.3. For all tests, the probability to test negative in class 
A (DSp) was substantial, exceeding 98%. LFI had the highest DSp and small variation of 
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7BC%G' <%G%=$EBA' CE&%=$%C' ;M' S"M%<E"A'  PK"GD%' "AC' C%KE"A=%' EALB&H"$EBA'
=&E$%&EBA'O4( Q'$B'EC%A$ELM'$!%'=BACE$EBA"G'C%#%AC%A=%'"HBAI'#"E&<'BL'$%<$<?  
Best model in bold. RT2PCR: reverse2transcriptase polymerase chain reaction; 
qRT2PCR: real2time reverse2transcriptase polymerase chain reaction; VI: virus 
isolation; IFAT: indirect fluorescent antibody test; LFIA: lateral flow 
immunoassay. 
 
 
Model RT-PCR qRT-PCR VI IFAT LFI Bayes-P DIC 
I      0.23 204.16 
II • •    0.26 179.66 
II •  •   0.23 181.62 
IV •   •  0.23 183.17 
V •    • 0.24 181.38 
VI  • •   0.24 182.70 
VII  •  •  0.23 182.86 
VIII  •   • 0.24 180.47 
IX   • •  0.24 181.83 
X   •  • 0.25 181.21 
XI    • • 0.42 152.01 
XII • •  • • 0.55 148.47 
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1";G%'>?F'
7BC%G' <%G%=$EBA' IDEC%C' ;M' S"M%<E"A'  PK"GD%<' "AC' C%KE"A=%' EALB&H"$EBA' =&E$%&EBA' K"GD%<' (DIC)' $B' EC%A$ELM' $!%' ;%<$'
=BH;EA"$EBA' BL' =BK"&E"A=%' L"=$B&<' ;%$R%%A' $!%' F' AD=G%E=' "=EC' "H#GELE="$EBA' $%<$<' (NAAT: RT2PCR & qRT2PCR)' "AC''
;%$R%%A' $!%' $RB' "A$E;BCMP;"<%C' "<<"M<' (ABA: IFAT & LFI),' =BACE$EBA"G' BA' $!%' EAL%=$EBA' <$"$D<?' Best model (most 
parsimonious) in bold. RT2PCR: reverse2transcriptase polymerase chain reaction; qRT2PCR: real2time reverse2transcriptase 
polymerase chain reaction; VI: virus isolation; IFAT: indirect fluorescent antibody test; LFIA: lateral flow immunoassay. 
 
 
Model covA-NAAT covA-ABA covB-NAAT covB-ABA covC-NAAT covC-ABA Bayes-P DIC 
I • • • • • • 0.55 148.47 
II  • • • • • 0.58 146.92 
II •  • • • • 0.55 148.07 
IV • •  • • • 0.55 147.96 
V • • •  • • 0.55 148.16 
VI • • • •  • 0.40 154.07 
VII • • • • •  0.28 180.42 
VIII     • • 0.54 146.17 
IX     •  0.25 181.37 
X      • 0.40 151.44 
XI       0.23 204.16 
covA: covariances for class A (non2infected) (specificity) 
covB: covariances for class B (infected) (sensitivity) 
covC: covariances for class C (infected) (sensitivity)
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'''
/EI?' >?T?' 9B<$%&EB&' CE<$&E;D$EBA<' BL' $!%' #&B;";EGE$E%<' BL' %"=!' (,0)' "<<"M' $B' $%<$' #B<E$EK%' EL' $!%' LE<!' E<' EAL%=$%C' EA' =G"<<' 0*' 4,%0' O0?QU'EAL%=$%C'S*'4,%S'OS?QU'"AC'ABAPEAL%=$%C*'@P4,#'O ?Q?  RT2PCR: reverse2transcriptase polymerase chain reaction; qRT2PCR: real2time reverse2transcriptase polymerase chain reaction; VI: virus 
isolation; IFAT: indirect fluorescent antibody test; LFIA: lateral flow immunoassay; DSe: diagnostic sensitivity; DSp: diagnostic specificity. 
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1";G%'>?N'
9B<$%&EB&' %<$EH"$%<' (mean, median and mode)' ' "AC' =B&&%<#BACEAI' VTW' =&%CE;EGE$M' #B<$%&EB&' EA$%&K"G<' (CPI)' BL'
#&B;";EGE$E%<'BL'$%<$EAI'#B<E$EK%'"AC'A%I"$EK%'EA'$!%'$!&%%'=G"<<'BL'LE<!'LB&'%"=!'BL'$!%'LEK%'(,0)'CE"IAB<$E='"<<"M<'
"AC''=G"<<'#&%K"G%A=%<'LB&'%"=!'BL'$!%'>'#B#DG"$EBA<'L&BH'$!%'LEA"G'N5 7X'EA=GDCEAI'=BACE$EBA"G'C%#%AC%A=%?'RT2
PCR: reverse2transcriptase polymerase chain reaction; qRT2PCR: real2time reverse2transcriptase polymerase chain 
reaction; VI: virus isolation; IFAT: indirect fluorescent antibody test; LFIA: lateral flow immunoassay; DSe: diagnostic 
sensitivity; DSp: diagnostic specificity; 3 classes of fish (A, B & C) where B & C are assumed infected. 
 
-<$EH"$%<'(%)' 31P9 3' ' Y31P9 3' ' )(' ' (/01' ' 5/('Mean Median Mode 95% CPI  Mean Median Mode 95% CPI  Mean Median Mode 95% CPI  Mean Median Mode 95% CPI  Mean Median Mode 95%CPI 
 
Class A     
                    
     Prob (negative) DSp 98.51 98.65 98.97 96.4299.9  98.39 98.53 98.81 96.0299.9  98.27 98.58 99.29 95.2299.8  99.25 99.37 99.66 97.9299.9  99.63 99.74 99.97 98.6299.9 
 
Class B     
                    
     Prob (positive) DSe 69.32 69.52 70.66 56.4281.3  73.85 74.12 71.26 61.0285.2  1.70 1.19 1.01 0.0426.16  2.60 2.19 1.37 0.3127.21  1.31 0.91 1.13 0.0324.76 
     Prob (negative) DSp 30.68 30.48 29.34 18.7243.6  26.15 25.88 28.74 14.8239.0  98.30 98.81 98.99 93.8299.9  97.40 97.81 98.63 92.8299.7  98.69 99.09 98.87 95.2299.9 
 
Class C     
                  
  
     Prob (positive) DSe 89.56 89.60 89.78 78.2299.4  88.10 88.18 88.37 76.4298.5  88.13 88.60 90.20 78.3295.3  61.07 61.00 62.20 47.6274.7  70.81 70.83 71.67 57.4284.0 
     Covariance* 7.37  7.58  10.85  0.14215.1       15.91  16.16  16.81  9.71220.7 
9&%K"G%A=%'(%)' 9B#DG"$EBA'(' ' 9B#DG"$EBA'((' ' 9B#DG"$EBA'(((' ' 9B#DG"$EBA'()'Mean Median Mode 95% CPI  Mean Median Mode 95% CPI  Mean Median Mode 95% CPI  Mean Median Mode 95% CPI 
Class A 97.3 97.9 96.8 91.2299.9  98.4 98.6 97.2 95.6299.8  12.8 12.6 9.2 2.36224.5  29.2 28.9 27.4 19.0240.9 
Class B 2.16 1.41 1.13 0.0128.05  0.82 0.57 1.01 0.0223.00  85.8 85.9 84.6 73.7296.5  12.3 11.9 10.9 5.14220.9 
Class C 0.57 0.30 1.13 0.0022.64  0.78 0.55 1.03 0.0222.87  1.44 1.00 1.14 0.0325.29  58.5 58.7 59.6 46.9269.2 
*Conditional dependence between the 2 RT2PCRs and between the 2 antibody2based tests 
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estimation (narrow distribution), while the DSp of VI was comparable to the NAATs but 
showed the largest uncertainty in the estimation (i.e. lack of evidence). In class B, only 
NAATs were likely to test positive while the other assays had almost zero probability. In 
class C, the probability for the ABAs to test positive was substantially lower compared to 
the three other tests. The LFI seemed to perform better than the IFAT that had the lowest 
DSe. VI has the highest DSe mode, albeit its narrow distribution suggested limited 
chance to reach higher values than 95%. Although the distribution of DSe for RT2PCR 
was wider, its average DSe estimate was the highest, as explained by a secondary peak 
(Fig. 4.5C). The DSe of qRT2PCR distribution also showed a tendency to bimodality, 
despite its profile appearing symmetrical. Significant dependencies between the NAATs 
and the ABAs were confirmed conditional on class C (Table 4.3). 
Posterior distributions of the prevalence of class B and C (infected fish) were 
presented in separate graphs for each population (Fig. 4.6A, B, C & D); and the detailed 
estimates were reported in Table 4.3. The prevalence of infected fish were almost nil in 
Pop I and Pop II. A Class B of infected fish was largely present in Pop III (post2outbreak 
cages). Class B infected fish were also found in a minority of cages encountering an 
outbreak (Pop IV), dominated by the presence of Class C fish. 
 
4.3.4 Sensitivity analyses 
' Conventional 2LCM with 5 tests showed strong evidence of lack of fit (Bayesian 
P2value = 0.01) (Table 4.4). Accounting for conditional dependence between the NAATs 
and ABAs did not particularly improve the fitness (Bayesian P2value = 0.03) (Table 4.4). 
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/EI?'>?Z?'9B<$%&EB&'CE<$&E;D$EBA<'BL'$!%'#&%K"G%A=%<'BL'=G"<<'S'"AC' 'BL'%"=!'BL'$!%'>'<"H#G%C'#B#DG"$EBA<* Population I (fish from non2
exposed cages, low prevalence expected), Population II (fish from  exposed cages, mild prevalence expected), Population III (fish from post2
outbreak cages, moderate prevalence expected), Population IV (fish from cages encountering an outbreak, high prevalence expected). 
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virus isolation; IFAT: indirect fluorescent antibody test; LFIA: lateral flow immunoassay; DSe: diagnostic sensitivity; DSp: diagnostic 
specificity; 3 classes of fish (A, B & C) where B & C are assumed infected. 
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The addition of a third class without covariance terms substantially increased the 
Bayesian P2value (0.23), while the best goodness2of2fit (0.54) and lowest DIC were 
obtained by including covariance factors in each of the 3 classes (Table 4.4).  
 Alternative ways to avoid conditional dependence using 2LCM were investigated 
using chosen combinations of 3 tests to break conditional dependence (Table 4.5). 
Although DSp estimates were similar to the final 52test 3LCM accounting for conditional 
dependence, DSe estimates for non2NAAT tests were approximately average for the class 
B and class C estimates (Table 4.5). Addition of the third class in 32test models resulted 
in some unstable estimates for NAATs and the class B prevalence (models VI & VII, 
Table 4.5). Removing one test at a time (i.e. 42test 3LCM) did not reveal any substantial 
changes in the estimation (Table 4.5). None of the tests had a major influence on the 
model. However, the absence of VI seemed to increase the DSe estimates in class C of 
other tests (model XI, Table 4.5). 
 Using different cutpoints for IFAT did not influence the estimation of the 
parameters (results not shown) (Fig. 4.7), while cutpoints for Ct values between 25 and 
30 cycles revealed instabilities mainly related to VI classification (Fig. 4.8). In Pop IV, 
VI generated positive results that were negative for all other tests, which explained its 
relatively low DSp. Conversely, some samples tested positive with any other tests were 
negative on VI, which explained its relatively low DSe in class C fish (Fig. 4.3). Between 
25 and 30 Ct cutoff, the data were weaker and the model seemed to give more weight to 
VI classification. Some of these samples (initially A and C) were reclassified as class B 
fish (increased proportion of class B and decreased proportions of class A and C in Pop  
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RT2PCR: reverse2transcriptase polymerase chain reaction; qRT2PCR: real2time reverse2transcriptase polymerase chain reaction; VI: 
virus isolation; IFAT: indirect fluorescent antibody test; LFIA: lateral flow immunoassay; DSe: diagnostic sensitivity; DSp: diagnostic 
specificity; 3 classes of fish (A, B & C) where B & C are assumed infected. 
 a 32test model run with only 2 classes (i.e. no class B value) 
DIC: deviance information criterion 
* final model run without thinning (i.e. different DIC and Bayes2P) 
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IFAT scoring ranged from 0 to 4. IFAT cutpoint was defined as any samples that yielded a score below the specified value were deemed negative. RT2PCR: 
reverse2transcriptase polymerase chain reaction; qRT2PCR: real2time reverse2transcriptase polymerase chain reaction; VI: virus isolation; IFAT: indirect 
fluorescent antibody test; LFIA: lateral flow immunoassay; DSe: diagnostic sensitivity; DSp: diagnostic specificity; 3 classes of fish (A, B & C) where B & C are 
assumed infected. 
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from 17.29  to 41.86 and the reaction was stopped at 45 cycles. Ct cutpoint was defined as that point where any sample that yielded a score above the specified 
value were deemed negative. RT2PCR: reverse2transcriptase polymerase chain reaction; qRT2PCR: real2time reverse2transcriptase polymerase chain reaction; VI: 
virus isolation; IFAT: indirect fluorescent antibody test; LFIA: lateral flow immunoassay; DSe: diagnostic sensitivity; DSp: diagnostic specificity; 3 classes of 
fish (A, B & C) where B & C are assumed infected. 
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IV) (Fig. 4.8A). Consequently, for VI, the DSp increased (Fig. 4.8B) and the DSe for 
class B fish increased (Fig. 4.8C). For the other tests, this reclassification resulted in a 
decreased DSe in class B for RT2PCR (Fig. 4.8C), and in an increased DSe in class C for 
all 4 tests, especially for ABAs (Fig. 4.8D). 
'
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4.4.1 Validity of the model 
 
 Addition of a third class and covariance terms increased the number of parameters 
to estimate in the model and may have compromised the identifiability of the final model. 
Adapting from Jones et al. (2010), the number of unknown parameters for a conditionally 
saturated 3 class model with 5 tests and 4 populations would be 101 (C(2P21)+ K(C21)). 
With a maximum number of covariance parameters (i.e. saturarted), the degrees of 
freedom (df = 124) in the dataset would be still larger and, therefore, the final model was 
assumed identifiable. This general rule (degrees of freedom greater that number of 
parameters) may not, however, be adequate to ensure model identifiability (Goodman, 
1974; Jones et al., 2010), and Jacobian ranking of the model would be a more appropriate 
approach to assess identifiability (Goodman, 1974; Jones et al., 2010). Eventually, only 2 
covariance parameters were kept to maintain a comfortable margin and assume 
identifiability (25 model parameters total). Removing one of the five tests (60 degrees of 
freedom for 21 to 22 parameters) did not impact the model estimations (Table 4.5). 
However, with only 3 tests in the model, the difference between degrees of freedom (df = 
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28) and numbers of parameters (17) decreased and the models may have identifiability 
issues.  
 By adding a third class, the model and the data fitness were radically improved 
compared to the conventional 2LCM, regardless of conditional dependence (Table 4.4). 
DSe estimates in the 2LCM were approximate averages of the estimates of DSe based on 
the two infection classes in the 3LCM. This difference in DSe between classes B and C 
supported the suspicion that the probability to test positive varied among ISAV infected 
salmon. The mixture distributions of infection classes changed across populations, 
suggesting a variation of the overall DSe (weighted average of class2specific DSe). 
Therefore, the initial assumption of a single constant DSe was unreasonable. The 
assumption of DSe within each infected sub2class seemed more appropriate.  
  The addition of a third class and covariance terms in the model intended to 
account for conditional dependence between the two NAATs and the two ABAs. Only 
covariance terms in the class C were significant confirming initial expectations of test 
dependence according to the agreement tree (Fig. 4.4) and the similarity of techniques 
used to detect the same analytical target (Gardner et al., 2000). The bimodal distribution 
of RT2PCR DSe, and to a lesser degree of qRT2PCR DSe, in class C were explained by 
the difficulty of the model to identify the dependence between NAATs (Fig. 4.5B). The 
distribution of the covariance estimates also demonstrated bimodality (data not shown). 
To a much lesser extent, similar features could be visualized from the DSe distributions 
of the two dependent ABAs. Overall, the model required further adjustments for 
conditional dependence, albeit Rindskopf & Rindskopf (1986) assumed that the multiple 
classes LCM would fully account for conditional dependence. The use of random effects 
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LCM with multiple classes has also been suggested to adjust for conditional dependence 
(Dendukuri et al., 2009). Conditional dependence could be avoided by breaking each pair 
of dependent tests. Unfortunately, analyses of 32test models were unstable and 
inconclusive (Table 4.5). With results from only one NAAT and one ABA, the data 
seemed not to support the existence of a third testing pattern resulting in decreased 
NAAT DSp (Table 4.5). When removing only one test at a time (42test models), none of 
the tests seemed to have a particular impact on the identification of the third class, despite 
the absence of VI, resulting in some variation of tests’ DSe in class C (Table 4.5). The 
influence of VI classification was further confirmed with the instability of estimates for 
qRT2PCR cutpoint between 25 and 30 cycles when data were weaker (Fig. 4.8). 
Ultimately, use of multiple latent classes in LCM required data that supported clear and 
distinct supplementary testing pattern. 
 In summary, the addition of a third class addressed concerns regarding 
assumptions of Hui & Walter for LCM and resulted in good data fit. However, other 
models might fit the data as well (i.e. similar Bayesian P2value). As an addendum to 
statistical consideration, biological considerations should be used to select and interpret 
suitable models (Dendukuri et al., 2009). 
 
4.4.2 Interpretation of the third class 
 
 In LCM, even with 2 classes, the identification of the classes is subjective 
(Dendukuri et al., 2009). Labelling of latent classes relies on sound biological judgment 
and often uses estimated prevalences to compare the original clinical information within 
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the sampled populations. In this instance, class A predominated in Pop I and II (near2zero 
and low prevalences) and was therefore identified as having non2infected salmon. Only 
present in Pop IV (cages encountering an outbreak with high prevalence), class C was 
identified as having infected fish. The class B fish were present at low frequency (~12%) 
in outbreak cages and at high frequency (~86%) after the outbreak. In addition, class B 
fish were exclusively detected by NAATs, although not as successfully as class C. Class 
B was the only class of fish in Pop III and salmon that tested positive to qRT2PCR in this 
population obtained high range of Ct values (i.e. 332 42, Fig. 2) corresponding to low 
load of target. Class B fish remained present after clinical outbreaks and positive for the 
targeted portion of the 8th RNA segment of the ISAV genome. If the diagnostic objective 
of the test was detection of disease, the clinical evidence supported class B fish being 
non2diseased. The diagnostic target is, however, infection with any genotype of ISAV, 
and two opposing biological interpretations are possible for class B individuals (i.e. 
infected or non2infected).  
 One interpretation of the results suggests that class B fish are non2infected salmon 
that recovered from an infection and carry residual viral RNA fragments (inactive viral 
particles). In 2LCM, tests are assumed to measure the same underlying latent trait 
(analytical target) that reflects the true latent infection/disease status (diagnostic target) 
(Hui & Walter, 1980) (Fig. 4.9A). The presence of more than 2 classes was interpreted as 
the violation of this assumption with tests that measure different latent variables 
(Dendukuri at al., 2009). A strong divergence between two analytical targets (low 
biological correlation) can result in the differentiation of 3 latent classes. The 3 latent 
classes consist of i) both analytical targets, ii) none of the analytical targets, and iii) either  
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analytical target (i.e. no fourth reciprocal combination). In this study, ABAs had a 
different analytical target than VI. However, they seemed to be in good agreement 
compared to the NAATs (Fig. 4.4). Therefore, the 3 assays were assumed to measure a 
similar latent variable that differed from the one measured by the 2 NAATs. Three 
classes of samples were indeed observed: salmon that test negative on all tests (no target), 
salmon that test positive on most or all tests (both targets), and salmon that only test 
positive on NAATs (only viral RNA target). Tests can measure variables that correspond 
to the true latent infection status or not. In their study of diagnostic tests for Chlamydia 
trachomatis, Dendukuri et al. (2009) interpreted the non2NAAT assays as measuring a 
latent variable that matched the true disease status (Fig. 4.9B). Considering that NAATs 
can detect “infections that are no longer active”, the authors assumed that NAATs 
measured a DNA latent variable that was only a proxy of the true disease status. 
Therefore, their multiple latent class variable models identified a third class of non2
diseased individuals with bacterial DNA. Conversely, in the present study the diagnostic 
target was infection and not disease. Thus, the first interpretation of class B as non2
infected fish assumes that, similar to Dendukuri et al. (2009), the non2NAATs measured 
the true infection status. This interpretation is supported by the fact that VI is traditionally 
believed to only detect replicating viral particles and NAATs cannot differentiate 
between an active and an inactive virus (OIE, 2009b). Devold et al. (2000) could detect 
ISAV by RT2PCR only in experimentally infected trout up to 135 days post2challenge 
and explained this observation by the neutralisation (inactivation) of the virus in 
surviving fish without damaging the integrity of the viral particle. If class B fish are 
confirmed as non2infected salmon, the probability to test negative (DSp) becomes the 
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parameter of interest that can be directly computed as the complement of the probability 
to test positive (12 DSe). Probabilities to test negative in class B were therefore presented 
in Table 4.3. However, it seemed surprising that the viral particle and associated RNA 
persist in the organism without being degraded by the host immune system. 
 The second interpretation considered that class B fish are infected salmon with 
low numbers of active viral particles and were either a recently infected fish (early stage) 
or a chronic carrier (recovering from the infection). Contrary to Dendukuri et al. (2009), 
this interpretation assumes that the true latent infection status is measured by the NAATs 
(Fig. 4.9C). This interpretation is supported by the fact that low numbers of active virus 
could only be detected by assays with high analytical sensitivity (ASe), and that the 
intended diagnostic target included avirulent genotype of ISAV (HPR0) that cannot be 
detected by VI (Kibenge et al., 2004). First, higher analytical sensitivity and earlier 
detection of ISAV infection by NAATs compared to ABAs and VI is widely documented 
and accepted (e.g. Snow et al., 2003; Giray et al., 2005). The limit of detection of qRT2
PCR was shown to be 100 times lower than conventional one2tube RT2PCR (Munir & 
Kibenge, 2004). In addition, qRT2PCR has been shown to detect virus that replicate (i.e. 
active particles) without production of CPE in cell cultures (Kibenge et al., 2004). 
 Therefore, NAATs seemed to be more sensitive to detect early infected fish that 
carry a low number of active particles. Furthermore, experimental challenge revealed that 
the level of infection decreased at 15 days post2infection due to of the host immune 
response (Mikalsen et al., 2001). Although ISA is often acute, chronic forms of the 
infection have been proposed based on antibody profiles (Kibenge et al., 2002). Fish that 
recovered from infection can still transmit ISAV by cohabitation with healthy fish despite 
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testing negative to VI (Kibenge et al., 2004). Therefore, NAATs may detect low level 
carrier stages after clinical outbreaks that were not detected by other tests. In these fish, 
however, the concentration of viral particles may be close to the limit of detection of the 
NAATs, resulting in detection inconsistencies (lower DSe) (McAllister et al., 2003) and 
decreased agreement between the 2 assays. Furthermore, the analytical specificity (ASp) 
differed amongst tests: the avirulent genotype HPR0 was detected by RT2PCR but not by 
VI (Kibenge et al., 2004). In our study, class B salmon may have been HPR0 infected 
fish since this isolate is present in the region, albeit this was not confirmed or verified in 
this study. Although there is no evidence that ABAs are not able to detect HPR0, low 
level of replication of this virus type may explain the rare detection by these assays 
(Gustafson et al., 2008). However, the outbreak cages where most class B fish were 
sampled were originally diagnosed with virulent types (HPR4 and HPR2). Also, the large 
proportion of class B fish in Pop III (~ 86%) did not suit previous descriptions of HPR0 
infection in the region (i.e. low proportion of fish infected) (Dr. Mike Beattie, pers. 
com.). In general, diagnostic tests dichotomize the measurement of an underlying 
biological trait either using a cutpoint or simply due to their limit of detection (Brenner & 
Gefeller, 1997). As a result, this second interpretation suggested that NAATs measured 
the true latent infection status and the non2NAATS, limited by their ASe and ASp, 
dichotomized the infected class into 2 sub2classes of low and high infected salmon (Fig. 
4.9C). 
 The lack of detailed information on ISAV infection dynamics and a weak 
understanding of the correlation between the analytical target and the intended diagnostic 
target compromised the interpretation of this supplementary class. For instance, 
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transmission studies under controlled conditions would determine the infectiveness of 
fish that are only detected by NAATs at different stages of the infection (i.e. pre2 and 
post2clinical manifestation). Class B fish could also be a mix of low2infected and 
convalescent fish. In addition, at least a portion of the samples that tested positive in Pop 
III (class B fish) should be sequenced to determine if some were HPR0 infected. Overall, 
the intended purpose and associated diagnostic target of a test should be clearly defined 
before evaluation, and a good understanding of its correlation with the analytical target is 
critical for the subsequent interpretation of multiple classes.  
 
4.4.3 Past evaluations and interpretation 
 
 A direct comparison of test estimates of this study with previous ISAV test 
evaluations would be inappropriate since some tests did not use identical protocol (e.g. 
RT2PCR or VI) and DSe and DSp are considered population2dependent (Greiner & 
Gardner, 2000). Furthermore, even if DSp estimates maybe be compared, DSe were split 
between class B and C in this study and no longer correspond to the definition. For 
instance, IFAT was the only standard assay used by all previous studies (McClure et al., 
2005; Nérette et al., 2005; Gustafson et al., 2008; Nérette et al., 2008a). Although DSp 
estimates were fairly similar, DSe differed substantively, except when the estimation 
accounted for dependence (Nérette et al., 2008a). This last comparison may be of little 
value since Nérette et al. (2008a) did not differentiate three classes of fish. However, the 
2LCM analysis conducted by Nérette et al. (2008a) considered non2infected samples that 
only tested positive to RT2PCR and estimated then a lower DSp for this assay. Therefore, 
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the estimated DSe corresponded to samples that test positive to several assays and is 
comparable to the DSe in class C. Comparisons of other tests would be futile given the 
discrepancies in test protocols and the complexity of the interpretation.  
 In this evaluation, the intended purpose was to use ISAV detection tests in 
surveillance programs to demonstrate population freedom from infection (i.e. cage, site, 
bay, region, country). In this instance, the tested population is assumed free and, if 
detected, the infection is assumed to exist at an early stage of the infection. For domestic 
surveillance, the parameter of interest is the positive predictive value of a positive test 
result (PPV). When the geographical region is not free of disease, the surveillance 
objectives change focusing on early detection of the infection to implement control 
measures (e.g. depopulation). In this instance, the parameter of interest is negative 
predictive value of a negative test result (NPV). Predictive values depend on the test 
operating characteristics (DSe/DSp) and the assumed prevalence in the sampled 
population (Dohoo et al., 2009). However, the applications of DSe and DSp traditionally 
involved two classes of animals, and an adjustment from the conventional approach 
would be required to apply three classes of information. A good understanding of the 
infection dynamics within the populations is then necessary to appreciate the proportion 
of the 3 classes of fish at different stages of a disease event and predict predictive values. 
In addition, the interpretation of test results relies on the context of its utilisation.  
 In Atlantic Canada, the control measures require that any cage declared infected 
should be culled within 7 days (DAA, 2007). Therefore, if class B fish are confirmed to 
be recovering fish, the probability of sampling these fish in this region is almost nil. If 
class B fish are, however, confirmed as low2infected fish, the proportion of low2 and 
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high2infected fish at the initial stage of the infection are critical for diagnostic test 
selection in this region. By comparison, in Norway, when a cage is declared infected, 
then the whole farm would be depopulated but within a flexible period of 80 days 
(Norwegian Food Safety Authority, 2007). Therefore, it appears critical that detailed 
descriptions of the ISAV infection dynamics and associated clinical information be 
investigated at the fish and population level to enhance the interpretation and application 
of multiple class models. Nonetheless, the computation of predictive values assumes that 
sampling of fish is representative of the targeted population (i.e. random sample). In 
practice, however, dead or moribund salmon are conveniently/purposefully targeted 
(DAA, 2007). As a consequence, the proportions of diseased fish (prevalence) may differ 
from the population of live fish.   
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 This study supports the use of multiple classes in LCM of diagnostic tests for 
ISAV in salmon when the assumption of constant DSe (or DSp) is inappropriate and 
when data clearly show distinct testing patterns. More than two classes should also be 
considered when tests target very different biological analytes and when the analytical 
target is weakly associated with the intended diagnostic target. Clearly defined diagnostic 
purposes and biological understanding are essential to subsequently identify the different 
classes needed for the LCM. Even with additional classes, the assumption of conditional 
independence should be verified and, if necessary, adjusted. Identifiability might restrict 
the use of multiple classes for models when a limited number of tests and populations are 
248 
 
available. Addition of informative priors can provide an alternative, but should be used 
with caution. With multiple classes, the evaluation and interpretation of diagnostic tests, 
not only for ISAV in salmon but for other pathogens and in other species, is evolving and 
requires further understanding of the infection/disease dynamics at the animal and 
population levels for relevant applications to surveillance situations. 
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Diagnostic laboratories frequently select an arbitrary cutpoint value for real7time 
amplification assays above which an obtained cycle threshold (Ct) value is deemed false. 
High Ct values are interpreted as amplification or fluorescence artifacts, or cross7
contaminations. However, the Ct cutpoint should be chosen with rational justification. 
This study reviewed analytical criteria to select cutpoints during the development of the 
assay, including fluorescence threshold, reaction end cycle, limit of detection, artifact 
investigation. The degree of variation of amplification efficacy within and between 
laboratories may result in cutpoint changes across runs requiring standardization 
procedures for the Ct cutpoints. Selection strategies were further reviewed based on 
epidemiological parameters considering the probability or the cost of a false test result 
based on a specified cutpoint. Depending on the intended purpose of the test, cutpoints 
can be selected graphically to maximize the probability of either true positive or true 
negative using the Two7Graph Receiver Operating Characteristics (TG7ROC). Diagnostic 
sensitivity and specificity may vary with the tested population, therefore, the estimated 
TG7ROC curve is population7dependent and should be validated for a specified purpose. 
Although the selection of a cutpoint based on misclassification cost depends on infection 
prevalence, the selection based on predictive values does not. 
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 In the past decade, polymerase chain reaction (PCR) tests have become a standard 
method for the detection of a wide range of pathogens and biomarkers in routine 
veterinary diagnostic testing. Lately, laboratories are progressively shifting from 
conventional PCR to a method referred to as kinetic, quantitative or real7time PCR 
(qPCR), which allows for quantification based on monitoring of the progression of the 
amplification during the cyclic reaction.  Compared to the standard PCR, this method 
provides substantial benefits to laboratorians, including: (i) reduced time of analysis, (ii) 
increased analytical sensitivity (ASe), (iii) increased reproducibility, and (iv) decreased 
cross7contamination (Mackay et al., 2002). Although the cost of equipment and reagents 
restricted the utilization of this method in the past (Mackay et al., 2002), qPCR is now 
more affordable making it a key technology used by many diagnostic laboratories today.  
 
 !"#$%&'(" )*&+)(" 
The resulting outcome of the qPCR is continuous, while that provided by 
conventional PCR is binary (i.e. absence or presence of an expected gel band). Referred 
to as the cycle threshold (Ct) or crossing point (CP) value, the qPCR outcome reflects the 
cycle value at which the fluorescence signal exceeds a defined background threshold 
(Fig. 5.1). Real7time PCR results differ from continuous outcomes of other diagnostic 
assays (e.g. ELISA) in that negative specimens do not yield Ct values since the 
fluorescent signal stays below the specified threshold. The distributions of Ct values are 
generally non7normal, heteroscedastic and truncated (Burns & Valdivia, 2008). A more 
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&%"J6$FH%' "H#JFIF>"$FCB@ The amplification curve experiences four different phases: 
linear ground (A); early exponential (B); log7linear (C); and plateau (D). A fluorescence 
threshold is set where the amplification curve is beginning the log7linear phase. The 
threshold level is determined using either complex algorithms or arbitrarily. The 
intersection between the threshold and the curve is the cycle threshold (Ct) value. 
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 appropriate description of the qPCR outcome would, therefore, be ,"('%+)-&'-*)*.. In 
addition, the quantitative Ct value is inversely proportional to the (log) concentration of 
nucleic acids detected (i.e. high Ct value reflects a low target concentration and /'+" 
/"0.#).  
Traditionally, regardless of the value intensity, when any Ct value is produced, 
the specimen tested is deemed to be positive. Recently, however, there is an increasing 
tendency among laboratory operators to consider as negative (i.e. false positive) any Ct 
values above a subjective cutpoint value. It is assumed that the high Ct value is generated 
by either the degradation of the probe7based fluorophore, cross7contamination, or non7
specific amplification of background nucleic acids (Burns & Valdivia, 2008). A sample 
with a Ct value greater than the cutpoint might, therefore, would be classified and 
reported to the end user as a negative result with no way to distinguish it from results that 
did not produce a Ct value.  
The objective of this work was to review published justifications based on 
biologically sound rationale for choosing cutpoint values in real7time PCR. Approaches 
for the selection of Ct cutpoint can be considered at the bench level (analytical approach) 
and at the population level (epidemiological approach) (Fig. 5.2). The application of the 
epidemiological principles was illustrated with the example of a quantitative reverse7
transcriptase PCR (qRT7PCR) used to detect the presence of infectious salmon anaemia 
virus (ISAV) in farmed Atlantic salmon in Canada.
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DSp: diagnostic specificity; DSe: diagnostic sensitivity; J: Youden index (DSe + DSp 71); DOR: 
diagnostic odds ratio; LR+: likelihood ratio of a positive test; LR7: likelihood ratio of a negative test. 
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Analytical criteria refer to technical parameters of the assay evaluated during the 
bench development, optimization and standardization of the method. 
'
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 The first consideration in the development of a qPCR protocol is the selection of a 
threshold level for the fluorescence signal. This limit is either selected by applying 
complex algorithms (Rebrinov & Trofimov, 2006) or visually by the operator. The 
approach to select the threshold is often directed by the equipment and/or the software 
associated with the thermocyclor. A simple approach is to set the threshold at several 
standard deviations above the baseline mean (Wong & Medrano, 2005) (Fig. 5.1), as it is 
done with other continuous assays (e.g. ELISA) (Ambruster et al., 1994). However, the 
intention in qPCR is, however, to ensure that the log7linear phase of the amplification is 
reached (Ruttledge, 2004) (Fig. 5.1), and not that a targeted proportion of the non7
infected/disease population is selected (Sunderman, 1975). Although the fluorescence 
signal threshold inherently influences the position of a Ct value, the operator primarily 
focuses on the discrimination among the Ct values themselves. 
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 Technically, qPCR already uses a cutpoint for Ct values by maximizing the 
number of amplification cycles. Hypothetical increases of the fluorescence signal above 
the threshold after the last reaction cycle are not detected and considered negative. In 
general, the number of run cycles is set on the assumption that if a single copy of the 
target is present in the tested specimen, amplicons should be generated in sufficient 
quantity to be detected before the last cycle. Usually, qPCR protocols are set up to 40 
cycles which yields, in theory, a trillion amplicons from a single target molecule (Table 
5.1), assuming that the number of copies doubles at each reaction (i.e. amplification 
efficacy (E) = 1). Amplification efficacy is, however, rarely equal to unity and the 
amplification may decrease as the reaction progresses due to the decline of reaction 
reagents (Mehra & Hu, 2005). Therefore, the numbers of generated amplicons can differ 
greatly (Table 5.1). Even if the qPCR is already limited by the number of run cycles, the 
operator may still select a Ct cutpoint before the last cycle. One technical justification to 
select a Ct cutpoint earlier during the reaction is to consider a sample negative when it is 
below the corresponding reliable limit of detection of the assay. 
'
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During the development of an assay, the linear operating range of the method 
must be determined, including the estimation of the lower and upper limits of detection 
(OIE, 2009). Referred to as analytical sensitivity (ASe), the lower limit of detection is  
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the formula: D- E DF <4GH>- (adapted from Rebrikov & Trofimov, 2006). DF refers to the 
initial number of target copies at cycle 0 (single copy here). 
 
$%&'()*+,*-.-/(0*  !*1#*R'AP'  !*1#*R'@SP'
10 1,024 613 
20 1,048,576 375,899 
30 1,073,741,824 230,466,617 
40 1,099,511,627,776 141,300,610,453 
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defined as the ability of the test to detect a minimum concentration of analyte with a 
known certainty (OIE, 2009). According to the OIE (2009), the ASe is determined as the 
end7point dilution at which 50% of the tested samples are positive. For PCR, the limit of 
“"I#+&$= 1FJ” positive test results is a recent modification from the previous 
international requirement of “#& $"#.& K1J” (Burns & Valdivia, 2008). Like most binary 
outcome diagnostic tests, qPCR is based on the dichotomization of individuals according 
to a measured continuous underlying trait (i.e. target concentration) (Brenner & Gefeller, 
1997). An analytical cutpoint could therefore be justified by selecting a Ct value 
corresponding to the lower limit of detection.  Any Ct value above this defined limit (i.e. 
lower amount of target) would not be considered reliable.  
Burns & Valdivia (2008) suggested two approaches to estimate the ASe. The first, 
referred to as “Experimental” ASe (ASeexp), determines the last investigated serial 
dilution where at least 95% of the samples tested positive (Burns & Valdivia, 2008). This 
approach is less precise since the exact concentration associated with 95% detection is 
not estimated; however, the design and the estimation are more forgiving and 
straightforward.  In Burns & Valdivia (2008), the number of replicates per concentration 
did not influence significantly the estimation of ASeexp. For the sake of simplicity, we 
suggest adapting the ASeexp estimation approach under the current OIE requirements of 
50% of positive test results associated to a certain degree of risk (type I error, α). This 
approach would lower the necessary number of samples tested for each dilution. For 
instance, the sample size calculation can be based on the computation to demonstrate 
freedom of disease (Dohoo et al., 2009). To demonstrate, at a specified concentration, 
that the assay detects at least 50% of samples (i.e. proportion of negative test results 
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lower than 50%) with a risk level set at α = 5% (95% confidence), a minimum of 5 
replicates per dilution would be necessary. The ASeexp will then be estimated as the last 
serial concentration that yields positives on all 5 replicates. For 99% level of confidence, 
7 replicates would be necessary. Furthermore, it would be of value to specify the dilution 
factor used in the serial dilution. The lower the dilution factor, the more refined is the 
estimation (i.e. smaller gap between serial dilutions).To fit the log scale, dilution factors 
of 10 are frequently used albeit Burns & Valdivia (2008) used a factor of 2 to increase the 
precision of estimation. 
 The second approach, referred to as “Theoretical” ASe (ASetheo), is estimated 
using computer7based regression modelling where the exact theoretical dilution of the 
95% positives is estimated (Burns & Valdivia, 2008). Although more complex and 
exacting, this method is more sensitive to the number of replicates per concentration. In 
addition, caution should be taken when using this approach since the regression 
computation requires certain assumptions that may not be reasonable with the atypical 
nature of Ct values (e.g. heteroscedasticity).  
Once the ASe has been estimated, the Ct cutpoint is selected as the Ct value 
corresponding to the estimated ASe. However, the efficacy of amplification can differ 
greatly across reactions. Further standardization can be achieved by either estimating the 
Ct value corresponding to the ASe using a standard curve (absolute quantification 
approach), or by normalization of the Ct cutpoint using the Ct value of a reference gene 
co7amplified in multiplex or parallel (relative quantification approach).  
 In conclusion, the selection of a Ct cutpoint can be based on the linear operating 
range of the assay. Specimens with pathogen concentrations lower than the ASe are, 
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however, considered negative when they can still be detected (i.e. with a probability 
lower than 50%). An alternative approach is to develop verification techniques to 
investigate cross7contaminations and potential amplification artifacts.  
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 Amplicon artifacts are spurious products or primer dimers that are usually 
observed toward the end of the reaction. According to the fluorophore chemistry 
employed, further procedures are routinely used to discriminate fluorescence signal 
artifacts. For instance, in SYBR green7based assays, investigation methods include 
melting curve, gel electrophoresis and sequencing. Comparatively, probe7based assays 
(e.g. Taqman), which are based on the detection of a specific sequence within the 
amplicon, limit potential non7specific fluorescence signal. 
 Alternatively, cross7contamination from positive controls to test samples is the 
other common type of false positive result. In this situation, the intended strategy is to use 
positive controls associated with an original marker that allows tracking of potential 
contamination afterward. Although the concept stays the same, a wide range of marking 
strategies and marker detection techniques exist. For instance, the design of a plasmid7
based positive control containing a unique target site for a probe is one such approach 
(Snow et al., 2009). The positive control is detected by the first probe specific to the 
target, and also by a second probe (different fluorophore) targeting a unique sequence. 
Both probes are added to test samples, and positive results are detected by the first probe. 
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The accidental introduction of the positive control plasmid to the sample will induce the 
second probe to also produce a signal. 
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 Factors that influence diagnostic misclassification of a test include parameters at 
the bench level and errors made in the “field” during sample collection and storage, 
which can greatly influence the interpretation and reporting of test results (OIE, 2009). 
An epidemiological approach that accounts for all these factors provides a pragmatic 
evaluation of a detection method and assists authorities in the decision7making process. 
Epidemiology7based justifications for the selection of a Ct cutpoint are twofold: i) to 
minimize the probability of misclassification; and ii) to minimize the cost associated with 
misclassification. The parameters of interest that quantify the epidemiological operating 
performances of an assay, and the justifications for Ct selection, will be defined, and the 
graphical tool used to monitor them will be described. 
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 The accuracy of a diagnostic test is traditionally reported separately within 
infected/diseased (D+) and non7infected/non7diseased (D7) individuals. Diagnostic 
sensitivity (DSe) refers to the probability of a specimen testing positive given that the 
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sampled individual is D+, and diagnostic specificity (DSp) refers to the probability of a 
specimen testing negative given that the sampled individual is D7 (Yerushalmy, 1947). 
 Overall assay performances can also be expressed using single parameters. The 
Youden index (J) expresses the average of “successes” of the test (difference between 
proportions of correctly classified and incorrectly classified) within the D+ group and 
within the D7 group (Youden, 1950), and was suggested as a potential criterion to select 
cutpoints (Greiner et al., 1995). The estimation of J can be directly computed from DSe 
and DSp as follows: 
 
5 E OP" G OP8 Q 4         <4>**
 
The test discrimination is deemed positive (i.e. test useful) when J is above 0.  
 The test efficiency (Ef) (proportion of correctly classified samples) is another 
single parameter expressing accuracy. Computed as Ef = Pr * DSe + (17Pr) * DSp 
(Greiner et al. 2005), this parameter is, however, of less value since it depends on Pr, the 
prevalence of D+ (Alberg et al., 2004). 
The DSe and Dsp are estimated during test evaluation studies that imply that the 
health status of tested specimens is known with certainty. In practice, the status is 
unknown and the test result is the only information available. As a result, a test user seeks 
the probability of D+ given a particular test result. This corresponds to estimating the 
positive predictive value of a positive test result (PPV), which refers to the probability 
that an individual is D+ given that its specimen tested positive. Alternatively, the 
negative predictive value (NPV) corresponds to the probability that an individual is D7 
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given that its specimen tested negative (Vecchio, 1966). Predictive values depend on 
DSe, DSp, and on Pr in the tested population, as shown in the following formulae: 
 
RRS E TOP" U R0V W TOP" U R G <4 Q OP8> U <4 Q R0>V    <3> 
XRS E TOP8 U <4 Q R0>V W T<4 Q O."> U R0 G OP8 U <4 Q R0>V   <B> 
 
Diagnostic accuracy can also be expressed as likelihood ratios (LR). In the 
situation of a binary test result (i.e. a cutpoint specific LR), the likelihood ratio for a 
positive test result (LR+) reflects how much more likely D+ individuals are to test 
positive compared to D7 individuals. The likelihood ratio for a negative test result (LR7) 
reflects how much less likely D+ individuals are to test negative compared to D7 
individuals (Dohoo et al., 2009). Likelihood ratios can be defined for specific cutpoints 
associated with a different set of DSe/DSp and are estimated using the following 
formulae: 
 
A!G E OP"  W <4 % OP8>        <L> 
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 The last parameter of interest is diagnostic odds ratio (DOR) and it is another 
single measure of diagnostic accuracy that reflects the ratio of the odds of 
infection/disease in positive test results over the odds of infection/disease in negative test 
results (Glas et al., 2003). DOR is therefore estimated using either LR+/LR7, DSe/DSp, 
or PPV/NPV: 
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As the DOR increases above 1, the test becomes more useful. If DOR is between 0 and 1, 
tested individuals have a greater chance of being misclassified than correctly classified 
(negative discrimination). 
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 Derived from the receiver operating characteristic (ROC) analysis, the two7graph 
receiving operating characteristic (TG7ROC) plot was first developed by Greiner et al. 
(1995) to graph the variation of DSe and DSp of a continuous outcome assay across a 
range of cutpoints. Assuming that the cutpoint value is an independent variable, TG7ROC 
identifies intermediate test performances and facilitates the graphical selection of cutpoint 
values. For conventional continuous outcome assays that directly quantify a target, the 
curve for DSe monotonically decreases toward 0% with an increase of the cutpoint, while 
the DSp curve increases toward 100%. Conversely, Ct values are inversely proportional 
to the (log) concentration of the target. Hence, DSe increases toward 100% with 
increasing Ct values while DSp decreases (Fig. 5.3). Except for technical limitations, all 
specimens tested with conventional methods yield a measurement and therefore both DSe 
and DSp can reach extreme values (i.e. 0% or 100%). For qPCR, DSp is expected to 
never reach 0% at the endpoint Ct value since most of D7 individuals would not yield a  
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Best DSp (line A); best DSe (line B); best combination of DSp/DSe (line C); 
best J (line D). DSp: diagnostic specificity; DSe: diagnostic sensitivity; J: 
Youden index (DSe + DSp 71).  
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Ct value. Similarly, DSe is not expected to reach 100% since false negatives, when they 
exist, do not yield a Ct value (Fig. 5.3).  
When the true status of the sample is known (i.e. a gold standard available), 
automated non7parametric or parametric (assuming a specified distribution), 
computations to generate TG7ROC curves exist in varying statistical packages. For 
instance, the Stata statistical package (Stata Corp., College Station, TX, USA, 2007) 
offers a  !"#$ command (Reichenheim, 2002). In the situation where the health status is 
unknown, Branscum et al. (2008) developed Bayesian estimations of semiparametric 
standard ROC curves that enable construction of the TG7ROC. 
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 According to the World Organisation for Animal Health (OIE) requirements, to 
be validated for international trade, an assay must be evaluated to demonstrate its fitness 
for a specific purpose (OIE, 2009). The purpose of the test is to be defined first, then DSe 
and DSp are evaluated to assess if the test operating characteristics suit that intended use. 
The OIE lists six different purposes for using a test (OIE, 2009): 
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A test will be validated and certified according to how well it performed for a 
specific purpose. For purposes (i), (ii) and (iii), the test validation will prioritize DSp 
(therefore PPV) over DSe. The Ct cutpoint is set such that DSp is maximized and DSe is 
optimized (Fig. 5.3, line A). For purpose (iv), the test validation will prioritize DSe 
(therefore NPV) over DSp. The Ct cutpoint is set such that DSe is maximized and DSp is 
optimized (Fig. 5.3, line B). Generally, for purpose (v), if the agent has zoonotic 
consequences for human safety, DSe (therefore NPV) will be prioritized over DSp, 
whereas, if the agent has mainly economic consequences, DSp (therefore PPV) will be 
prioritized over DSe. Finally, for purpose (vi), minimization of overall misclassification 
is the priority, regardless of the infection/disease status. This situation occurs when the 
test user intends to optimize the estimation of prevalence of infection/disease in a 
population. In this instance, the nature of misclassification (false positive or false 
negative) does not have an impact on the final purpose of the test as the estimated 
apparent prevalence will be corrected to obtain the true prevalence.  
The most intuitive way to select a Ct cutpoint to minimize misclassification is to 
identify the Ct cutpoint that yields the best combination of DSe and DSp. That is, the Ct 
value for which DSe and DSp are equal or for which the square of the difference between 
the two parameters is minimized (Reichenheim, 2002). Practically, this cutpoint 
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corresponds to the Ct value where DSe and DSp curves intersect (Fig. 5.3, line C). This 
approach is used when no clear purpose of the test is predefined and operators desire a 
balanced performance for misclassification of both positives and negatives. This 
approach does not, however, minimize overall proportion of misclassification given the 
health status. The alternative approach is to select the cutpoint where J is maximized (Fig. 
5.4, line A). Maximizing Youden's Index minimizes the sum of the false positive and 
false negative proportions. This approach may differ from the best pair approach (Fig. 
5.3, line D).  
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 LR+ compares the proportion of correctly classified D+ individuals (true positive 
probability) over the proportion of misclassified D7 individuals (false positive 
probability). The selection of a Ct cutpoint using LR+ can follow two different 
approaches. First, a cutpoint can be set such that the probability to be incorrectly 
classified equals the probability to be correctly classified (i.e. LR+ = 1). As a result, when 
the Ct value is below this cutpoint, the sample is deemed positive and the probability of a 
true positive is higher than the probability of false positive. According to Eq. (4), this is 
translated as DSe = DSp = 0.5 which is rarely a desirable case in practice. Therefore this 
approach is of little value and not recommended. Alternatively, a cutpoint can be set such 
that the probability to be correctly classified, compared to the proportion of incorrectly 
classified, is as large as possible. In this instance, the cutpoint is selected for the 
maximum corresponding LR+ (Fig. 5.4, line B). 
A similar approach is used for LR7, whereby LR7 compares the proportion of  
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Best J (line A); best DOR (line B); best LR+ (line C), best LR7 (line D). J: Youden index 
(DSe + DSp 71). DOR: diagnostic odds ratio; LR+: likelihood ratio of a positive test; LR7: 
likelihood ratio of a negative test. 
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misclassified D+ individuals (false negative probability) over the proportion correctly 
classified of D7 individuals (true negative probability). Then, the preferred cutpoint is 
selected where LR7 is minimal (Fig. 5.4, line C). The DOR combined both LR+ and LR7. 
In this instance, the Ct cutpoint is selected to maximize the chance of a correct 
classification relative to the chance of misclassification when DOR is maximal (Fig. 5.4, 
line D). DOR expresses how much more likely a sample is to be correctly classified than 
misclassified. Due to its symmetry, DOR can be interpreted either for a given test result 
or a given health status. 
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 The following probabilistic approach selects a Ct cutpoint to optimize the 
predictive value that depends on the assumed prevalence of D+ in the population. Similar 
to LRs, two approaches can be used. First, the cutpoint is set such that, above this limit, 
the probability of being truly classified (PPV) is lower than the probability of a false 
positive (complement of PPV, 17PPV). This differs from the LR+ approach since the 
given information is the test result and not the health status. This approach may appear as 
the most relevant since the true status is, in reality, unknown. The cutpoint corresponds to 
the Ct value where PPV = 17PPV, which is equivalent to PPV = 50%. Since, depending 
on the prevalence, the predictive value might never cross the 50% limit (Fig. 5.5), 
cutpoints set where either both PPV and NPV are maximal (Fig. 5.5A and B, 
respectively) is a preferred approach. Based on the tested population, realistic 
prevalences should be hypothesized to optimize the selection of the cutpoint. 
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 DOR also expresses the ratio of the odds of PPV over the odds of NPV (Eq. (6)). 
Therefore, DOR combines both predictive value criteria and is conveniently independent 
of the prevalence. DOR is therefore a practical parameter that combines the optimization 
of all test operating characteristics at once regardless of the intended purpose. 
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 The cost of a misclassification is a relative concept that can refer to either the 
economic value (e.g. treatment cost) or the clinical and psychological consequences of a 
misclassification (e.g. fatal disease, treatment safety). Adapted from Vizard et al. (1990), 
a parameter “r” is used to relate the cost of misclassification in D+ (false negative cost) 
compared to D7 (false positive cost) (r = false negative cost/ false positive cost). 
Depending on the context, misclassification costs are usually different (r ≠ 1), although 
they can be equal (r =1). 
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  In the misclassification cost approach, the Ct cutpoint will be selected such that 
the overall cost is minimized. The proportional cost of misclassification can be computed 
and monitored across Ct values using a formula derived from Anderson (1958): 
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For instance, proportional costs were generated for a fixed prevalence (P = 10%) and 
using different values of r (Fig. 5.6). When r = 2 (cost of false negative is 2 time higher 
than the cost of a false positive), the curve clearly showed a minimum (Fig. 5.6, line A).  
When r < 1(cost of a false negative is inferior to the cost of a false positive), the curve 
only showed a minimum at Ct value = 0 when r = 0.5 (Fig. 5.6). For any given 
prevalence, the minimum of the proportional cost curve (cutpoint) moves towards the 
right (more sensitive test) as r increases (i.e. misdiagnosed D+ are becoming more 
costly). 
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 According to Eq. (7), for r =1, the proportional cost equals P*(17DSe) + (17P)*(17
DSp). In this particular situation, the cost is the same for a false positive and a false 
negative. The monitored parameter now reflects the inefficiency (Inef) of the assay in 
contrast to the efficiency (Ef). The cutpoint is then set such that the Inef is minimized (or 
Ef maximized) (Fig. 5.6, line B). 
'
 In summary, the intended purpose of the test is critical in the selection process 
since Ct cutpoint may substantively change the operating characteristic of the test. 
Depending on the justification and the approach, several parameters may have to be 
considered (e.g. prevalence). However, DOR represents a good compromise to optimise 
the average test performance for positive and negative tests. 
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A[¥'#&%U"J%B>%' CI' FBI%>$%DVDF=%"=%D@ The parameter “r” represents the 
ratio of cost of a false negative over cost of a false positive. The Ct 
cutpoint is selected for the minimum proportional cost (lines A & B) in 2 
situations for r. 
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A real7time reverse7transcriptase polymerase chain reaction (qRT7PCR) was 
recently developed and evaluated to detect infectious salmon anaemia virus (ISAV) in 
cultured Atlantic salmon in Canada (Chapter IV). The assay uses a Taqman probe in 
addition to a pair of primers to amplify a 120 base fragment of the 8th RNA segment of 
the viral genome. Analytically, the fluorescence threshold was set by the computer 
software associated to the thermocyclor (MxPro QPCR Software, Stratagen). The 
reaction was run for a maximum of 45 cycles so that even a low copy number of target 
would be amplified and detected.  
The initial purpose of this new test was to demonstrate freedom from infection 
(not disease) in a defined population. A total of 400 salmon were sampled from 4 
different populations, and 112 samples generated Ct values ranging from 17.29 to 41.86 
(Chapter IV). Interestingly, Ct values revealed a bimodal distribution suggesting two sub7
populations of positive fish (Fig. 5.7). An estimation procedure without gold standard 
information (i.e. Latent Class Model) was run involving 4 other ISAV detection assays in 
a Bayesian framework (Chapter IV). The model identified three different classes of fish 
which were hypothesized as non7, low7 and high7infected salmon (NI, LI and HI, 
respectively) (Chapter IV).  The qRT7PCR was associated with two estimates of DSe 
(DSeLI & DSeHI), while DSp was unique (NI). The model was run for each possible qRT7
PCR cutpoint along the range of obtained Ct values. For each CT cutpoint, three  
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estimates (DSeLI, DSeHI, DSp) were obtained and plotted into a TG7ROC (Fig. 5.8). To 
facilitate the interpretation of this example, a combined DSe (DSeC) was generated 
corresponding to weighted7averages of both DSe estimates as a function of the estimated 
proportions of LI and HI at each cutpoint (Fig. 5.8) and was used for all subsequent 
examples. In addition, we smoothed the curves to reduce noise due to statistical 
instability during the estimation process (Fig. 5.8). 
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 The original test purpose was the demonstration of freedom from infection in a 
salmon population. For trade purposes, an animal producer may be required to prove that 
the products are free of a specified pathogen. The initial concern was to minimize false 
positives because of substantial economic consequences when a population is falsely 
declared not free.  
 Three different approaches can be used by the test operator to select a Ct cutpoint. 
To ease the process, a TG7ROC was generated for J, DOR, LR+ and LR7 computed from 
either the exact (Fig. 6.9A) or the smoothed estimates of DSeC and DSp (Fig. 6.9B). 
Smoothing intended to remove the statistical noise, however, it modified the curves 
profile and the subsequent interpretation of the cutpoints when curves are not monotonic. 
Corresponding with the reality of the data, we selected the cutpoints based on exact 
estimates profiles. First, the test operator wants to minimize the probability of false 
positives among infected salmon, which corresponds to the maximum DSp associated  
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>E&U%' %=$FH"$%D' IC&'"' &%"J6$FH%'5-64 5'"=="K' IC&' FBI%>$FCE=' ="JHCB'
"B"%HF"'UF&E='(ISAV) NF$!'=%J%>$FCB'CI'>E$#CFB$='IC&'<%=$'8*#'(line A)'
"BD'<%=$'>CH<FB%D'8*% '(line B)@ Grey curves show original estimations 
that were smoothed in black. DSp: diagnostic specificity; DSeHI: 
diagnostic sensitivity in highly infected fish (HI); DSeLI: diagnostic 
sensitivity in lowly infected fish (LI); DSeC: combined diagnostic 
sensitivity. 
 
 
282 
 
2@  
Y@  
1FG@' ?@S@' *%J%>$FCB' =$&"$%GF%=' $C' =%J%>$' "' >K>J%' $!&%=!CJD' (Ct)' >E$#CFB$'
<"=%D'CB'DFII%&%B$'=FBGJ%'HF=>J"==FIF>"$FCB'#"&"H%$%&='CI'$%=$'">>E&">K@ 
Estimated curves are based on exact estimates of DSe and DSp (A), and 
based on smoothed estimates of DSe and DSp (B). Best LR+ (line A); best 
J, DOR and LR7 (line B). DSp: diagnostic specificity; DSe: diagnostic 
sensitivity; J: Youden index (DSe + DSp 71); DOR: diagnostic odds ratio; 
LR+: likelihood ratio of a positive test; LR7: likelihood ratio of a negative 
test. 
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with an acceptable DSe (subjective assessment) (Ct = 31, Fig. 6.8, line A). Alternatively, 
the test operator desires to maximize the probability of true positives among infected fish 
relative to the probability of false positives among non7infected fish (i.e. maximal LR+) 
(Fig. 6.9, line A). Finally, the operator wants to minimize the probability of false 
positives among positive tests. In this instance, the cutpoint is selected for the maximum 
PPV and, regardless of the prevalence, the maximum PPV is reached at the same cutpoint 
as previously (Ct = 31, Fig. 6.10A). Interestingly, the different approaches selected the 
same cutpoint. The objective of minimizing false positives may also be compatible when 
seeking the confirmation of a clinical or suspect case, the determination of the immune 
status of an individual, or the eradication of infection associated with economic impact 
(see section 5.2.2.2). 
 Nonetheless, the “#:."-+" )6 "/'7"-+" '. -)& "/'7"-+" )6 #:."-+"” and 
disregarding all results between 31 and 45 cycles may minimize false positives 
but ignores many probable true positives. Therefore, a buyer may want to screen 
the products to verify the absence of infection. In this instance, the operator would 
prioritize the minimization of false negatives to avoid the introduction of the 
pathogen. Similarly, these alternative approaches include maximization of DSe to 
minimize the probability of false negatives among infected fish (Fig. 5.8, line A), 
or minimization of LR7 to minimize the probability of false negatives among 
infected fish relative to the probability of true negatives among non7infected fish 
(Fig. 5.9, line B), or maximization NPV to minimize the probability of false 
negatives among negative tests (Fig. 5.10B). Regardless of the approach, identical 
cutpoints are selected (Ct= 42). No Ct values were observed above 42 cycles  
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which provided an end plateau. Believed to be representative of the full range of 
ISAV infection in true salmon population, it seems unlikely that infected salmon 
would yield Ct above this limit and the reaction could therefore be ended earlier at 
42 cycles. Amplification efficiency may, however, vary across runs and a same 
sample could yield different Ct values (estimated repeatability = ±2 cycles), 
making 45 cycles a reasonable endpoint. 
 In addition, to satisfy both trade partners, the test operator may want to optimize 
the overall performance of the assay. The most intuitive approach is to select the best 
combination of DSe and DSp occurring when both curves cross each other. 
Unfortunately, the two curves do not intersect and the best combination is obtained when 
DSe is maximal at Ct = 42 (Fig. 5.8A). Otherwise, the operator may select a cutpoint to 
minimize overall misclassification regardless of the animal health status. First, by 
minimizing the proportion of misclassification, a cutpoint is selected for maximum J (Ct 
= 42, Fig. 5.8B). Alternatively, a cutpoint might be selected for the maximum DOR 
(proportion of correctly classified compared to misclassified samples). The corresponding 
cutpoint is again 42 cycles. 
 The majority of the above mentioned justifications (minimal false negatives or 
overall misclassification) strongly support 42 cycles as the recommended cutpoint. The 
initial objective was, however, to limit or avoid the economic burden associated with 
false positive results and as a result 31 cycles would be a more appropriate choice. 
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 The initial objective of demonstrating freedom from infection in a population 
implies that the cost of a false positive is more important than the cost of a false negative. 
As a consequence, for this approach, the relative cost of misclassification in D+ (false 
negative) compared to D7 (false positive) was set at half (r = 0.5). In addition, the reverse 
scenario (r = 2) and the equal cost (r = 1) options were also investigated. Associated to r, 
DSe and DSp, the proportional cost of misclassification also depends on prevalence (Eq. 
(7)). As the prevalence was expected to be fairly low when demonstrating freedom from 
infection, 3 low prevalences were included in the simulation: 0.17%, 1.7%, 17% (Fig. 
5.11A, B & C, respectively). All curves were monotonic and none demonstrated an 
intermediate minimum. At 0.17% prevalence, regardless of the relative cost (r), the 
lowest proportional cost was obtained for the minimum observed Ct value (i.e. 17 
cycles). This was explained by the fact that at such a low prevalence, most of the positive 
results obtained were highly likely to be false. At 1.7% prevalence, the Inef of the test (r 
= 1) was stable due to a constant probability of a false test result regardless of the Ct 
value. This may be explained by a progressive increase of false positives, and a reciprocal 
decrease of false negatives, as the cutpoint increases. The proportional cost was therefore 
increased when the relative cost of false positives increased (r = 0.5), and proportional 
cost decreased when the relative cost of false negatives increased (r = 2) Fig. 5.11B). At 
17% prevalence, the probability of false negatives increased when the cutpoint increased. 
Therefore, regardless of the relative cost, the proportional cost progressively decreased, 
establishing the largest obtained Ct value as the cutpoint (i.e. Ct =42). At a low 
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prevalence, none of the positive test results can be verified and confirmed in the field, 
regardless of the cutpoint. As a result, the selection of a cutpoint would not really change the 
test performance since the probability of detection is dominated by the very low probability 
to sample an infected fish. 
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Although TG7ROC curve is a convenient visual tool to select a cutpoint for real7time 
PCR, interpreting the profiles should be done cautiously. DSe and DSp are strongly 
influenced by the population7level distribution of biological factors associated with the 
pathophysiology of the disease (e.g. age, gender, infection stage) (Greiner and Gardner, 
2000). In this instance, the profile of DSe curves in the TG7ROC is expected to substantially 
change according to the stage of ISAV infection in a salmon. Since the distribution of 
infection stages (associated with the viral load and therefore Ct values) varies across 
populations, the TG7ROC profile is population7dependent and should be validated for 
specific targeted populations. Similarly, false positive results that yield a certain Ct value 
might be explained, for instance, by cross7contamination (Wilson, 1997). Therefore, the 
profile of the DSp curve might also change dramatically due to increased contamination 
pressure when handling tissues from heavily infected populations. The representativeness of 
specimens used to construct the TG7ROC and the strong dependence of curve profiles on the 
tested population should be of primary consideration when selecting a cutpoint (Greiner & 
Böhning, 1994). The methods used to estimate the TG7ROC curves may be complex and 
require the use of advanced statistical models (Branscum et al., 2008). The use of 
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experimentally challenged animals to evaluate test operating characteristics is not 
recommended since the specimens are not representative of the infection spectrum in field 
populations and parameters are often overestimated (OIE, 2009). 
The selection of a cutpoint for real7time amplification assays relies on interpretation 
of test results (Ct value) that can be justified based on a variety of factors. The purpose of 
the test and the parameters of interest should, however, be clearly stated prior to initiating 
the evaluation to assist the identification of the most appropriate cutpoint. For instance, for 
demonstration of freedom from infection/disease, the primary objective would be to 
minimize the probability or the cost of a false positive. Corresponding DSe (or NPV) can, 
however, be quite low and limit the detection of infected specimens, suggesting that other 
parameters, such as DOR, may be of greater interest. 
Theoretically, it would be rare to observe the DSe and DSp curves intersecting for 
real7time amplification assays. Indeed, as found in the example, DSp (especially with probe7
based fluorophore chemistry) only decreased moderately, and DSe did not reach perfection 
(100%) preventing the intersection. An easy way to predict the presence or absence of 
intersection is to compare the estimates of DSe and DSp when no Ct cutpoint is set. When 
DSe is higher than DSp, an intersection is expected; alternatively, when DSe is lower than 
DSp, no intersection is expected. 
Predictive values (PPV & NPV) depend on prevalence. However, their respective 
maxima rely only on the test DSe and DSp and are fixed regardless of the prevalence. 
Conversely, the proportional cost of misclassification is highly influenced by prevalence, 
such as when DSe is not perfect, the proportion of false negative results increases with 
prevalence. 
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 Several analytical and epidemiological approaches exist to select a cutpoint for real7
time amplification assays. Often, the same Ct cutpoints may be selected, despite the use of 
different approaches and justifications. The epidemiological cutpoints are population7
dependent and their validity is directly associated with the targeted population. Based on our 
example study on ISAV in salmon, even if the use of a cutpoint is reasonable, it is still 
recommended to report the Ct value to the end decision7maker with complementary 
analytical or epidemiological information on the test performance to justify the 
classification of infection/disease status. Finally, real7time amplification efficiency varies 
within and between laboratories, and a set cutpoint might not be constant across runs. 
Therefore, when used, it is recommended to normalize cutpoints with relative or absolute 
quantification approaches. 
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Likelihood ratio of a positive test result (LR+) as function of diagnostic sensitivity (DSe) and specificity 
(DSp). LR+ was computed as DSe / (1*DSp). 
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>>@>' 10.0 10.5 11.1 11.8 12.5 13.3 14.3 15.4 16.7 18.2 20.0 22.2 25.0 28.5 33.3 40.0 50.0 66.6 100 200 999 
>>' 9.9 10.4 11.0 11.6 12.4 13.2 14.1 15.2 16.5 18.0 19.8 22.0 24.8 28.3 33.0 39.6 49.5 66.0 99.0 198 990 
>G' 9.8 10.3 10.9 11.5 12.3 13.1 14.0 15.1 16.3 17.8 19.6 21.8 24.5 28.0 32.7 39.2 49.0 65.3 98.0 196 980 
>F' 9.7 10.2 10.8 11.4 12.1 12.9 13.9 14.9 16.2 17.6 19.4 21.6 24.3 27.7 32.3 38.8 48.5 64.7 97.0 194 970 
>E' 9.6 10.1 10.7 11.3 12.0 12.8 13.7 14.8 16.0 17.5 19.2 21.3 24.0 27.4 32.0 38.4 48.0 64.0 96.0 192 960 
>A' 9.5 10.0 10.6 11.2 11.9 12.7 13.6 14.6 15.8 17.3 19.0 21.1 23.8 27.1 31.7 38.0 47.5 63.3 95.0 190 950 
>D' 9.4 9.9 10.4 11.1 11.8 12.5 13.4 14.5 15.7 17.1 18.8 20.9 23.5 26.9 31.3 37.6 47.0 62.7 94.0 188 940 
>C' 9.3 9.8 10.3 10.9 11.6 12.4 13.3 14.3 15.5 16.9 18.6 20.7 23.3 26.6 31.0 37.2 46.5 62.0 93.0 186 930 
>B' 9.2 9.7 10.2 10.8 11.5 12.3 13.1 14.2 15.3 16.7 18.4 20.4 23.0 26.3 30.7 36.8 46.0 61.3 92.0 184 920 
>(' 9.1 9.6 10.1 10.7 11.4 12.1 13.0 14.0 15.2 16.5 18.2 20.2 22.8 26.0 30.3 36.4 45.5 60.7 91.0 182 910 
>?' 9.0 9.5 10.0 10.6 11.3 12.0 12.9 13.8 15.0 16.4 18.0 20.0 22.5 25.7 30.0 36.0 45.0 60.0 90.0 180 900 
G>' 8.9 9.4 9.9 10.5 11.1 11.9 12.7 13.7 14.8 16.2 17.8 19.8 22.3 25.4 29.7 35.6 44.5 59.3 89.0 178 890 
GG' 8.8 9.3 9.8 10.4 11.0 11.7 12.6 13.5 14.7 16.0 17.6 19.6 22.0 25.1 29.3 35.2 44.0 58.7 88.0 176 880 
GF' 8.7 9.2 9.7 10.2 10.9 11.6 12.4 13.4 14.5 15.8 17.4 19.3 21.8 24.9 29.0 34.8 43.5 58.0 87.0 174 870 
GE' 8.6 9.1 9.6 10.1 10.8 11.5 12.3 13.2 14.3 15.6 17.2 19.1 21.5 24.6 28.7 34.4 43.0 57.3 86.0 172 860 
GA' 8.5 8.9 9.4 10.0 10.6 11.3 12.1 13.1 14.2 15.5 17.0 18.9 21.3 24.3 28.3 34.0 42.5 56.7 85.0 170 850 
GD' 8.4 8.8 9.3 9.9 10.5 11.2 12.0 12.9 14.0 15.3 16.8 18.7 21.0 24.0 28.0 33.6 42.0 56.0 84.0 168 840 
GC' 8.3 8.7 9.2 9.8 10.4 11.1 11.9 12.8 13.8 15.1 16.6 18.4 20.8 23.7 27.7 33.2 41.5 55.3 83.0 166 830 
GB' 8.2 8.6 9.1 9.6 10.3 10.9 11.7 12.6 13.7 14.9 16.4 18.2 20.5 23.4 27.3 32.8 41.0 54.7 82.0 164 820 
G(' 8.1 8.5 9.0 9.5 10.1 10.8 11.6 12.5 13.5 14.7 16.2 18.0 20.3 23.1 27.0 32.4 40.5 54.0 81.0 162 810 
G?' 8.0 8.4 8.9 9.4 10.0 10.7 11.4 12.3 13.3 14.5 16.0 17.8 20.0 22.9 26.7 32.0 40.0 53.3 80.0 160 800 
F>' 7.9 8.3 8.8 9.3 9.9 10.5 11.3 12.2 13.2 14.4 15.8 17.6 19.8 22.6 26.3 31.6 39.5 52.7 79.0 158 790 
FG' 7.8 8.2 8.7 9.2 9.8 10.4 11.1 12.0 13.0 14.2 15.6 17.3 19.5 22.3 26.0 31.2 39.0 52.0 78.0 156 780 
FF' 7.7 8.1 8.6 9.1 9.6 10.3 11.0 11.8 12.8 14.0 15.4 17.1 19.3 22.0 25.7 30.8 38.5 51.3 77.0 154 770 
FE' 7.6 8.0 8.4 8.9 9.5 10.1 10.9 11.7 12.7 13.8 15.2 16.9 19.0 21.7 25.3 30.4 38.0 50.7 76.0 152 760 
FA' 7.5 7.9 8.3 8.8 9.4 10.0 10.7 11.5 12.5 13.6 15.0 16.7 18.8 21.4 25.0 30.0 37.5 50.0 75.0 150 750 
FD' 7.4 7.8 8.2 8.7 9.3 9.9 10.6 11.4 12.3 13.5 14.8 16.4 18.5 21.1 24.7 29.6 37.0 49.3 74.0 148 740 
FC' 7.3 7.7 8.1 8.6 9.1 9.7 10.4 11.2 12.2 13.3 14.6 16.2 18.3 20.9 24.3 29.2 36.5 48.7 73.0 146 730 
FB' 7.2 7.6 8.0 8.5 9.0 9.6 10.3 11.1 12.0 13.1 14.4 16.0 18.0 20.6 24.0 28.8 36.0 48.0 72.0 144 720 
F(' 7.1 7.5 7.9 8.4 8.9 9.5 10.1 10.9 11.8 12.9 14.2 15.8 17.8 20.3 23.7 28.4 35.5 47.3 71.0 142 710 
F?' 7.0 7.4 7.8 8.2 8.8 9.3 10.0 10.8 11.7 12.7 14.0 15.6 17.5 20.0 23.3 28.0 35.0 46.7 70.0 140 700 
E>' 6.9 7.3 7.7 8.1 8.6 9.2 9.9 10.6 11.5 12.5 13.8 15.3 17.3 19.7 23.0 27.6 34.5 46.0 69.0 138 690 
EG' 6.8 7.2 7.6 8.0 8.5 9.1 9.7 10.5 11.3 12.4 13.6 15.1 17.0 19.4 22.7 27.2 34.0 45.3 68.0 136 680 
EF' 6.7 7.1 7.4 7.9 8.4 8.9 9.6 10.3 11.2 12.2 13.4 14.9 16.8 19.1 22.3 26.8 33.5 44.7 67.0 134 670 
EE' 6.6 6.9 7.3 7.8 8.3 8.8 9.4 10.2 11.0 12.0 13.2 14.7 16.5 18.9 22.0 26.4 33.0 44.0 66.0 132 660 
EA' 6.5 6.8 7.2 7.6 8.1 8.7 9.3 10.0 10.8 11.8 13.0 14.4 16.3 18.6 21.7 26.0 32.5 43.3 65.0 130 650 
ED' 6.4 6.7 7.1 7.5 8.0 8.5 9.1 9.8 10.7 11.6 12.8 14.2 16.0 18.3 21.3 25.6 32.0 42.7 64.0 128 640 
EC' 6.3 6.6 7.0 7.4 7.9 8.4 9.0 9.7 10.5 11.5 12.6 14.0 15.8 18.0 21.0 25.2 31.5 42.0 63.0 126 630 
EB' 6.2 6.5 6.9 7.3 7.8 8.3 8.9 9.5 10.3 11.3 12.4 13.8 15.5 17.7 20.7 24.8 31.0 41.3 62.0 124 620 
E(' 6.1 6.4 6.8 7.2 7.6 8.1 8.7 9.4 10.2 11.1 12.2 13.6 15.3 17.4 20.3 24.4 30.5 40.7 61.0 122 610 
E?' 6.0 6.3 6.7 7.1 7.5 8.0 8.6 9.2 10.0 10.9 12.0 13.3 15.0 17.1 20.0 24.0 30.0 40.0 60.0 120 600 
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Likelihood ratio of a negative test result (LRH) as function of diagnostic sensitivity (DSe) and specificity 
(DSp). LR* was computed as (1*DSe) / DSp. 
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>>@>' .001 .001 .001 .001 .001 .001 .001 .001 .001 .001 .001 .001 .001 .001 .001 .001 .001 .001 .001 .001 .001 
>>' .011 .011 .011 .011 .011 .011 .011 .011 .011 .011 .011 .010 .010 .010 .010 .010 .010 .010 .010 .010 .010 
>G' .022 .022 .022 .022 .022 .022 .022 .021 .021 .021 .021 .021 .021 .021 .021 .021 .020 .020 .020 .020 .020 
>F' .033 .033 .033 .033 .033 .032 .032 .032 .032 .032 .032 .031 .031 .031 .031 .031 .031 .030 .030 .030 .030 
>E' .044 .044 .044 .044 .043 .043 .043 .043 .043 .042 .042 .042 .042 .041 .041 .041 .041 .041 .040 .040 .040 
>A' .056 .055 .055 .055 .054 .054 .054 .053 .053 .053 .053 .052 .052 .052 .052 .051 .051 .051 .051 .050 .050 
>D' .067 .066 .066 .066 .065 .065 .065 .064 .064 .063 .063 .063 .063 .062 .062 .062 .061 .061 .061 .060 .060 
>C' .078 .077 .077 .077 .076 .076 .075 .075 .074 .074 .074 .073 .073 .073 .072 .072 .071 .071 .071 .070 .070 
>B' .089 .088 .088 .087 .087 .086 .086 .086 .085 .085 .084 .084 .083 .083 .082 .082 .082 .081 .081 .080 .080 
>(' .100 .099 .099 .098 .098 .097 .097 .096 .096 .095 .095 .094 .094 .093 .093 .092 .092 .091 .091 .090 .090 
>?' .111 .110 .110 .109 .109 .108 .108 .107 .106 .106 .105 .105 .104 .104 .103 .103 .102 .102 .101 .101 .100 
G>' .122 .122 .121 .120 .120 .119 .118 .118 .117 .116 .116 .115 .115 .114 .113 .113 .112 .112 .111 .111 .110 
GG' .133 .133 .132 .131 .130 .130 .129 .128 .128 .127 .126 .126 .125 .124 .124 .123 .122 .122 .121 .121 .120 
GF' .144 .144 .143 .142 .141 .141 .140 .139 .138 .138 .137 .136 .135 .135 .134 .133 .133 .132 .131 .131 .130 
GE' .156 .155 .154 .153 .152 .151 .151 .150 .149 .148 .147 .147 .146 .145 .144 .144 .143 .142 .141 .141 .140 
GA' .167 .166 .165 .164 .163 .162 .161 .160 .160 .159 .158 .157 .156 .155 .155 .154 .153 .152 .152 .151 .150 
GD' .178 .177 .176 .175 .174 .173 .172 .171 .170 .169 .168 .168 .167 .166 .165 .164 .163 .162 .162 .161 .160 
GC' .189 .188 .187 .186 .185 .184 .183 .182 .181 .180 .179 .178 .177 .176 .175 .174 .173 .173 .172 .171 .170 
GB' .200 .199 .198 .197 .196 .195 .194 .193 .191 .190 .189 .188 .188 .187 .186 .185 .184 .183 .182 .181 .180 
G(' .211 .210 .209 .208 .207 .205 .204 .203 .202 .201 .200 .199 .198 .197 .196 .195 .194 .193 .192 .191 .190 
G?' .222 .221 .220 .219 .217 .216 .215 .214 .213 .212 .211 .209 .208 .207 .206 .205 .204 .203 .202 .201 .200 
F>' .233 .232 .231 .230 .228 .227 .226 .225 .223 .222 .221 .220 .219 .218 .216 .215 .214 .213 .212 .211 .210 
FG' .244 .243 .242 .240 .239 .238 .237 .235 .234 .233 .232 .230 .229 .228 .227 .226 .224 .223 .222 .221 .220 
FF' .256 .254 .253 .251 .250 .249 .247 .246 .245 .243 .242 .241 .240 .238 .237 .236 .235 .234 .232 .231 .230 
FE' .267 .265 .264 .262 .261 .259 .258 .257 .255 .254 .253 .251 .250 .249 .247 .246 .245 .244 .242 .241 .240 
FA' .278 .276 .275 .273 .272 .270 .269 .267 .266 .265 .263 .262 .260 .259 .258 .256 .255 .254 .253 .251 .250 
FD' .289 .287 .286 .284 .283 .281 .280 .278 .277 .275 .274 .272 .271 .269 .268 .267 .265 .264 .263 .261 .260 
FC' .300 .298 .297 .295 .293 .292 .290 .289 .287 .286 .284 .283 .281 .280 .278 .277 .276 .274 .273 .271 .270 
FB' .311 .309 .308 .306 .304 .303 .301 .299 .298 .296 .295 .293 .292 .290 .289 .287 .286 .284 .283 .281 .280 
F(' .322 .320 .319 .317 .315 .314 .312 .310 .309 .307 .305 .304 .302 .301 .299 .297 .296 .294 .293 .291 .290 
F?' .333 .331 .330 .328 .326 .324 .323 .321 .319 .317 .316 .314 .313 .311 .309 .308 .306 .305 .303 .302 .300 
E>' .344 .343 .341 .339 .337 .335 .333 .332 .330 .328 .326 .325 .323 .321 .320 .318 .316 .315 .313 .312 .310 
EG' .356 .354 .352 .350 .348 .346 .344 .342 .340 .339 .337 .335 .333 .332 .330 .328 .327 .325 .323 .322 .320 
EF' .367 .365 .363 .361 .359 .357 .355 .353 .351 .349 .347 .346 .344 .342 .340 .338 .337 .335 .333 .332 .330 
EE' .378 .376 .374 .372 .370 .368 .366 .364 .362 .360 .358 .356 .354 .352 .351 .349 .347 .345 .343 .342 .340 
EA' .389 .387 .385 .383 .380 .378 .376 .374 .372 .370 .368 .366 .365 .363 .361 .359 .357 .355 .354 .352 .350 
ED' .400 .398 .396 .393 .391 .389 .387 .385 .383 .381 .379 .377 .375 .373 .371 .369 .367 .365 .364 .362 .360 
EC' .411 .409 .407 .404 .402 .400 .398 .396 .394 .392 .389 .387 .385 .383 .381 .379 .378 .376 .374 .372 .370 
EB' .422 .420 .418 .415 .413 .411 .409 .406 .404 .402 .400 .398 .396 .394 .392 .390 .388 .386 .384 .382 .380 
E(' .433 .431 .429 .426 .424 .422 .419 .417 .415 .413 .411 .408 .406 .404 .402 .400 .398 .396 .394 .392 .390 
E?' .444 .442 .440 .437 .435 .432 .430 .428 .426 .423 .421 .419 .417 .415 .412 .410 .408 .406 .404 .402 .400 
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Component of the computation for the Cohen’s Kappa coefficient. 
'
 !!"#$%&'D 
 
Sample size required to estimate diagnostic sensitivity (or specificity) when the true status is known (adapted from Flahaut et 
al., 2005). For an expected DSe (or DSp), the table gives the number of infected/diseased samples required to estimate with a 
probability of 95% (1 – β) that DSe is at least higher than a defined value DSemin (i.e. lower bound of the confidence interval) with a 
minimum confidence level of 95% (one sided, 1 H α). 
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In the appropriate settings, the study population contains a mix of nonH and infected/diseased individuals. Assuming the studied population 
prevalence (Pr), the required number of nonHinfected/nonHdiseased can thereafter be computed as follows: nNI = nI * (1*Pr) / Pr 
 
Exemple: when DSe is expected to be 0.9 with in a minimum DSemin of 0.75, the sample size requires 65 infected/diseased individuals and 
260 nonHinfected/nonHdiseased if the assumed prevalence is 20% in the population.
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Latent Class Model mechanic for 2 tests and 2 populations 
 
Contingency table of the 2 tests results for Population 1 
 
Population k =1 Test2=1 Test2=0 
Test1=1 P111   P101 
Test1=0 P111   P101 
 
Contingency table of the 2 tests results for Population 1 
 
Population k =2 Test2=1 Test2=0 
Test1=1 P112   P102 
Test1=0 P112   P102 
 
 
The degree of freedom for each table is 3 since it can be deduce from 3 cells probability the 
fourth one. Therefore, for each population, only 3 essential information are provided by the 
data.  
 
Let’s defined Pijk the observed probability of a Test 1 result (i) and a Test 2 result (j) in the 
population k: 
 
→ Pijk = Prob(i,j | Popk)  
An individual from the population k that yield a test result combination (i,j) and can either be 
diseased (D+) or not (D*), therefore: 
 
↔ Pijk = Prob(i,j ∩ D+| Popk) + Prob(i,j ∩ D*| Popk)  
 
According to the Bayes theorem: 
 
↔Pijk = Prob(D+, Popk) Prob(i,j |D+, Popk) + Prob(D*, Popk) Prob(i,j |D*, Popk) 
 
Where Prob(D+, Popk)= Prk (prevalence in population k) and Prob(DH, Popk) = 1H Prk 
 
↔Pijk = Prk Prob(i,j |D+, Popk) + (1*Prk) Prob(i,j |D*, Popk) 
 
Assuming the probability of testing i in Test1 is independent of the probability of testing j in 
Test2 conditional on the disease status (()*'-))J,6*+/4): 
 
→Pijk = Prk Prob(i|D+, Popk) Prob(j|D+, Popk) + (1*Prk) Prob(i|D*, Popk) Prob(j|D*, Popk)  
 
 
For i (or j) = 1 (positive), Prob(1|D+, Popk) = DSek and Prob(0|D+, Popk) = (1HDSek) 
For i (or j) = 0 (negative), Prob(1|D+, Popk) = (1HDSpk) and Prob(0|D+, Popk) = DSpk 
 
Therefore, we can express P for 4 combinations of the two tests results: 
 
→P11k = DSe1,k DSe2,k Prk + (1*DSe1,k)(1*DSe2,k) (1*Prk) →P10k = DSe1,k (1*DSe2,k)Prk + (1*DSe1,k)(1*DSe2,k) (1*Prk) →P01k = DSe1,k DSe2,k Prk + (1*DSe1,k)(1*DSe2,k) (1*Prk) →P00k = DSe1,k DSe2,k Prk + (1*DSe1,k)(1*DSe2,k) (1*Prk) 
 
For a single population k, we need to estimate 5 parameters (i.e. DSe & DSp of each test & 
the prevalence) from 3 equations. As previously mentioned, only 3 of the observed 
proportions are useful since the fourth can be deduced from the 3 others (free of 
dependence). Therefore, the dataset degree of freedom is smaller than the number of 
parameter and the model is not identifiable. 
 
If a second population is added, the degree of freedom doubles (6) and equals the number of 
parameter only increased by one (i.e. different prevalence in the second population). 
Therefore, it is required at least 2 populations and 2 tests for the model to be, in theory, 
identifiable (B42'-))J,6*+/4). Furthermore, it is also essential to assume that DSe and DSp 
of both tests are constant across the two populations (CK2'-))J,6*+/4). 
 
 
In summary, basic LCM mechanism requires 3 assumptions: 
 
8+: Tests are independent conditional on the disease status 
 
8++: A minimum of 2 tests run on the same samples from at least 2 populations of 
different prevalences 
 
8+++: Test operating characteristics (DSE/DSp) are constant across populations 
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Using PGS definition for fish classification, these graphs predict descriptive estimated repeatability of ISAV RTHPCR within the reference laboratory for nonH
homogenized and homogenized sample ; and reproducibility for nonHhomogenized and homogenized sample as a function of prevalence of infection and 
proportion of lowH (vs. highH) infected among all infected fish. Filled circle represent the originally observed estimates under the same testing conditions. 
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Using StrictHPGS definition for fish classification, these graphs predict descriptive estimated repeatability of ISAV RTHPCR within the reference laboratory for 
nonHhomogenized and homogenized sample ; and reproducibility for nonHhomogenized and homogenized sample as a function of prevalence of infection and 
proportion of lowH (vs. highH) infected among all infected fish. Filled circle represent the originally observed estimates under the same testing conditions. 
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Using LenientHPGS definition for fish classification, these graphs predict descriptive estimated repeatability of ISAV RTHPCR within the reference laboratory for 
nonHhomogenized and homogenized sample ; and reproducibility for nonHhomogenized and homogenized sample as a function of prevalence of infection and 
proportion of lowH (vs. highH) infected among all infected fish. Filled circle represent the originally observed estimates under the same testing conditions. 
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Using PGS definition for fish classification, these graphs predict descriptive chance repeatability of ISAV RTHPCR within the reference laboratory for nonH
homogenized and homogenized sample ; and reproducibility for nonHhomogenized and homogenized sample as a function of prevalence of infection and 
proportion of lowH (vs. highH) infected among all infected fish. Filled circle represent the originally observed estimates under the same testing conditions. 
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Using StrictHPGS definition for fish classification, these graphs predict descriptive chance repeatability of ISAV RTHPCR within the reference laboratory for nonH
homogenized and homogenized sample ; and reproducibility for nonHhomogenized and homogenized sample as a function of prevalence of infection and 
proportion of lowH (vs. highH) infected among all infected fish. Filled circle represent the originally observed estimates under the same testing conditions. 
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Using LenientHPGS definition for fish classification, these graphs predict descriptive chance repeatability of ISAV RTHPCR within the reference laboratory for 
nonHhomogenized and homogenized sample ; and reproducibility for nonHhomogenized and homogenized sample as a function of prevalence of infection and 
proportion of lowH (vs. highH) infected among all infected fish. Filled circle represent the originally observed estimates under the same testing conditions. 
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Using PGS definition for fish classification, these graphs predict descriptive Cohen’s Kappa values of ISAV RTHPCR within the reference laboratory for nonH
homogenized and homogenized sample ; and among laboratories for nonHhomogenized and homogenized sample as a function of prevalence of infection and 
proportion of lowH (vs. highH) infected among all infected fish. Filled circle represent the originally observed estimates under the same testing conditions. 
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Using StrictHPGS definition for fish classification, these graphs predict descriptive Cohen’s Kappa values of ISAV RTHPCR within the reference laboratory for 
nonHhomogenized and homogenized sample ; and among laboratories for nonHhomogenized and homogenized sample as a function of prevalence of infection and 
proportion of lowH (vs. highH) infected among all infected fish. Filled circle represent the originally observed estimates under the same testing conditions. 
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Using LenientHPGS definition for fish classification, these graphs predict descriptive Cohen’s Kappa values of ISAV RTHPCR within the reference laboratory for 
nonHhomogenized and homogenized sample ; and among laboratories for nonHhomogenized and homogenized sample as a function of prevalence of infection and 
proportion of lowH (vs. highH) infected among all infected fish. Filled circle represent the originally observed estimates under the same testing conditions. 
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Validity of the assumption of constant DSe and DSp to predict agreement across prevalences 
 
 Prediction of agreement assumed that agreement within each infection categories was constant 
and that test performances did not depend on the factors varying across populations. Although, it is 
commonly accepted that DSp (or DSe) are constant parameters within each infection category and do not 
vary with population factors such as prevalence, various studies have challenged this postulate (e.g. 
Leeflang et al., 2009). Indeed, it is reasonable to think that when the prevalence of infection increases in a 
population, the proportion of advanced stages of infection also increases (Greiner & Gardner, 2000). It is 
also reasonable to assume that DSe will be greater in advanced stages compared to earlier stage of 
infection (Begg, 1987). Therefore, DSe and agreement in infected individuals may vary across 
prevalences. Furthermore, it is reasonable to think that test performance in NI individuals (DSp) is 
dependent on the pressure of crossHcontamination from infected samples or/and positive controls. As the 
proportion of infected in the sampled population (prevalence) and/or the tested sample pool becomes 
larger, the pressure and chance of crossHcontamination likely becomes greater. Therefore, DSp and 
agreement in nonHinfected individuals may also vary across prevalence groups.  
 The validity of these assumptions may introduce estimation bias for predicted agreement. For 
instance, agreement predicted for only NI fish (0% prevalence) may have been underestimated since 
agreement estimation within NI fish derived from a sample pool of 48% assumed prevalence 
corresponding to a much stronger pressure of crossHcontamination. For instance, during a screening 
program, prevalence and associated contamination pressure are expected to be low and subsequently DSp 
and agreement to be higher. Assumption of constant performance within infection categories might not be 
appropriate and requires further investigation to estimate the degree of dependence between agreement 
and prevalence. If strong dependence of DSe and DSp with prevalence is confirmed, variation of DSe and 
DSp can be predicted from prevalence as illustrated by Brenner & Gefeller (1997). For instance, DSe and 
DSp could be assessed for a 50% prevalence population and predicted across prevalences using 
information about population infection distribution (e.g. normal, bimodal). The constructed equation 
between DSe (or DSp) and prevalence can thereafter be directly included in Eqs. (2), (5) and (6). 
However, no information on the spectrum of ISAV loads across prevalences is yet available. By 
separating LI and HI fish, we intended to alleviate the dependence of DSe on prevalence, conditional on 
the assumption of constant DSe within each of the two subHcategories of infected salmon. Conversely, no 
subHclassification of NI fish was achievable and dependence of DSp on prevalence would have to be 
further investigated to refine the prediction of agreement in this infection category.  
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Count per combination of test result of the five studied assays in each of the 4 prevalence level 
populations (low, mild, moderate, high). Studied assays included in the order: reverseH
transcriptase polymerase chain reaction (RTHPCR), realHtime RTHPCR (qRTHPCR), virus 
isolation (VI), indirect fluorescent antibody test (IFAT), lateral flow immunoassay (LFI). 
 
Test result combination 
(RT-PCR, qRT-PCR, VI, IFAT, LFI) 
Low 
Prevalence 
Mild  
Prevalence 
Moderate 
Prevalence 
High  
Prevalence Total 
      
11111 0 0 0 31 31 
11110 0 0 0 0 0 
11101 0 0 0 6 6 
11100 0 0 0 10 10 
11011 0 0 0 5 5 
11010 0 0 1 0 1 
11001 0 0 0 0 0 
11000 0 0 35 4 39 
10111 0 0 0 0 0 
10110 0 0 0 0 0 
10101 0 0 0 0 0 
10100 0 0 0 1 1 
10011 0 0 0 0 0 
10010 0 0 0 0 0 
10001 0 0 0 0 0 
10000 3 0 10 3 16 
01111 0 0 0 0 0 
01110 0 0 0 0 0 
01101 0 0 0 0 0 
01100 0 0 0 0 0 
01011 0 0 0 0 0 
01010 0 0 0 0 0 
01001 0 0 0 0 0 
01000 3 0 11 6 20 
00111 0 0 0 0 0 
00110 0 0 0 0 0 
00101 0 0 0 0 0 
00100 0 1 0 8 9 
00011 0 0 0 0 0 
00010 0 1 0 0 1 
00001 0 0 0 0 0 
00000 94 128 13 26 261 
Total 100 130 70 100 400 
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WinBUGS code for fitting a threeHlatent classes model with 4 populations and 5 tests with dependence among two pairs of tests (1&2 and 
3&4), including the computation of the Bayesian pHvalue. 
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